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Part I
Summary

”In part because individual judgment is not accurate enough or
consistent enough, cognitive diversity is essential to good decision
making.”
James Surowiecki
Our daily lives consist of a constant stream of decisions. These decisions may af-
fect only oneself, but often they affect other people as well. Substantial progress
has recently been made in the understanding of the neuroscientific aspects of com-
plex human decision making processes on both the individual and the social level.
While these advancements are substantially driven by the recent merging of the
two disciplines neurosciences and economics, neuroeconomic research has mostly
provided correlative data. To overcome the limitations of mere correlation stud-
ies, the present thesis offers three experiments that employ neuromodulatory ap-
proaches for investigating the causal relationship between neurobiological systems
and aspects of human decision making.
The theoretical part of this thesis outlines the framework in which human deci-
sion making will be investigated (Chapter 1) and presents the neuromodulatory
approaches that will be employed (Chapter 2). Separate sections describe the ad-
vantages and also the limitations of the different methods. Based on these theoret-
ical considerations, the experiments described in the empirical part use neurostim-
ulation, neuropharmacological and neuroendocrinological approaches to modulate
individual and social decision making, respectively (Chapters 3−5). Each chapter
closes with critical comments on the main findings. Considerations regarding the
contents and methodology and its putative impact on future studies are provided.
With respect to neurostimulation, a methodological study (Chapter 3) will be pre-
sented that investigates the neurophysiological after-effects of low frequency ”off-
line” repetitive transcranial magnetic stimulation applied to the right dorsolateral
prefrontal cortex, a brain region which is critically involved in decision making
processes. The ”off-line” stimulation protocol has recently received much interest
as research tool due to its ability to transiently disrupt normal brain function of
the stimulated area. The disruptive effects outlast the stimulation train, however,
the duration and effects on remote connected brain regions are unknown. Using
sequential H215O positron emission tomography scans, we found that regional cere-
bral blood flow was increased immediately after stimulation, mainly in the dorso-
lateral and ventrolateral prefrontal cortex. These changes were restricted to the
ipsilateral side and returned to baseline within nine minutes.
xi
On the neuropharmacological level, the study presented in Chapter 4 describes the
causal manipulation of individual decision making behavior using the dopamine
precursor L-dihydroxphenylalanine (L-DOPA). Previous evidence suggests that a
subgroup of patients suffering from Parkinson’s disease develop pathological gam-
bling after initiation of L-DOPA therapy. Using a pharmacogenetic approach, we
showed that L-DOPA or placebo administration to healthy young males increases
gambling behavior conditional on the dopamine D4 receptor gene. Specifically,
we found that subjects who carry at least one copy of the 7 repeats allele of the
dopamine receptor D4 variable number tandem repeat polymorphism show an in-
creased propensity to gamble after dopamine modulation.
On the neuroendocrinological level, the study presented in Chapter 5 offers data on
the causal influence of testosterone (TE) administration on social decision making
in healthy women. We showed that TE administration is associated with a sub-
stantial increase in fair bargaining behavior in the Ultimatum Game in humans,
thereby greatly reducing bargaining conflicts and increasing the efficiency of social
interactions. Moreover, we showed that beliefs about TE treatment also had a major
impact on bargaining behavior: subjects who merely believed that they received TE
regardless of whether they actually received it or not behaved much more selfishly
during bargaining compared to those who believed they were treated with placebo.
In summary, the present thesis shows experimental evidence that the neuroeco-
nomic approach is valuable to investigate causal relationships between neurobio-
logical systems and individual as well as social human decision making. Further-
more, the data presented in this thesis suggest that neurostimulation is useful to
investigate the causal role of prefrontal brain regions in decision making. The find-
ings presented in this thesis may have potential applications for a variety of psy-
chiatric and neurological diseases such as addiction, depression and Parkinson’s
disease. Moreover, the data may stimulate future research in neuroeconomics, neu-
roendocrinology and neuropsychopharmacology.
xii
Part II
Zusammenfassung

Wir faellen taeglich eine grosse Zahl an Entscheidungen. Diese Entscheidungen
betreffen manchmal nur einen selbst, aber haeufig betreffen sie auch andere Per-
sonen. Vor kurzem sind entscheidende Fortschritte im Verstehen der neurowis-
senschaftlichen Aspekte von komplizierten menschlichen Entscheidungsprozessen
sowohl auf der individuellen als auch auf der sozialen Ebene gemacht worden.
Waehrend diese Fortschritte vor allem durch die Kombination der beiden Diszi-
plinen Neurowissenschaften und Oekonomie vorangetrieben wurden, wurden in
der daraus resultierenden interdisziplinaeren Forschungsrichtung, der Neurooeko-
nomie, bisher vor allem korrelative Studien durchgefuehrt. Die vorliegende Disser-
tation praesentiert drei Experimente, die neuromodulatorische Ansaetze verwen-
den, um die kausale Beziehung zwischen neurobiologischen Systemen und Aspek-
ten der menschlichen Entscheidungsfindung zu untersuchen. Der theoretische Teil
dieser Dissertation beschreibt den Rahmen, in welchem menschliches Entschei-
dungsverhalten (Kapitel 1) untersucht werden soll und die neuromodulatorischen
Methoden, die zur Anwendung kommen (Kapitel 2). Mehrere Abschnitte beschrei-
ben die Vorteile und auch die Nachteile der verschiedenen Methoden. Basierend
auf diesen theoretischen Ueberlegungen werden im empirischen Teil Experimente
beschrieben, die Neurostimulation, neuropharmakologische sowohl als auch neu-
roendokrinologische Ansaetze verwenden, um individuelle und soziale Entschei-
dungsfindung zu untersuchen (Kapitel 3 − 5). Jedes Kapitel schliesst mit kritis-
chen Kommentaren zu den Hauptergebnissen, sowohl auf der inhaltlichen als auch
auf der methodischen Ebene. Ausserdem werden moegliche zukuenftige Studien
diskutiert.
Im Bezug auf die Neurostimulation wird eine methodologische Studie (Kapitel 3)
vorgestellt, die die neurophysiologischen Auswirkungen von ”off-line” repetitiver
transkranieller Magnetstimulation (rTMS) des rechten dorsolateralen praefronta-
len Kortex untersucht. Dieses Hirnareal spielt eine wichtige Rolle bei Entscheid-
ungsprozessen. Beim ”off-line” Stimulationsprotokoll wird fuer eine gewisse Zeit
rTMS bei niedriger Frequenz ueber einem Hirnareal appliziert, was zur Folge hat,
dass die normale Gehirnfunktion in diesem Areal voruebergehend gestoert wird.
Obwohl die Effekte von niedrig-Frequenz rTMS normalerweise ueber die Dauer der
Stimulation hinausgehen, ist nach wie vor unklar, wie lange diese Effekte andauern
und welche Areale, die mit dem stimulierten Hirnareal verbunden sind, beein-
flusst werden. Mittels funktioneller Bildgebung (H215O-Positronen-Emissionstomo-
graphie) konnten wir zeigen, dass die regionale Hirndurchblutung unmittelbar
nach der Stimulation hauptsaechlich im dorsolateralen und ventrolateralen prae-
frontalen Kortex ansteigt. Diese Veraenderungen waren auf die ipsilaterale Seite
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beschraenkt und kehrten innerhalb von neun Minuten auf die Ausgangswerte zu-
rueck. Auf der neuropharmakologischen Ebene wird im Kapitel 4 eine Studie
beschrieben, die die kausale Manipulation von individuellem Entscheidungsver-
halten mittels der Verabreichung einer der biochemischen Vorstufen von Dopamin,
L-Dihydroxy-phenylalanin (L-DOPA), zeigt. Bisherige Evidenz weist darauf hin,
dass eine Untergruppe von Patienten die an der Parkinson’schen Krankheit leiden,
nach Beginn der L-DOPA Therapie eine Spielsucht entwickelt. Mittels eines phar-
makogenetischen Ansatzes konnten wir zeigen, dass die Verhaltenseffekte nach
Verabreichung von L-DOPA oder einem Plazebo bei gesunden jungen Maennern
davon abhaengen, welche Variante sie vom Dopamin D4 Rezeptor-Gen haben. Es
hat sich herausgestellt, dass Versuchspersonen die mindestens eine Kopie des 7R
Allels des Dopamin Rezeptor D4 variable number tandem repeat Polymorphismus
tragen, eine erhoehte Neigung zum Spielverhalten zeigten.
Auf der neuroendokrinologischen Ebene zeigt die Studie die im Kapitel 5 vorgestellt
wird Daten ueber den kausalen Einfluss von Testosteron (TE) Verabreichung auf
soziales Entscheidungsverhalten bei gesunden jungen Frauen. In dieser Studie
konnten zeigen, dass die Verabreichung von TE mit einer Zunahme an fairen Ange-
boten bei proposern im Ultimatum-Spiel fuehrt. Dies resultierte in einer Reduk-
tion von Verhandlungskonflikten und ging somit mit einer erhoehten Effizienz des
Verhandlungsprozesses einher. Ausserdem konnten wir zeigen, dass ein grosser
Teil des Verhandlungsverhaltens dadurch bestimmt war, was die Versuchsperso-
nen bezueglich TE glaubten: Diejenigen, welche glaubten, dass sie TE erhielten,
unabhaengig davon, ob sie auch tatsaechlich TE gekriegt haben, haben sich viel
egoistischer verhalten im Vergleich zu denjenigen, die glaubten, dass sie Plazebo
erhalten haben.
Zusammenfassend zeigt die gegenwaertige Dissertation experimentelle Evidenz,
dass im Rahmen des neurooekonomischen Ansatzes auch kausale Beziehungen
zwischen neurobiologischen Systemen und dem individuellen sowie dem sozialen
Entscheidungsverhalten moeglich sind. Ausserdem weist die in dieser Dissertation
praesentierte Evidenz darauf hin, dass Neurostimulation eine nuetzliche Meth-
ode ist, um die kausale Rolle von praefrontalen Hirnarealen im Entscheidungsver-
halten zu untersuchen. Mglicherweise haben die in dieser Dissertation praesen-
tierten Ergebnisse potenzielle Anwendungen fuer eine Vielfalt von psychiatrischen
und neurologischen Krankheiten wie Sucht, Depression und fuer die Therapie der
Parkinson’schen Krankheit. Ausserdem werden die Resultate womoeglich auch
zukuenftige Forschung im Bereiche der Neurooekonomie, Neuroendokrinologie und
Neuropsychopharmakologie inspirieren.
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Part III
Theoretical Part

Chapter 1
Introduction to the topic
The study of human decision making attempts to understand the fundamental abil-
ity to process multiple choice options and to choose an optimal course of action. De-
cision making refers to the process of selecting one out of several options based on
how much reward or punishment each option will bring, on the needs of the decision
maker and if learning is involved, on previous experience with the outcomes of the
respective options [Doya, 2008]. The recent merging of the two disciplines, neuro-
science and economics, has fuelled research on the neurobiological aspects of human
decision making. The resulting interdisciplinary research field is termed ”neuroe-
conomics”, although it is largely informed by findings from sociology, social psychol-
ogy, cognitive and neuropsychology. It is therefore often difficult to draw a sharp
line between neuroeconomics and social neuroscience, which is a more comprehen-
sive attempt to understand the reciprocal association between social behaviour and
neurobiological processes [Cacioppo and Berntson, 2002]. A defining feature of neu-
roeconomic experiments, including the ones presented in Chapters 4 and 5, is the
use of monetary incentives to quantify how much an individual subjectively values
an outcome of a chosen option. These options are usually presented in the form of
paradigms involving one decision maker or many simultaneously interacting deci-
sion makers. During individual decision making, the decision maker is confronted
with a set of choice options that may include choices between monetary gambles
with clearly defined probabilities and outcomes (referred to decision making under
risk), choices between monetary gambles of unknown probabilities (decision mak-
ing under ambiguity) or choices between an immediate, but smaller and a delayed,
but larger payoff (intertemporal choice). These choices will only affect the decision
maker himself. During social decision making, the decision maker is presented with
options that depend also on the decisions of others. Moreover, the decision taken
affects other decision makers as well. Such situations are created in the form of
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simple behavioural tasks derived from experimental economics, in which individ-
uals bargain over money. The standard economic model assumes that individuals
behave in a payoff-maximising manner in such situations. However, since fairness,
reciprocal, status and other motives are inherent to human social behaviour; these
may cause individuals to act in ways that are not profit-maximising. The experi-
mental economics approach allows the assessment of these motives devoid of any
social desirability bias, since interactions are set up anonymously. Moreover, by
using real monetary incentives, motives can be quantitatively assessed. Finally,
deception of the experimental subjects is not allowed for [Hertwig and Ortmann,
2001], i.e. the interacting decision makers should all be present in the laboratory,
when the decisions are taken. The Dictator Game is a well suited paradigm to ex-
emplify the study of social decision making: if a given player A in a dyad receives
a certain amount of money of which he can offer a certain amount to a player B, he
should offer nothing, if he is profit-maximising. Empirical evidence shows, however,
that a significant number of players A offer non-zero amounts to player B, perhaps
due to fairness concerns. From this, one can derive that people are willing to sacri-
fice money because they have non-selfish motives, since it is costly for them to offer
non-zero amounts. Naturally, subjects have to believe that the other interaction
partner is real, simply because there would otherwise be no reason at all for the
players A to offer anything to the players B.
Research into the neurobiology of decision making is largely dominated by correl-
ative studies. Only few studies have used neuromodulatory approaches to inves-
tigate a causal relationship between decision making and the underlying neuro-
biological processes. The three studies presented in this thesis were designed to
address some aspects of this gap of knowledge. Experimental modulations on the
neurochemical, neuroendocrine and neuroanatomical level will be used to study in-
dividual and social decision making, respectively. In particular, a modulation of the
dopaminergic (DAergic) system using a single dose of L-dihydroxyphenylalanine
(L-DOPA) will be employed to investigate risky decision making. A modulation of
the androgen system using a single dose of testosterone (TE) will be used to in-
vestigate social bargaining behaviour. Finally, a neurostimulation approach using
transcranial magnetic stimulation (TMS) is presented which allows experimental
modulation on the anatomical level to investigate aspects of decision making.
Chapter 2
Neuromodulatory approaches to
study decision making
2.1 Brain stimulation
Motivation The investigation of the neuroanatomical correlates of risky decision
making has received considerable attention so far. A large number of neuroimaging
studies revealed brain structures that are activated during risky decision making,
including structures related to behavioural control, such as the lateral prefrontal
cortex (PFC) (mostly right lateralised) and ”reward-related” DAergic brain struc-
tures such as the striatum. However, these studies only provide correlative evi-
dence and fail to show a direct causal link between brain structure and function.
Investigating patients with focal brain lesions can partially overcome the discrep-
ancy between correlation and causation. Patients who suffer from traumatic in-
juries of the PFC exhibit profound problems with behavioural control, including
problems with self-conduct and in making decisions within the context of their ev-
eryday lives [Damasio, 1994]. Moreover, they show an apparent disregard for nega-
tive consequences of their actions [Rahman et al., 2001]. In line with these observa-
tions are the findings in patients with ventrolateral prefrontal cortex (VLPFC) and
orbitofrontal cortex (OFC) lesions who show pronounced risk-seeking behaviour in
various gambling tasks, including the Iowa Gambling Task and the Cambridge
Gamble Task [Clark et al., 2003, Manes et al., 2002, Floden et al., 2008]. Little is
known, however, about functional compensation following brain damage; although
lesions may appear focal, their impact on remote brain regions may be substantial.
This prevents us from transferring observations from the lesioned to the healthy
brain. Moreover, patients with brain lesions often require anti-convulsive medica-
tion, constituting an additional confound. TMS offers a means for overcoming some
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of the limitations of lesion studies. Its ability to disrupt normal function of hu-
man brain transiently makes it a unique tool for studying the causal contribution
of different brain areas to human behaviour, including risk taking behaviour. This
section offers a short review of the use of TMS to study the role of the dorsolat-
eral prefrontal cortex (DLPFC) in risk taking and outlines the questions that arise
from the approach used therein. The study presented in Chapter 3 was designed to
answer some of these questions.
2.1.1 Transcranial magnetic stimulation
TMS is based on the principle of electromagnetic induction and utilises a time-
varying magnetic field to induce electrical currents in conducting tissue [Jalinous,
1991]. The magnetic field is generated when electrical energy with a very high cur-
rent (up to 8000 A) for a duration of approximately 250 µs flows through a wired
coil placed over the scalp. The magnetic flux density can reach up to 2.5 T under
the coil but decays by the square of the distance to the coil. The magnetic field is
oriented perpendicularly to the coil and induces currents which are oriented par-
allel to the plane of the coil. An obvious advantage of TMS is that the magnetic
field passes the skull practically unhindered and can induce electrical currents in
the underlying cortex relatively painlessly. These currents are sufficiently large to
cause depolarisation of neurons and can thus induce action potentials. This acti-
vation can disrupt ongoing processes in neuronal networks. While the application
of single pulse TMS is able to disrupt such a process with a high temporal preci-
sion (approximately 1 ms), the duration of the disruption is also very limited. The
application of temporally ordered repetitive TMS (rTMS) pulses has been shown to
cause a more prolonged disruption of brain function (”virtual lesion”, see section
3.7.2 on page 53) [Robertson et al., 2003]. In cognitive neuroscience, the approach
most frequently used in recent years is to apply a continuous train of low frequency
(1 Hz) rTMS over a given brain region for several min before performing a given
task. This is often referred to as the ”off-line” approach and has the advantage
that it partially eludes the unspecific effects of concurrent rTMS stimulation [Abler
et al., 2005, Pascual-Leone et al., 1998, Robertson et al., 2003].
By applying low frequency rTMS to the right and the left dorsolateral prefrontal
cortices, Knoch et al. [2006a] investigated risky decision making ”off-line” using
the Cambridge Gamble Task [Rogers et al., 1999]. Sham stimulation, which pro-
duces a click, but no magnetic field, served as a control condition. Subjects stimu-
lated over the right DLPFC were more likely to choose the high-risk prospect and
earned significantly less points than those who were either stimulated over the ho-
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mologue contralateral site or received sham stimulation. The authors suggest that
the risk task primarily involves an active suppression of an option that appears
most seductive because of the immediate higher payoffs. Moreover, they suggest
that rTMS suppression of the right, but not the left PFC reduced inhibitory con-
trol, leading to overly risky decision-making. However, this reasoning only applies
if a unilateral stimulation leads to unilateral, and not bilateral neurophysiological
”off-line” effects.
Using the same task, two positron emission tomography (PET) studies suggest that
risky decision making may recruit ventrolateral rather than dorsal aspects of the
PFC [Rogers et al., 1999, Rubinsztein et al., 2001]. Furthermore, the ventrolateral
areas (mostly right-lateralised) of the PFC are traditionally implicated in inhibitory
control functions [Clark et al., 2003]. It is also possible, however, that stimulation
of the DLPFC has indirect effects on the VLPFC via a transsynaptic mechanism.
Evidence for this hypothesis comes from studies using retrograde and anterograde
tracer techniques showing that Brodmann areas (BA) 45/46 and BA47 are inter-
connected in the macaque brain [Petrides and Pandya, 1999]. Hence, the indirect
stimulation of the VLPFC could have accounted for the subjects’ reduced inhibitory
control over choosing the risky, but more seductive options in the study by Knoch
et al. [2006a].
The combination of neuroimaging techniques such as electroencephalography (EEG),
functional magnetic resonance imaging (fMRI) or PET with the ”off-line” rTMS
protocol offers ways to answer these questions. The general idea underlying this
approach is to gain information about whole brain activity over time after the ap-
plication of rTMS to the brain region of interest by comparing it with activity before
stimulation.
The advantage of EEG in probing such effects is that it provides a direct measure
of neuronal activity. It suffers, however, from the relative low spatial resolution
and fails to provide information about deeper brain structures such as the basal
ganglia. The strength of other neuroimaging methods such as PET and fMRI lies
in their ability to obtain localised information about activity throughout the brain.
However, fMRI is not ideally suited for repeated, task-independent measurements,
since a high-pass filter is used in the data pre-processing stage (typical cut-off fre-
quency: 0.008 Hz) to control for scanner drift and therefore prevents the measure-
ment of absolute blood-flow changes over prolonged time periods. Moreover, the
strong magnetic field of the MRI scanner also requires the use of non-ferromagnetic
TMS coils.
PET constitutes a good compromise with regard to the desired criteria. Radioac-
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tively labelled water (H215O) is a widely used PET tracer in functional neuroimag-
ing. The tracer is injected intravenously and is distributed with the blood through-
out the vascular tree. H215O acts as a diffusible tracer, entering the perfused brain
tissue, and displaying the distribution of regional cerebral blood flow (rCBF), which
has been suggested to reflect presynaptic neuronal activity [Jueptner and Weiller,
1995]. H215O has a short half-life of approximately 2 min, allowing a series of injec-
tions to be performed every 6 − 10 min. Although it has a relatively low temporal
and spatial resolution, this method provides direct and quantitative measures of
rCBF. Since these are stable over time, serial, task-independent measurements can
be taken. Only a few available studies have examined the effects of low frequency
rTMS applied to the PFC using either H215O−PET or fMRI so far (see Table 2.1). No
study has looked at the time-course of rCBF effects following low frequency rTMS
of the right DLPFC using the ”off-line”-approach.
2.1.2 Summary
Evidence from patient studies, neuroimaging, and an rTMS experiment identified
the human right lateral PFC as an important substrate for making adaptive de-
cisions under risk. Low frequency rTMS over the course of several min recently
received much interest, as it can create ”off-line” effects outlasting the stimulation
train in the targeted brain area. However, when applied to the right lateral PFC it
is not clear how long these effects last and, in particular, which brain regions remote
from the stimulated area are affected as well. No previous study has addressed this
issue.
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2.2 Neuropharmacological modulation
Motivation Interpretations based on neuroimaging data are often subject to the
reverse inference problem [Poldrack, 2006]. For example, many neuroimaging ex-
periments report that risky decision making recruits DAergic brain structures. If,
for example, the choice of an option associated with a high, but unlikely reward
reveals an increased blood-flow in striatum, the activity of which is known to be
modulated by DA from studies in animals, this observation does not allow the
stringent conclusion that this increased blood-flow reflects an involvement of the
DAergic system in risky decision making. Yet again, a distinction between cau-
sation and correlation can be made also on the systemic level using patient data.
Parkinson’s disease patients, who have a dysfunctional DAergic system, receive
DAergic medication as part of the treatment strategy to alleviate the prominent
motor deficits (see section 2.2.3 on page 18). By experimentally investigating these
patients during risk taking tasks before and after medication, a causal relationship
was revealed between the modulation of the DAergic system and impulsive betting
on the Cambridge Gamble Task [Cools et al., 2003]. Findings of such studies have
converged on a useful model to understand the role of DA in behavioural control
and risk taking. It assumes that the DAergic drug doses necessary to remediate
the motor symptoms of Parkinson’s disease cause a DAergic ”overdose” of relatively
unaffected brain regions, such as the ventral frontostriatal circuitry, resulting in
poor behavioural control. However, this model still suffers from a lack of general-
isability, since DA receptor up regulation might have occurred in distinct parts of
the brain due to the general reduction in DAergic neurotransmission in Parkinson’s
disease patients.
With two exceptions [Hamidovic et al., 2008, Riba et al., 2008], neuropharmaco-
logical approaches known to modulate the DAergic system have not been used to
investigate risk taking behaviour in healthy humans. If such a systemic approach
is used, a clearer picture can be drawn by using additional genetic information. For
example, we now know of many DA receptor polymorphisms that determine the
efficiency of how these receptors convey neurochemical signals. Genetic associa-
tion studies have linked these polymorphisms to risk taking proneness. However,
no study has yet investigated how a modulation of the DAergic system influences
risk taking behaviour conditional on genetic information. The study presented in
Chapter 4 was designed to fill this gap of knowledge, based on the theoretical con-
siderations presented in this section.
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2.2.1 Dopaminergic system
Biosynthesis and metabolism of dopamine The neurotransmitter DA is bio-
chemically synthesised from the amino acid L-tyrosine. Circulating L-tyrosine
is transported through the blood-brain-barrier (BBB) into the cerebrospinal fluid
(CSF) and DAergic neurons by amino acid transporter systems. The enzyme tyro-
sine hydroxylase (TH) hydroxylates it there to L-DOPA. This is also the rate limit-
ing step in the biosynthesis of DA. The enzyme aromatic L-amino acid decarboxy-
lase (AADC) further converts L-DOPA to DA. This enzyme is present in many types
of neurons, including the cytosol of DAergic neurons and in blood plasma. It rapidly
metabolises L-DOPA, such that concentration of L-DOPA in blood and in neurons
is usually very low under normal conditions (i.e. when the AADC is not inhibited
pharmacologically) [Elsworth and Roth, 1997]. The use of L-DOPA to elevate DA
concentrations thus requires very high doses, unless a decarboxylase inhibitor such
as benserazide is used. It is worthwhile to point out that L-DOPA may inhibit
tryptophan hydroxylase (TrpH), thereby decreasing the synthesis of the serotonin
(5-HT) precursor 5-hydroxy tryptophan (5-HTP) [Naoi et al., 1994]. Thus, L-DOPA
administration may well affect the serotonergic system indirectly.
Figure 2.1: Human brain
metabolism of DA.
The enzymes monoamino-oxidase (MAO) and aldehyd-
dehydrogenase (ADH) mainly metabolise DA to di-
hydroxyphenylacetic acid (DOPAC), while the en-
zyme catechol-O-methyl-transferase (COMT) converts
it to homovanillic acid (HVA). DOPAC may be fur-
ther metabolised into HVA. There are other minor
metabolisation pathways which will not be considered
here (see Figure 2.1). The concentration of DOPAC in
DA-containing brain areas and in CSF is much lower
than that of HVA. Removal of HVA and DOPAC from
the brain tissue occurs via an active transporter sys-
tem from CSF into the blood stream [Kopin, 1985].
These metabolites, HVA in particular, could thus po-
tentially serve as peripherally measurable correlates
of brain DA turnover [Prockop et al., 1974]. However, DA is also metabolised into
the neurotransmitter norepinephrine (NE). This step requires the presence of a
specific enzyme, DA-β-hydroxylase (DBH), which is present in sympathetic neu-
rons and in locus coeruleus neurons [Kopin, 1985, Curet et al., 1985]. Therefore, L-
DOPA administration may cause an increase in NE neurotransmission in the brain
as well. This issue and the fact mentioned above that L-DOPA may inhibit TrpH
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are critical in defining L-DOPA’s relative DAergic specificity and will be discussed
in section 4.6.4 on page 70.
Dopamine receptors Five DA receptors are known and are all members of the
superfamily of seven transmembrane domain G-protein coupled receptors. Based
on shared pharmacological features, second messenger coupling, and conserved
structural features among individual receptors, they are clustered into D1 and D2-
like families of receptors. The D1-like DA receptors consist of the D1 and the D5
receptors. These two receptors share similar pharmacological profiles and are cou-
pled to adenylate cyclase via a stimulatory G-protein (Gs). The D2-like family of
DA receptors consists of the D2, D3 and D4 receptors which are coupled to adeny-
late cyclase via an inhibitory G-protein (Gi) [Bloom et al., 1995]. These two sub-
types of DA receptors have differential effects on the formation of cyclic adenosine
monophosphate (cAMP) via regulating activity of the adenylate cyclase.
The DA D4 receptor (DRD4) is of particular importance if the current framework,
because variants of its gene have been linked to behavioural phenotypes (see sec-
tion 2.2.1 on page 15) that are potentially relevant for risky decision making. Im-
munohistochemical studies in the primate brain indicate that the D4 receptor is
present in both pyramidal and in higher density on non-pyramidal neurons of the
cerebral cortex as well as in the hippocampus [Mrzljak et al., 1996, Lidow et al.,
1998]. Most of the non-pyramidal neurons that express the D4 receptor are gamma-
aminobutyric acid (GABA) releasing interneurons [Mrzljak et al., 1996]. Activation
of D4 receptors reduces GABA-A receptor currents via Gi - mediated reduction of
cAMP signalling in rat prefrontal cortical pyramidal neurons [Wang et al., 2002].
Autoradiographic methods are often used to visualise the distribution of specific
receptors in human post-mortem brains. With respect to the D4 receptor this has
been difficult, however, due to a lack of available, selective radioligands. Early stud-
ies used subtractive methods which take advantage of the fact that the D4 recep-
tor has a low affinity for C11-raclopride (a selective D2/D3 receptor antagonist) but
high affinity to the D2/D3/D4 receptor antagonists H3-spiperone or H3-nemonapride
[Seeman et al., 1993]. The subtraction of the brain distribution of C11-raclopride
binding from H3-spiperone binding revealed D4 receptor distribution in the PFC
and hippocampus. Although the results regarding the presence or absence of the D4
receptor in striatum is somewhat conflicting [Oak et al., 2000], the most selective
radioligand H3−NGD94-1 available did not detect D4 binding sites in striatum of
human post-mortem brain sections. Binding was observed predominantly in areas
of the cerebral cortex, septum, hippocampus, amygdala and hypothalamus [Primus
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et al., 1997, Lahti et al., 1997].
Dopamine receptor D4 exon III VNTR polymorphism The D4 receptor gene
contains a highly polymorphic region within its third exon, also referred to as the
DRD4 exon III variable number tandem repeat (VNTR) polymorphism (DRD4 poly-
morphism) . This 48 base-pair polymorphic region encodes a proline-rich protein
domain in the third cytoplasmatic loop of the DRD4. The DRD4 polymorphism is
an imperfect repeat translated into 16 amino acids found to be present 2-11 times
in different alleles of DRD4 [Oldenhof et al., 1998]. The most common alleles in hu-
mans are variants with two, four and seven repeats (2R, 4R and 7R, respectively)
[van Tol et al., 1992]. The 4R allele is found most frequently (global allele frequency
of 64%), followed by the 7R allele (21%) and the 2R allele (8%). High differences oc-
cur, however, in frequency distributions among different populations with the 7R
allele being virtually absent in Asiatic populations [Chang et al., 1996].
Various attempts have been made to investigate potential differences in the molec-
ular biological properties of the D4 variants. Only the variants which occur most
frequently in humans will be mentioned here. It has been hypothesised that the dif-
ferent cytoplasmatic loops might interact differently with downstream G-proteins
thereby changing second-messenger signalling efficiency [Lichter et al., 1993]. Ac-
cordingly, the 7R variant has been associated with a two-fold diminished potency
of DA to inhibit forskolin stimulated cAMP formation compared to the 2R and the
4R variants [Asghari et al., 1995]. Others have shown that the amount of expres-
sion of the 7R sequence was lower compared to the 2R and 4R variants [Schoots
and Van Tol, 2003]. Moreover, differences in folding efficiency have been shown,
with the shorter repeat sequence coding for a more efficiently folded protein and
the longer repeat sequence for a less efficiently folded protein [van Craenenbroeck
et al., 2005]. In summary, these studies suggest the following order of functional
potency of the D4 receptor variants: 7R < 4R = 2R.
A recent experiment [Wedemeyer et al., 2007] suggested significant differences in
electrophysiological responses after DA binding. The three receptor isoforms (2R,
4R and 7R variants) were expressed on a xenopus laevis oocyte (egg of African
clawed frog) together with a G-protein coupled inward rectifying K+ channel (GIRK).
Previous evidence showed that the D4 receptor readily couples to GIRK channels
[Werner et al., 1996]. The effective DA concentration necessary to induce GIRK me-
diated K+ currents was approximately five-fold lower for the 2R and the 7R receptor
variants compared to the 4R variant. This study is important because it suggests a
different order of functional potency of these variants: 7R = 2R > 4R.
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DRD4 exon III VNTR polymorphism and human behaviour An increasing
amount of studies, however, link the single DRD4 exon III VNTR polymorphism
to a number of human traits and behaviours which are relevant in the context of
risk taking. When comparing different variants of a given allele contributing to
behaviour, it has to be kept in mind that the comparison of genotypes and their be-
havioural correlates is always relative. The rationales for forming groups according
to genotypes can comprise arguments based on functional potency of the different
receptor variants (see above), but it can also entail evolutionary aspects. For ex-
ample, it has been suggested that the 7R allele arose from the 4R allele as a rare
mutation event some 40’000 y ago, and has been under positive selection ever since
[Wang et al., 2004]. This suggests that the 4R variant could be used as a ”reference”
when comparing it with carriers of the 7R variant. The most often used approach in
the literature is either the comparison of the most common with a specific genotype
(e.g., 4/4 vs 4/7) or the comparison of subjects who carry at least one ”special” allele
(e.g. the 7R allele) with those who do not carry the allele. In most studies, the 2R
variant is neglected, which is mostly due to the fact that its frequency is consider-
ably lower than that of the 4R and the 7R variants. It should be emphasised that
the attempt to link one single gene to one single behaviour is an oversimplifica-
tion of complex neurobiological processes, which most consider untenable (see also
section 4.6.6 on page 72).
Ebstein et al. [1996] initiated research into the behavioural phenotypes associated
with the DRD4 exon III polymorphism. They reported that the 7R variant carri-
ers have higher scores on the sensation-seeking dimension of Cloninger’s tridimen-
sional personality questionnaire [Cloninger et al., 1991], which has been widely
used in genetic association studies. However, this finding appears to be somewhat
inconsistent and has spurred a dispute in the literature. It has been suggested, for
example, that it may not be the DRD4 genotype per se, but rather an interaction
with substance use or abuse associated with novelty-seeking [Lusher et al., 2001,
Kluger et al., 2002]. There is indeed evidence that links this polymorphism with
increased odds for substance addiction [Comings et al., 1999]. The issue remains
similarly inconclusive, however, since other studies also failed to find such effects
[Lusher et al., 2001]. It is worthwhile to mention, however, that subjects who carry
the 7R variant of the receptor seem to face an increased likelihood of suffering from
pathological gambling [Perez de Castro et al., 1997]. The most consistent finding
is the association of the 7R variant with attention deficit hyperactivity disorder
(ADHD), a childhood-onset psychiatric disorder whose cardinal symptoms are inat-
tention, hyperactivity, and impulsivity [Faraone et al., 2001, Li et al., 2006]. ADHD
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affects an estimated 3% of elementary school children. As in all association studies,
one cannot assume that the presence of the 7R allele is neither necessary nor suf-
ficient to ”cause” ADHD. Interestingly however, it was found that among children
with ADHD, carriers of the 7R allele differed significantly from the group without
this allele in that they were faster and less accurate in the Matching Familiar Fig-
ures Test, suggesting higher impulsivity in these children [Langley et al., 2004]. A
similar finding was observed in a sample of healthy adults showing that 7R carri-
ers have a significantly longer reaction time on the Stop Signal Task (compared to
carriers without the 7R allele), suggesting poor inhibitory control in these subjects
[Congdon et al., 2008].
2.2.2 Pharmacogenetics and behaviour
The term ”pharmacogenetics” refers to the study of the hereditary basis for dif-
ferences in drug responses. While a wealth of pharmacogenetic research has fo-
cused on individuals’ genetic susceptibility to adverse drug reactions [Pirmohamed,
2001, Pirmohamed and Park, 2001] and how polymorphisms and mutations in neu-
rotransmitter receptors can alter functional activity and pharmacological profiles
[Wong et al., 2000], only little evidence is available that links receptor gene vari-
ants to drug responses in terms of human behaviour. With respect to the seroton-
ergic system, a number of studies investigated the interaction of tryptophan deple-
tion, which is an way to lower 5-HT transmission in the CNS, with the serotonin-
transporter polymorphism (5HTTPP) on object choice [Blair et al., 2008], recogni-
tion of fear facial expressions [Marsh et al., 2006], passive avoidance and response
reversal instrumental learning performance [Finger et al., 2007], emotional pro-
cessing, memory and attention [Roiser et al., 2007] and performance on a cued
reinforcement reaction time task [Roiser et al., 2006]. Only one study is presently
available with respect to the DAergic system. This study used cabergoline, a fairly
selective D2 receptor agonist, to investigate reversal learning performance condi-
tional on the Taq1A DA D2 receptor polymorphism (DRD2 polymorphism) . Com-
pared with placebo, cabergoline administration made A1+ allele carriers take sig-
nificantly longer to reach learning criteria, but made A1- allele carriers learn faster
[Cohen et al., 2007]. With respect to the DRD4 polymorphism, no studies are avail-
able that investigated pharmacogenetic effects on behaviour.
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2.2.3 Pathological gambling in Parkinson’s disease patients
Parkinson’s disease is a neurodegenerative disease characterised by a progressive
loss of DAergic neurons in the nigrostriatal and, to a lesser extent, in the mesocor-
ticolimbic system. In early Parkinson’s disease, DA depletion is restricted to the
putamen and the dorsal caudate nucleus, and later progresses to the more ventral
parts of the striatum and the mesocorticolimbic DAergic system [Kish et al., 1988].
Administering L-DOPA is efficient for treating the motor symptoms, however, the
effect on cognitive functions seems to be two-fold: medication ameliorates deficits
on set-shifting, associated with dorsal striatal-DLPFC circuitry [Sohn et al., 2000],
while it impairs performance on probabilistic reversal learning, associated with
ventral fronto-striatal circuitry [Cools et al., 2002]. Based on this and previous work
[Gotham et al., 1986, Swainson et al., 2000], the hypothesis was formulated that L-
DOPA normalises DA levels in severely depleted areas in the Parkinsonian brain,
such as the dorsal striatum and its connections to the DLPFC, while ”overdosing”
the relatively intact ventral striatum (vStr) and its connections to the ventral PFC
[Cools et al., 2003]. This ”overdose” hypothesis is based on evidence suggesting that
there is an optimal amount of DA receptor stimulation, meaning that too little or
too much stimulation of DA receptors decreases several performance and neural
activity measures (”inverted-U” relationship) [Williams and Goldmanrakic, 1995,
Vijayraghavan et al., 2007]. .
Thus, a relative DA ”overdose” of the ventral frontostriatal circuitry might explain a
diminished performance during reversal learning tasks; the poorer performance re-
flects impaired impulse control [Dias et al., 1996]. Following this line of reasoning,
it was hypothesised that L-DOPA administration causes impulse control deficits in
early stage Parkinson’s disease patients. The procedure most commonly employed
to assess the neuropsychological effects of L-DOPA in Parkinson’s disease patients
is the controlled L-DOPA withdrawal procedure. It requires patients to abstain
from their L-DOPA for a period of approximately 15 h prior to the neuropsycholog-
ical assessment. Performance in this ”off-state” state is compared with that in a
separate testing session during which patients take their medication as usual, the
”on-state” [Cools et al., 2006]. This procedure showed that patients who were in the
”on-state” exhibited more impulsive betting strategies in the Cambridge Gamble
Task, relative to the ”off-state” [Cools et al., 2003]. Figure 2.2 depicts an illustration
of the ”overdose”-model, based on the hypothesis initially put forward by Swainson
et al. [2000] and extended by the current state of knowledge [Cools et al., 2003,
2006, Cools, 2008]. Consistent with the finding of a generally decreased impulse
control in medicated early-stage Parkinson’s disease patients is the observation of
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Figure 2.2: The DA ”overdose” hypothesis applied to cognitive functions within
dorsal and ventral frontostriatal circuitry. DA depletion severe enough to produce
functional deficits may be present in all regions of the putamen and only in the
most dorsal, rostral aspect of the head of the caudate nucleus thereby affecting
only the motor system and the dorsolateral prefrontal loops. DAergic medication
results in beneficial effects on motor control and set-shifting in these loops; it may,
however increase the amount of DAergic activity above the optimal level in the less
affected ventromedial head and tail of the caudate nucleus (parts of the VLPFC re-
spectively), resulting in impaired reversal learning, decreased behavioural control,
and increased reward/ decreased punishment sensitivity. The arrows indicate the
potential direction of effects of a particular dose of DAergic medication on levels of
overall DAergic activity and on task performance. Adapted from Swainson et al.
[2000].
pathological gambling in these patients. Pathological gambling is classified as an
impulse control disorder and defined as a failure to resist gambling impulses de-
spite severe personal, familial, and financial losses [APA, 1995]. While the lifetime
prevalence of pathological gambling in the North American general population is
1.6%, it was reported to lie between 3% and 8% in Parkinson’s disease patients
using medication [Voon et al., 2007a]. Molina et al. [2000] investigated a sample
of 250 patients receiving L-DOPA and identified twelve who had problems with
gambling. Importantly, ten started gambling after the onset of L-DOPA treatment,
suggesting a causal role of DAergic drug treatment in the aetiology of the gambling
disorder.
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2.2.4 Summary
In healthy humans, relatively few studies are available that examined the role of
DA in risky decision making from a pharmacological perspective. Showing that a
relatively coarse manipulation of the DAergic system can alter risky decision mak-
ing would be an initial step in bridging this gap. The DA precursor L-DOPA is a
useful substance for achieving this for two reasons: first, it increases the presy-
naptic availability of DA without having direct effects on specific subtypes of re-
ceptors. Second, evidence from studies of Parkinson’s disease patients suggests
that L-DOPA treatment might be associated with decreased impulse control and
pathological gambling. Thus, findings in these patients can serve as a model for in-
vestigating healthy humans in a placebo-controlled L-DOPA administration study.
To provide more specificity, additional genetic information at the receptor level can
be introduced. The D4 receptor seems to be a promising candidate, given its re-
ported association with impulsivity and impulse control related disorders, includ-
ing ADHD and pathological gambling. Such a pharmacogenetic approach allows
investigating the influence of L-DOPA on risk taking behaviour in subpopulations
identified through the DRD4 polymorphism, whereby the common group (4R allele
carriers) may acts as a control group for the 7R allele carriers. So far, no study has
used this approach in the domain of risky decision making in humans.
2.3 Neuroendocrine modulation
Motivation While the use of modulatory approaches to investigate the neuroen-
docrinological aspects of social decision making has just recently begun [Kosfeld
et al., 2005, Baumgartner et al., 2008], neuroendocrine ”biomarkers” such as sali-
vary and serum measures of sex hormones have long been used to predict human
social behaviour. TE, which is perhaps the best known sex hormone, has received
paramount attention. As early as the seventies, [Ehrenkranz et al., 1974] reported
that serum concentrations of TE is positively related to dominant social behaviour
in male prisoners. Many experiments followed and the possibility of detecting hor-
mones in saliva [Landman et al., 1976] set the stage for large scale field experi-
ments investigating the neuroendocrine correlates of human social behaviour. This
work has posed a major challenge for sociologists, because it represented a shift
away from the classical sociological injunction that social behaviour can only be ex-
plained by social facts [Udry et al., 1995]. Those who agreed with the idea that
biological factors may also influence our social behaviour have defined a new inter-
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disciplinary research field, termed ”biosociology”. Two important models emerged
from his field: the basal model, which assumes that endogenous TE levels can be
thought of as a trait, whereby individual differences in basal TE cause variation
in dominance (i.e. enhancing of one’s status over that of other people) and the re-
ciprocal model, which assumes that certain social situations (such as dominance
disputes and competition) cause TE levels to change, and that these changes in TE
then feed back to reinforce or discourage further behaviours which led to the TE
change in the first place [Mazur and Booth, 1998]. The measurement of endogenous
TE levels obviously does not provide evidence that TE actually causes the behaviour
in question. The reciprocal model suggests particular caution in interpreting cor-
relative data gained from field studies. A well suited example for describing this
issue is the following study: Coates and Herbert [2008] investigated a sample of
stock-market traders and their salivary TE levels. They reported that a trader’s
morning TE level was positively related with his day’s profitability on the stock
market. However, according to the reciprocal model, it might well be the case that
a successful trader experienced a TE surge due to his profitable trading behaviour
in the morning. Thus, morning trading performance would perhaps have been a
better predictor of a trader’s day’s profitability. Morning TE levels would therefore
reflect a subsidiary variable, rather than a good predictor. By using economic so-
cial interaction paradigms, which quantify social decision making behaviour in the
context of a well controlled experimental environment, many limitations of these
field studies can be overcome. Moreover, the combination of placebo-controlled TE
administration using such paradigms offers insight into the causal relationship be-
tween TE and social decision making behaviour. In this section, a general overview
of the pharmacological properties of TE and its behavioural effects in animals and
humans will be given. The study presented in Chapter 5 resulted from the consid-
erations herein.
2.3.1 The androgen system
Biosynthesis of testosterone TE is synthesised from cholesterol in five ba-
sic enzymatic steps. First, cholesterol is converted to pregnenolone. This is the
rate-limiting step in the synthesis of all steroid hormones. The conversion en-
compasses three sub steps - C20-hydroxylation, C22-hydroxylation, and cleavage
of the C20-C22 bond - to produce pregnenolone and isocaproic acid. These three
sub steps are mediated by a single mitochondrial cytochrome [P450scc, Chung et al.,
1986]. In a second step, pregnenolone is hydroxylated at the C17 position by the
steroid-17-hydroxylase (cytochrome P450c17) to form 17-hydroxy-pregnenolone. A
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third enzymatic step involving a C17/C20 lyase (cytochrome P450c17) yields dihy-
droepiandrosterone (DHEA). The fourth and fifth metabolic steps include reduction
to androstenedione (by the 17-β-hydroxysteroid dehydrogenase [17-β-HSD]) and ul-
timately the conversion to TE by the 17-β-HSD. TE is the main androgen in the hu-
man body and is characterised by an oxygen group at position C3, a hydroxy group
at position C17 and a double bond in position C4 [Voet et al., 1992, Nieschlag, 2006].
The following paragraph briefly describes the sources of androgens in females, since
the experiment described in Chapter 5 was conducted with female subjects exclu-
sively. TE is secreted by the adrenal zona fasciculata (25%) and the ovarian stroma
(25%), the remaining 50% are produced from circulating androgens such as DHEA.
DHEA is primarily an adrenal product, regulated by the adrenocorticotropic hor-
mone (ACTH) and acts as a precursor for the peripheral synthesis of more potent
androgens such as TE and dihydrotestosterone (DHT) [Davis and Burger, 2003].
Daily production rate of TE is in the order of 0.1 − 0.4 mg and circulating levels are
in the range of 0.2 − 0.7 ng/ml (0.6 − 2.5 nmol/l). TE is at its lowest concentrations
in the early follicular phase of the cycle and rises to a mid-cycle peak [Abraham,
1974]. The following luteal phase concentrations are higher than those in the early
follicular phase. Hormone assays have indicated that TE shows circadian variation,
peak levels being seen in the early morning hours [Davis and Burger, 2003].
Metabolism TE is metabolised both into active and inactive metabolites. The
formation of the inactive metabolites involves hydroxylation at the C6, C7, C15,
C16 positions, glucuronidation at the C3 or C17 position and subsequent excretion
of these metabolites via the urinary pathway. Androsteron and etiocholanone are
the most abundant urinary androgen metabolites [Nieschlag, 2006] and play an
important role in detecting abuse of anabolic steroids in urine by athletes [Catlin
et al., 1997]. TE is, however, also metabolised into the highly neuroactive steroids
DHT and 17β-estradiol (E2). E2 results from an aromatisation of TE at the C4
position by the enzyme aromatase; DHT results from reduction of TE via the 5α-
reductase. Since many of TE’s actions are assumed to result from its conversion
to these neuroactive metabolites, it has also been referred to as a prohormone (see
section 5.5.5 on page 105).
Transport and blood-brain barrier permeability By virtue of its lipophilic-
ity, TE diffuses easily through cell membranes including the capillary walls of the
BBB without the need of an active transporter mechanism (William M. Pardridge,
personal communication). A significant proportion of hormones is bound to globu-
2.3. Neuroendocrine modulation 23
lins present in serum. The globulins are specific for classes of hormones; the sex
hormone binding globulin (SHBG) binds TE and E2 and occurs in such species
as primates but not rodents [Corvol and Bardin, 1973]. The hormone fraction
in plasma available for transport into brain is inversely related to the amount of
SHBG present in the circulation [Pardridge and Mietus, 1979].
Pharmacodynamics Both TE and DHT bind to the androgen receptor (AR). Al-
though it was initially assumed that steroids exert their effects uniquely through a
genomic pathway via intracellularly located receptors, it is now recognised that
they may also act through a non-genomic pathway via membrane bound recep-
tors [for a review, see Simoncini and Genazzani, 2003]. The genomic pathway in-
volves diffusion of the steroid through the cell membrane, binding of the hormone
to the AR, separation of the receptor from cytoplasmic chaperone proteins (hsp-90),
translocation of the receptor from the cytosol into the nucleus and dimerisation of
the receptor. This dimer binds to specific hormone-responsive elements on the des-
oxynucleic acid (DNA) resulting in down- or up regulation of transcription of certain
genes [Voet et al., 1992]. This mode of action is considered to be slow, ranging from
hours to days. The non-genomic pathway does not depend on gene transcription or
protein synthesis and involves steroid-induced modulation of cell membrane-bound
regulatory proteins coupled to ion-channels [Simoncini and Genazzani, 2003].
DHT is also a classical androgen binding exclusively to the AR. It has however, a
fourfold higher affinity to the receptor than TE [Grino et al., 1990]. Moreover, it
exhibits a five-fold slower dissociation rate from the receptor, compared to TE. As a
consequence, substantially lower concentrations of DHT are necessary to activate
cellular processes [Grino et al., 1990]. E2 activates the estrogen receptor type alpha
(ER-α) and type beta (ER-β) in several tissues including different areas of the brain
[Couse et al., 1999]. The conversion of TE to E2 gives rise to a number of questions
in interpreting results from TE modulation experiments. These will be discussed
in section 5.5.5 on page 105.
Testosterone preparations A number of TE preparations (injectables, oral and
sublingual formulations and gels) are available allowing the experimental manip-
ulation of TE levels in humans to investigate causality in social decision making
behaviour. In order to have good experimental control, TE administration and be-
havioural testing should be performed in the same experimental session. This en-
sures that no experiences outside the laboratory (perhaps influenced by TE admin-
istration) confound social decision making behaviour in the laboratory. Therefore,
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the duration until the maximum blood concentration is achieved after TE adminis-
tration (tmax) is an important parameter. The following paragraphs briefly describe
the pharmacokinetic parameters of some of the available compounds as well as
their advantages and limitations.
Injectable forms of testosterone The injectable TE preparations available have
important clinical importance in the treatment of male hypogonadism [Behre et al.,
1999]. Most of them are also illicitly used by athletes to increase muscle mass.
The intramuscular injection of TE-esters is the most widely used approach for TE
substitution therapy of male hypogonadism. For these purposes, chemical esteri-
fication of TE has to be performed, since unmodified TE has a half-life of only 10
min and would thus have to be injected very frequently. Esterification at position
C17 of the molecule prolongs the half-life in proportion to the length of the added
side-chain. These side-chains usually derive from propionic acid, enanthic acid, cy-
pionic acid or undecanoic acid, resulting in TE-ester half-lives of 0.8, 4.5, 29.5 and
33.9 d, respectively [Nieschlag, 2006]. For a number of reasons, these preparations
are all not favourable for investigating decision making in humans. First, even the
fastest acting preparation, TE-propionate, does not reach tmax until 14 h after ad-
ministration [Nieschlag, 2006]. Second, subjects who are afraid of injections might
experience stress and this may itself lead to altered TE secretion from the adrenal
gland (see page 27). Third, the time course of neurophysiological effects in the cen-
tral nervous system (CNS) is not known. A sublingual application of TE in female
subjects can overcome these limitations.
Sublingual administration From a pharmacological viewpoint, the resorption
of TE through the oral mucosa is advantageous, since it leads to a rapid rise in sys-
temic TE concentrations but also avoids the pronounced intestinal and hepatic first
pass metabolism usually observed if ingested orally. Moreover, it is non-invasive.
However, since TE is hydrophobic, it does not dissolve in saliva and it is therefore
difficult to bring the molecule into close contact with the cell membranes of the
oral mucosa. The use of hydroxy-propyl-β-cyclodextrin (HP-β-CD) [Figure 2.3 (A)]
inclusion complexes as a carrier system can overcome this obstacle. Cyclodextrins
are cyclic oligosaccharides consisting of a number of dextrose molecules. All sec-
ondary hydroxyl groups are located on one edge of the molecule, while the primary
hydroxyl groups are located on the other edge. The internal cavity of HP-β-CD is
relatively hydrophobic, and thus, lipophilic guest molecules such as TE reside par-
tially within the ring cavity of the cyclodextrin without being covalently bound to
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the host molecule. In solution with saliva, the cyclodextrin solubilises the otherwise
insoluble TE, and the lipophilic TE molecules are absorbed by the oral mucosa and
eventually enter the systemic circulation [Hirayama and Uekama, 1999]. Stuenkel
et al. [1991] showed that the sublingual administration of 2.5 mg and 5 mg TE
complexed with HP-β-CD to hypogonadal males leads to a rapid increase in serum
TE concentrations [Figure 2.3 (B)] and Tuiten et al. [2000] reported similar phar-
macokinetics after the application of 0.5 mg of sublingual TE to healthy female
subjects [Figure 2.3 (C)]. So far, this is the only study that has investigated the
time-course of neurophysiological effects after a single-dose of TE in healthy hu-
mans [Tuiten et al., 2000]. The authors reported a significant increase in vaginal
pulse amplitude (VPA, a measure reflecting vaginal blood-flow and sexual arousal)
in response to the presentation of erotic movie clips after about 4 h. This effect was
absent when movies with a neutral content were presented, suggesting that the
effects on the VPA was not related to unspecific vasodilatatory effects of TE [Figure
2.3 (D)]. The VPA seems to be the only physiological response known to possess a
non-habitual nature, thus allowing multiple measures throughout the day. In sum-
mary, this study provides evidence that neurophysiological effects following a single
sublingual administration of 0.5 mg TE peak 2.5 h after that TE levels in the blood
have already returned to baseline [Tuiten et al., 2000]. It was hypothesised that
this time lag is due to the genomic way of action of TE.
2.3.2 Neuroendocrinology
The two neuroendocrine regulatory systems, the hypothalamic-pituitary-gonadal
axis (HPG axis) and the hypothalamic-pituitary-adrenal axis (HPA axis), are inter-
dependent systems each affecting one another. The HPA axis is a system which is
activated during physiological (infections, injuries) as well as psychological stress
(as part of the fight-or-flight response) [Hellhammer, 2008]. It triggers the release
of three key hormones (corticotropin-releasing hormone [CRH], adrenocorticotropic
hormone [ACTH] and, in humans, cortisol [CORT]). Stress provokes the release of
CRH from the hypothalamus into the anterior pituitary via the portal vein. Upon
activation of CRH receptors, ACTH is released into the general circulation. ACTH
triggers the biosynthesis and release of CORT from the adrenal cortex into the
bloodstream. The HPA axis is controlled via a negative feedback system in which
the end product, CORT, inhibits the production of the initiation substance, CRH. In
addition, CORT inhibits ACTH secretion [Miller and O’Callaghan, 2002, Birbaumer
and Schmidt, 2006].
The HPG-axis regulates development and reproductive function of the gonads. More-
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Figure 2.3: (A) The basic structure of the TE- hydroxy-propyl-β-cyclodextrin in-
clusion complex, which can be administered sublingually. (B) Pharmacokinetics of
serum TE after the administration of a single dose of 2.5 mg (◦) and 5.0 mg (•)
of sublingual TE to five hypogonadal men. The shaded area indicates the normal
physiological range of TE levels in males. (C) Pharmacokinetics of serum TE after
administration of a single dose of 0.5 mg of sublingual TE (2) or placebo (N) to eight
healthy females. (D) Average relative increase in vaginal pulse amplitude (VPA) in-
duced by erotic film excerpts viewed at six consecutive times during placebo (N) and
TE (2) treatment in eight healthy females. Error bars indicate SEM.
over, it controls sex hormone production via hormone-dependent feedback loops.
This feedback loop consists of the key hormones gonadotropin-releasing-hormone
(GnRH), luteinising-hormone (LH), follicle-stimulating hormone (FSH) and the male
(androgens) and female sex hormones (estrogens and gestagens). GnRH is released
from the hypothalamus in a pulsatile fashion. These pulses will only stimulate the
release of LH and FSH from the anterior pituitary into the blood-stream if they are
generated in a regular fashion. In the female ovaries, FSH stimulates the growth
of immature follicles to maturation. In male testes, FSH stimulates spermatoge-
nesis. LH regulates the biosynthesis and secretion of androgens in males. TE is
secreted into the blood-stream in spurts, and measured levels can change consider-
ably within a few min. In females, LH regulates the biosynthesis and secretion of
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both androgens and estrogens. Moreover, LH triggers ovulation which releases the
egg from the follicle and initiates the conversion of the residual follicle into a corpus
luteum that, in turn, produces progesterone [Birbaumer and Schmidt, 2006].
Chemical castration takes advantage of the fact that GnRH pulsatility is necessary
for LH and FSH secretion. Thus, by applying either a GnRH agonist or antago-
nist with a long half-life, both of which continuously occupy GnRH receptors, the
secretion of the gonadotropins LH and FSH can be suppressed [Nieschlag, 2006]. A
temporary chemical castration and subsequent placebo-controlled administration
of TE would be the state-of-the-art model for investigating the causal role of TE in
human decision making behaviour. Although this method is clearly superior to a
simple placebo-controlled administration of TE, it was not considered suitable for
the study that will be presented in Chapter 5 for ethical reasons.
Stress as a modulator of testosterone secretion Stress can influence TE at
the level of the hypothalamus, pituitary gland, and adrenal cortex. Since DHEA,
which is mainly a product from the adrenal cortex regulated by ACTH, is the source
for up to 50% of the female production of TE, increasing DHEA levels will lead to
changes in TE levels [Burger and Davis, 2002, see also section 2.3.1 on page 22].
Thus, acute stress, which leads to increased levels of ACTH, might cause increased
TE levels in females. On the other hand, it has been suggested that prolonged stress
may act at the level of the pituitary and hypothalamus to suppress LH and GnRH
pulsatility [Tilbrook et al., 2000] which could lead to lowered TE levels secreted
from the ovaries.
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2.3.3 Behavioural effects of testosterone
The effects of TE in adults depend on the interaction of long-term organisational
and short-term activational effects [Mazur and Booth, 1998]. The organisational
effects occur around birth. During fetal and neonatal life, relatively higher con-
centrations of TE (in males versus females) are thought to influence brain develop-
ment by defeminising the brain into a relatively male-like configuration. Studies
in rodents and primates have shown that the hypothalamus, the hippocampus, the
preoptic-septal region and the limbic system are important target areas for sex
steroid action during development [Mcewen, 1992, Collaer and Hines, 1995, Chris-
tiansen, 2001]. These brain structures are then thought to be activated later in life,
when TE concentrations rise (e.g. due to aggressive and non-aggressive battles over
status). In the adult male and female brain, highest concentrations of TE are found
in the hypothalamus, preoptic area, and substantia nigra as radioimmunoassay of
post-mortem brains revealed [Bixo et al., 1995].
As it is the case with many neuroactive substances, TE does not cause behavioural
changes per se; it rather alters the probability that a particular behaviour will occur
in the presence of a particular stimulus. For example, if TE levels are within or
above the physiological range, the hormones action on hypothalamic regions allows
normal sexual interest in males [Christiansen, 2001] and females [Davis and Tran,
2001]. If TE levels are below a certain limit, libido is markedly impaired.
Aggression in rodents The activational effects of TE have been shown in many
rodent experiments investigating aggression [e.g. Beeman, 1947, Edwards, 1969,
Lumia et al., 1994, Melloni et al., 1997]. When caged together, mice usually es-
tablish social hierarchies based on dominance-subordination relationships. Such
hierarchy formation happens to be established aggressively, sometimes resulting in
severe injuries or death of these animals. One of the first comprehensive experi-
ments that investigated the role of TE in aggression in rodents was performed by
Beeman [1947]. Aggressive behaviour was assessed in groups of normal (n = 20)
and castrated mice (n = 48). They were staged in a neutral cage, which was divided
into two equal sections by a partition that could be readily raised. To investigate
aggressive behaviour the partition was raised and fighting was observed. Strik-
ingly, none of the castrated mice showed any form of aggressive behaviour, while
all normal mice fought. In a second stage of the experiment, a subset of castrated
mice received either a TE propionate (15 mg, n = 25) or dextrose (n = 15) implant.
Each of the TE treated mice, but none of those with the dextrose implant, behaved
aggressively. This aggression was similar as in normal mice suggesting that TE
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plays a causal role in maintaining the ability to behave aggressively in combat.
The organisational effects of TE are illustrated by an experiment performed by
Edwards [1969], where the influence of postnatal TE administration on aggressive
behaviour in male and female mice that were previously castrated was investigated.
Figure 2.4: The percent of the total
number of gonadectomised adult pairs
in each group fighting (y-axis) at each
dose level of TE (x-axis). Figure taken
from Edwards [1969].
The experiment can be summarised in the
following way: 1 d after birth, a group of
males and a group of females were injected
with a vehicle (oil). Another group of females
received 0.5 mg of TE 1 d after birth. Yet
another group of females received oil 1 d af-
ter birth and 0.5 mg of TE 10 d after birth.
All mice were castrated 30 d after birth. Af-
ter 60 d, they were given injections of various
doses of TE (oil [sham], 10, 20, 50, 100 & 500
µg). They were then tested in a resident in-
truder paradigm. A dose-dependent fighting
behaviour after pairing was observed, which
was highest and identical in males treated
with oil and females treated with 0.5 mg of
TE 1 d after birth, somewhat lower in fe-
males treated with 0.5 mg of TE 10 d after
birth and lowest in females treated with oil (Figure 2.4). These results suggest
that there seems to be a critical period for the androgen influenced organisation of
the CNS to allow aggression. This period in the development of the mouse may be
characterised as a period of time during which endogenous or exogenous TE stimu-
lation will enhance adult sensitivity to androgens with respect to the tendency for
aggression. However, it has to be noted that later experiments suggested that E2
is the agent that causes these organisational effects.
2.3.4 Social behaviour in humans
Most studies that investigate the relationship between TE and social behaviour are
correlative, meaning that endogenous TE levels are measured in saliva or serum
and correlated with a behavioural measure or questionnaire scores. Most of these
correlative studies are based on an important premise, according to which TE lev-
els can be thought of as a trait, whereby individual differences in basal TE cause
variation in social behaviours. This has been referred to as the basal model . In
support of this model is evidence that basal TE levels are relatively temporally sta-
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ble across 5 d [Sellers et al., 2007], 8 wk [Dabbs, 1990], or even 1 y [Granger et al.,
2004]. Moreover, there is evidence from twin studies showing that basal TE levels
are partly heritable [Harris et al., 1998]. Taken together, these findings support the
basal model and suggest that basal TE can be thought of as an individual difference
variable that explains distinct domains of our social behaviour.
Anti-social behaviour Putatively driven by the scientific findings of TE induced
aggression in rodents and the case reports describing steroid induced rage, a num-
ber of studies sought to establish a link between TE and violent and anti-social
behaviour in humans. Several studies aimed at establishing such a relationship
with prison inmates. Generally, a positive relationship between basal TE levels
and past crime severity could be established [Dabbs et al., 1995, Dabbs and Har-
grove, 1997]. However, prison inmates constitute a subpopulation with potential
confounding pre-existing personality traits such as e.g. psychopathy and impul-
sivity. A more comprehensive study was performed by [Dabbs, 1990], in which a
sample of 4462 U.S. military veterans was investigated. In this study, subjects who
ranged at the top 10% of circulating TE levels were reported to have an increased
likelihood of having committed anti-social activities since being 18 years old, in-
cluding assaultive marital or relationship problems, negligence toward children,
job trouble, trouble with debts, traffic offenses, non-traffic arrests, lying, violence,
and vagrancy. The authors acknowledged that the effects in the study are small
and that only the extreme levels of TE seemed to account for appreciable variance
[Dabbs, 1990].
Many researchers in the field of TE research, however, view anti-social behaviour
rather as a form of dominance behaviour that occurs in settings where authority
figures require behaviour to conform closely to rigid standards and rules. This may
occur in schools, prisons, or in the military [Booth et al., 2006]. Individuals who are
predisposed to dominant behaviour but hold subordinate positions in settings such
as prisons or in the military are likely to break the rules in order to prevail over the
constraining environment [Booth et al., 2006].
Dominance, status and leadership In their biosociological review, Mazur and
Booth [1998] argue that TE’s role in social behaviour is mainly to assert an individ-
ual’s dominance and status. The main aim of their paper was to dissociate the link
between TE induced aggressive dominance behaviour, which is frequently observed
in rodents, from a link between TE and non-aggressive dominance behaviour, which
is more often observed in non-human primates and humans.
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Dominance is defined as behaviours with the intent to gain or maintain high status
[Mazur and Booth, 1998]. Individuals with a high status have unrestricted access
to resources and can influence others in the group. Low status individuals have
little influence and are constrained in their choices [Mazur, 2005]. The hypothesis
that TE is related to status receives support from a number of primate studies, in
which it has been shown that endogenous TE levels and the position in the status
hierarchy are positively correlated [Rose et al., 1971]. Importantly, the relation-
ship between TE and status tends to emerge most strongly during periods of social
instability [Muller and Wrangham, 2004]. In wild baboons for example, TE levels
predicted status-related behaviours only after the alpha male had been crippled in
fights and the status hierarchy was destabilised. When the hierarchy was stable,
however, TE and behaviour were unrelated [Sapolsky, 1991].
The association between TE and dominance has also been extended to humans. For
instance, people with high basal TE tend to be more socially dominant and value
being in a high status position more highly than individuals with low basal TE
[Cashdan, 1995, Grant and France, 2001, Josephs et al., 2003, 2006, Newman et al.,
2005, Sellers et al., 2007]. An approach which has often been used to investigate
status effects in humans is to randomly assign individuals to victory (high status)
and defeat (low status) in competitive social interactions by rigging the outcome of
the competitions. These studies showed that individuals with high endogenous TE
levels function better in high status positions than in low status ones. Specifically,
high TE individuals paid more attention to status cues, became dysphoric, and per-
formed poorly on complex cognitive tasks after a defeat, but paid less attention to
status cues, showed no evidence of dysphoria, and performed well on complex cogni-
tive tasks after victory [e.g. Josephs et al., 2003, 2006, Newman et al., 2005]. Taken
together, these studies suggests that humans with high TE levels experience plea-
sure and adaptive functioning (e.g., good cognitive performance) when they achieve
high status. When they fail to achieve high status, however, individuals high in
TE experience dysphoria and maladaptive functioning (e.g., poor cognitive perfor-
mance).
The main body of research examining TE and dominance has been conducted in
men [Mazur and Booth, 1998, Grant and France, 2001]. A small, but growing litera-
ture suggests, however, that basal TE may also explain status seeking behaviours in
women. For example, women with high basal TE tend to have dominant personali-
ties [Dabbs and Hargrove, 1997, Dabbs et al., 1988] and occupy high socioeconomic
status positions such as being a student, managerial, or technical worker [Purifoy
and Koopmans, 1979]. Moreover, female adolescents with relatively high TE levels
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more often chose the words ”enterprising”, ”initiative”, ”original”, and ”dominant”
to describe themselves in an adjective check list [Udry and Talbert, 1988]. Another
study involving female co-residential students showed that self-reported status po-
sition in relation to the peer group was positively correlated with basal TE levels
[Cashdan, 1995]. Two of the laboratory experiments mentioned above [van Honk
et al., 1999, Josephs et al., 2003] involved female subjects and showed a similar
relationship between dominance and endogenous TE levels.
The relationship between TE and prosocial status-seeking behaviours such as lead-
ership behaviour has received little attention so far. Because leadership is associ-
ated with the ability to influence others, it seems plausible that TE may be involved
in regulating who is more likely to behave more dominantly in such high status po-
sitions. There is some evidence supporting this logic in research on adolescent boys
[Rowe et al., 2004]. The study found that TE levels were positively correlated with
an average of self and parent ratings of leadership, but only among boys in prosocial
environments (operationalised as an absence of deviant peers). Among those boys
in antisocial environments (operationalised as definitely having deviant peers), TE
was unrelated to leadership. This study is important because it suggests that TE
may be associated with prosocial behaviours such as leadership, at least for indi-
viduals in prosocial environments.
Reciprocal relationship Another important aspect of the theory put forward by
Mazur and Booth [1998] is that TE not only affects behaviour but also responds to
it. This bidirectional relationship seems to be highly dependent on individual differ-
ences in social perception, previous experience as well as the demand of the social
context for particular behaviours [Booth et al., 2006]. According to this reciprocal
model , dominant behaviours or dominance disputes cause TE levels to change, and
these changes in TE then feed back to reinforce or discourage further acts of dom-
inance [Mazur and Booth, 1998]. There is ample evidence supporting this model.
For example, studies of real-world sports competitions and rigged laboratory com-
petitions have shown that winner’s TE levels increase relative to that of losers for
a few hours following a competition [Mazur et al., 1992, Mazur and Lamb, 1980,
Mccaul et al., 1992], although additional studies suggest that the effect of wins and
losses on TE changes depend on personality dispositions [Schultheiss and Stief,
2005]. Studies also provide support for the feed-back aspect of the model - that
these temporary changes in TE after competing influence subsequent competitive
behaviours [Mehta and Josephs, 2006]. Because of this reciprocal relationship be-
tween behaviour and testosterone secretion, it is particularly important to perform
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TE administration studies to investigate the role of TE in social behaviour.
Only one study investigated the influence of TE administration on social behaviour
in a laboratory setting so far [Pope et al., 2000]. In the task employed [Cherek et al.,
1996], a given player A can either increase his own payoff by pressing a button A,
or reduce another (fictitious) player B’s payoff by pressing a button B. In this study,
gradually increasing doses of TE cypionate or placebo were administered over the
course of several weeks (150 mg/week for two weeks, 300 mg/week for two weeks
and 600 mg/week for two weeks) and decision-making behaviour was tested at the
end of the respective substance administration cycle. TE treatment (compared to
placebo) resulted in a significantly higher number of button B presses. The experi-
mental design of this study was disadvantageous due to a number of factors. First,
TE cypionate was administered over several weeks and might have influenced ex-
periences outside the laboratory. These experiences might have confounded the
behavioural measure in the task. Second, the doses of TE that were used led to
changed parameters in the hypothalamo-pituitary axis (the authors reported sig-
nificant suppression of FSH, LH and prolactin concentrations; see also discussion
section 5.5.6 on page 109). These confounds prevent us from learning about the
causal role of TE effects on behaviour. Third, subjects were deceived (i.e. the in-
teracting partner was fictitious). Therefore, in essence, the behavioural measure
reported in this study cannot be considered as social decision making according to
our operationalisation (see section 1).
The public’s view about testosterone The well known fact that males have
much higher circulating levels of TE than women likely contributed to the forma-
tion of public beliefs about this hormone. It can be assumed that people associate
the hormone with the stereotype ”manliness”, which includes physical attributes
such as body strength but also behaviours such aggressiveness, dominance, and im-
pulsivity. In addition, the public’s view about TE was certainly also influenced by
reports in the news media describing homicides committed by athletes who abused
anabolic steroids. Following the publication of a study in the late eighties showing
that androgen abuse may lead to psychiatric conditions including manic episodes,
major depression and even delusions and hallucinations [Pope and Katz, 1988], the
issue received attention on the part of defence lawyers. They described individuals
who committed homicide while taking steroids, hoping to improve their legal posi-
tions in court. Pope and Katz [1990] described three men who impulsively commit-
ted crimes while taking anabolic steroids and who successfully used steroid induced
rage (’roid rage’) as a legal defence. These issues suggest that the general public has
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endorsed the view that TE causes aggression, violence, and anti-social behaviour.
However, these cases are anecdotes and not scientific evidence. So far, there is one
study available showing results that reflect the public’s view about TE. Following
a double-blind, placebo controlled TE administration, participants had to fill out
questionnaires assessing their mood [Bjorkqvist et al., 1994]. A third control group
received no substance and subjects in this group were also informed about the fact
that they neither received TE nor placebo. The authors found that self-reported
anger, irritation, impulsivity and frustration scores were higher in subjects who
received placebo compared to the TE group or the control group. These results sug-
gest that TE administration may raise expectations, rather than an actual increase
in anger and irritability.
2.3.5 Summary
Neuroendocrinology is a relatively old discipline [Carmody, 2008]. Previously, a vast
number of behavioural experiments using TE administration have been conducted,
mostly in rodents, generally showing an increase in social aggression. Nonetheless,
relatively little is known about this hormone’s role in human social behaviour. The
bulk of studies available on the topic is correlative, whereby TE is measured in
saliva or blood, and levels are correlated with (social) behaviour. However, TE can
also be injected or applied sublingually, with a cyclodextrin carrier system. The lat-
ter is favorable, since it is non-invasive as opposed to injections and does therefore
not produce stress in subjects. After sublingual application, blood levels of TE rise
quickly and reach its peak after 15 min. The time between maximum serum con-
centration and appearance of behavioural effects is delayed, perhaps due to the fact
that the conventional genomic pathway is slow. Research on this matter in females
has established a time-lag of approximately 4 h. Due to its lipophilic nature, non-
SHBG bound TE crosses the BBB easily and changes in circulating TE levels re-
flect changes in TE concentration within the CNS. In humans, increasing TE levels
have been associated mainly with dominant or status seeking behaviour. Opposed
to this stands the public view that TE causes aggressive, violent, and anti-social
behaviour. However, no study has yet investigated the role of TE administration in
a social decision making paradigm that involves real interacting partners bargain-
ing over money and no study has assessed the impact of public beliefs about TE on
social decision making.
Part IV
Empirical Part

Chapter 3
Study 1: Time-course of ”off-line”
prefrontal rTMS effects − a PET
study
3.1 Contributions
Experimental design was done by Daria Knoch and me. Data collection and data
analysis was done by me. Daria Knoch coauthored the paper that resulted from
this study. The comments about this study were written by me (section 3.7).
3.2 Introduction
TMS has become an indispensable investigation tool in cognitive neuroscience. Its
ability to transiently disrupt normal function of human brain regions makes it
a unique tool for studying the causal contribution of different brain areas to be-
haviour. A very promising approach is the application of low frequency rTMS for
several min before performing a given task in order to partially elude the unspe-
cific effects of concurrent rTMS stimulation [Abler et al., 2005, Pascual-Leone et al.,
1998, Robertson et al., 2003]. This approach, also referred to as ”off-line” rTMS, has
been used extensively in recent years. It has been applied, inter alia, to study pari-
etal contributions to spatial attention [Hilgetag et al., 2001] and spatial hearing
[Lewald et al., 2002], or prefrontal contributions to visual working memory [Mot-
taghy et al., 2002], affective processes [d’Alfonso et al., 2000] and decision making
[Knoch et al., 2006b].
Despite considerable advances in this field of research, cognitive neurosciences still
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rely primarily on the use of functional imaging. Imaging experiments, however,
do not allow drawing firm conclusions about the nature of neural network nodes:
activation could be spuriously correlated with task performance and not necessary
for proper task execution [Sack and Linden, 2003, Sack et al., 2005, 2007, Walsh and
Cowey, 2000]. rTMS seems to be a method well suited for studying the functional
relevance of a cortical region, which has been previously identified by a functional
imaging experiment, for a specific cognitive function [Hallett, 2007].
When designing an experiment using ”off-line” low frequency rTMS, several as-
pects should be considered. First, the duration of the ”off-line” disruptive effect
restricts the number of trials in an experiment and, hence, the data collection. Pre-
vious studies [d’Alfonso et al., 2000, Mottaghy et al., 2002, Robertson et al., 2001]
have provided some information about the duration of behavioural effects after low
frequency ”off-line” long-train rTMS applied to the DLPFC. The findings of these
studies led to the formulation of a rule of thumb: The duration of the after effects is
generally half the duration of the stimulation train [Robertson et al., 2003]. How-
ever, these studies only report behavioural measures and provide no information
about the duration of the neurophysiological effect of ”off-line” low frequency rTMS
applied to the PFC. Second, stimulation of the homologue contralateral region as a
control stimulation site has proven to be an expedient strategy for the control of the
side effects of rTMS intervention. Likewise, the side effects of rTMS intervention
that ultimately influence the outcome variable are similar. rTMS induces muscle-
twitches and tickling sensations at the stimulation site. Especially when rTMS is
applied to frontal regions, it causes discomfort, constituting a possible confounding
effect [Abler et al., 2005]. As these side effects typically are equally present in the
homologue contralateral region one can control for them by also stimulating this
region. Thus, if - for example - the stimulation of the right DLPFC causes a be-
havioural change in task performance while the stimulation of the left DLPFC does
not, this effect cannot be attributed to the side effects of rTMS. However, a con-
tralateral control stimulation is only reasonable if a unilateral stimulation leads
to unilateral, and not bilateral neurophysiological ”off-line” effects. It is therefore
important to know whether ”off-line” rTMS leads to unilateral or bilateral lasting
effects. Third, related to the second point, one should consider that applying rTMS
to a given brain region not only affects the target site itself, but also brain areas ef-
fectively connected to the target area. Such remote effects evoked by low frequency
rTMS over prefrontal areas have been shown in several studies [Kimbrell et al.,
2002, Knoch et al., 2006c, Nahas et al., 2001, Ohnishi et al., 2004, Speer et al.,
2003]. These studies, however, differed from the usual ”off-line” protocol in that ei-
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ther rCBF [Nahas et al., 2001, Speer et al., 2003] or glucose uptake [Kimbrell et al.,
2002] was measured ”online”, (i.e., during rTMS application) or in that the duration
of the stimulation trains were shorter than usual in the ”off-line” approach [Knoch
et al., 2006c, Ohnishi et al., 2004].
Despite the wide-spread use of ”off-line” rTMS in cognitive tasks, and more recently,
social cognitive neuroscience, no experiment has ever investigated the time-course
of the neurophysiological lasting effects after a single train of low-frequency rTMS
applied to the PFC. We specifically designed our study to assess the issues men-
tioned above. We were particularly interested in the after effects of right sided
prefrontal stimulation as we previously found lateralised behavioural effects using
this stimulation protocol [Knoch et al., 2006a]. We used H215O PET to assess the
effects of rTMS on rCBF. An advantage of this imaging technique is the possibility
to compare the relative size of regional blood flow across different brain regions and
over time. We applied one single train of low-frequency rTMS to the right DLPFC
of twelve subjects and subsequently performed eight sequential H215O PET scans.
3.3 Materials and methods
3.3.1 Subjects
Twelve healthy right-handed male subjects [25.3 ± 4.0 years, mean ± standard de-
viation (SD)] participated in the study that the local ethics committee approved. All
subjects provided written informed consent. Subjects had no history of psychiatric
illness or neurological disorder and were naive to TMS.
3.3.2 PET procedures
We used H215O PET as a measure of regional synaptic activity. Eight sequential
scans were performed in each subject (one baseline scan, seven post stimulation
scans). PET scans were acquired on a whole-body scanner (DLS GE Medical Sys-
tems, Waukesha, WI) in 3D mode with a 15-cm axial field of view. In each scan, 300 -
400 MBq H215O were administered as a bolus using a remotely controlled injection
device. Injection of the H215O bolus was initiated with an automatic preparation
and pump system 30 s before the start of the actual H215O PET scan. The accumu-
lated radioactivity counts over 60 s were then taken as measure for cerebral blood
flow. Data were reconstructed into 35 image planes with a resolution of 7 mm full
width at half maximum (FWHM). Subject preparation included the insertion of an
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indwelling cubital vein catheter for injection of the H215O. In order to ensure com-
plete head fixation, the head of the subject was confined in a vacuum cushion. The
scan room was darkened and subjects wore foam earplugs for hearing protection.
One low-dose CT scan for attenuation correction was performed at the beginning
of the experiment, which was immediately followed by the baseline H215O scan.
Subjects kept their eyes closed during all scans. The remaining seven scans were
divided into two blocks. Each block consisted of three and four scans, respectively
(Figure 3.1). The order of the two blocks was pseudorandomised across subjects.
3.3.3 Location of the target region
For the exact localisation of the stimulation site, a T1- weighted MRI was acquired
for all subjects prior to the PET-experiment. The right DLPFC was located based
on fixed coordinates: x = 39, y = 37, z = 22, radius = 6 in Talairach space. These
coordinates were then transformed to each subject’s native brain space using Brain-
voyager QX 1.6 software (Brain Innovation BV, Maastricht, NL). The real-time neu-
ronavigation option for Brainvoyager QX 1.6 with the Zebris CMS20S measuring
system for real-time motion analysis (Zebris Medical GmbH, Isny, GE) allowed cor-
rect placement of the TMS coil in space.
3.3.4 rTMS procedure
rTMS was applied to the right DLPFC for 15 min before each PET scanning block
(see Figure 3.1). A Magstim Rapid 2 Stimulator (Magstim, Winchester, USA) and
a commercially available figure-of-eight-coil (70 mm diameter double circle, air-
cooled) was used. Intensity of stimulation was set to 54% maximum stimulator
output. The coil was held tangentially to the subject’s head with the handle pointing
rostrally. Each subject received one train of 15 min duration at 1 Hz (900 pulses)
before each block of PET scanning, amounting to a total of 1800 pulses per session
and subject. The time interval between the two stimulation blocks was 30 min.
The rTMS parameters employed were well within recommended safety guidelines
[Wassermann et al., 1998].
3.3.5 Image analysis
All images were processed using Statistical Parametric Mapping software SPM99
(Wellcome Department of Imaging Neuroscience, UCL, UK. http://www.fil.ion.ucl.u-
k/spm). Image processing was performed as follows: Head movements were cor-
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Figure 3.1: Experimental design. To achieve a virtual time resolution of 4 min
between H215O scans, we set up an interleaved scanning procedure. In every ses-
sion (A, B), each scanning sequence was preceded by a baseline scan, which was
followed by 15 min of 1 Hz rTMS at a fixed intensity of 54% maximum stimulator
output and either scanning block A or B. Time points (in min after rTMS train) of
H215O scans are indicated within the grey arrow. t = time.
rected using the least-squares method and images were then normalised into stereo-
taxic space [Montreal Neurological Institute coordinates (MNI) as provided by SPM-
99] by bilinear interpolation using a PET template. Scans were smoothed using a
Gaussian filter of 15 mm in-plane and axial FWHM in order to improve the signal
to noise ratio. To remove the effect of global differences in cerebral blood flow be-
tween scans, a subject-specific ANCOVA scaling of global activity to a mean of 50
ml/100 g/min was applied.
3.3.6 Region of interest analysis
We performed whole-brain analyses after 1, 5, 9, 13, 17, 21 and 25 min to deter-
mine the contrast with the largest rCBF response to low-frequency rTMS. Based on
these analyses, the contrast ”1 min > baseline” was used to determine regions of
interest (ROIs) in the PFC (see Table 3.1; for rCBF increases or decreases in other
than prefrontal cortical regions please see Table 3.2 and Table 3.3). Analysis of
later time points did not reveal additional clusters of either significantly increased
or decreased rCBF. The ROIs were defined as follows: for the stimulation site, a
spherical ROI was defined (MNI- coordinates, radius and volume of ROI: x = 50, y
= 48, z = 16; radius = 7 mm, volume = 339 mm3). A second spherical ROI was cre-
ated in the right VLPFC (x = 42, y = 42, z = -8; radius = 7 mm, volume = 339 mm3)
and a third spherical ROI was created in the right inferior frontal sulcus (x = 32, y
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= 36, z = 20; radius = 7 mm, volume = 339 mm3). Three homotopic contralateral
ROIs were defined by mirroring the ROIs in the right hemisphere using MARSBAR
[Brett et al., 2002]. In order to control for unspecific arousal effects [Critchley et al.,
2000], please see discussion section), two additional control regions were defined in
the cerebellum (ipsilaterally: x = 32, y = -70, z = -41 and contralaterally: x = -32,
y = -70, z = -41; both 16936 mm3). ROIs were then normalised to baseline and
analysed using SPSS version 13.0 (SPSS, Inc., Chicago, IL, USA). A two-way re-
peated measures analysis of variance (ANOVA) was calculated for each region with
the factors: ”hemisphere” (left/right) and ”time” (1, 5, 9, 13, 17, 21 and 25 min).
3.3.7 Masked correlation analysis
Subject specific time-courses were derived from the right DLPFC and the control
region (left/right cerebellum) using MARSBAR [Brett et al., 2002]. These individ-
ual time-courses were then incorporated as covariates of interest (correlation anal-
ysis). The linear association between rCBF at every time-point and each value
derived from the ROI in the right DLPFC and the control region was tested on
a voxel-by-voxel basis using the SPM covariates option. To focus only on those
regions within the PFC that showed significant rCBF changes in response to ”off-
line” low frequency rTMS, the correlation analysis of rCBF in the right DLPFC was
subsequently masked by the subtraction contrast ”1 min > baseline” (P < 0.001,
corresponding to a single-voxel threshold of t > 3.22). Threshold in the correlation
analysis was set at P < 0.001, corresponding to a single-voxel threshold of t > 3.22.
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3.4 Results
3.4.1 Time-course of ”off-line” prefrontal rTMS effects on rCBF
The contrast ”1 min> baseline” revealed a significant rCBF increase at the stimula-
tion site (P < 0.05, corrected for multiple comparisons over the whole brain). Figure
3.2 illustrates the anatomical coordinates of the stimulation site chosen for naviga-
tion and the corresponding region of increased rCBF.
Figure 3.2: Three-dimensional illustra-
tion depicts the chosen stimulation coor-
dinates (x = 39, y = 37, z = 22; radius =
6) and the locus of significant increase in
rCBF at the stimulation site. Blue spot,
stimulation coordinates; orange spot, sig-
nificantly increased rCBF.
The contrasts at other time-points (i.e. 5, 9,
13, 17, 21, 25 min after rTMS) showed no
significant rCBF effects compared to base-
line (P < 0.05, corrected for multiple com-
parisons over the whole brain). After hav-
ing identified the time-point where rTMS
effects were most prominent, we used this
contrast to define ROIs for further analysis.
Besides the activation cluster at the stim-
ulation site, increased rCBF was present
in two other prefrontal areas, i.e. in the
VLPFC (BA47) and in the inferior frontal
sulcus (BA46/48) which were all located ip-
silateral to the stimulation site (P < 0.001,
uncorrected; see Table 3.1). These three
regions were then defined as ROIs as de-
scribed in the methods section.
The two-way repeated measures ANOVA re-
vealed a significant main effect of ”time” (F
= 2.98, df = 6,66; P = 0.01) and ”hemi-
sphere” (F = 6.62, df = 1,11; P = 0.03) in the
stimulated region. Importantly, the ”hemi-
sphere”x”time” interaction was significant (F = 6.40, df = 6,66; P < 0.001), indi-
cating that the stimulated region shows a time effect of rCBF that is specific to
one hemisphere [Figure 3.3 (A)]. In the VLPFC, a significant main effect of ”hemi-
sphere” (F = 15.09, df = 1,11; P = 0.003), but not ”time” (F = 1.44, df = 6,66; P
= 0.21) was identified. As in the DLPFC, the ”hemisphere”x”time” interaction was
also significant in the VLPFC (F = 2.68, df = 6,66; P = 0.02) [Figure 3.3 (B)]. In
the inferior frontal sulcus, a significant main effect of ”hemisphere” (F = 5.72, df
= 1,11; P = 0.04) was identified. However, neither the main effect of ”time” (F =
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1.38, df = 6,66; P = 0.24) nor the interaction term (”hemisphere”x”time”) was sig-
nificant (F = 0.49, df = 6,66; P = 0.81) [Figure 3.3 (A)]. Thus, this region shows
a hemispheric rCBF effect that is not time specific [Figure 3.5 (A)]. In the control
region (cerebellum), the main effect of ”hemisphere” was not significant (F = 3.275,
df = 1,11; P = 0.098), while the main effect of ”time” was significant (F = 3.28,
df = 6,66; P = 0.007) [Figure 3.3 (B)]. The interaction effect ”hemisphere”x”time”
was not significant (F = 1.39, df = 6,66; P = 0.23), suggesting that there is no time
effect of rCBF specific to one hemisphere in the control region [Figure 3.5 (B)]. In
summary, these findings suggest a spatially and temporally well described specific
”off-line” effect of prefrontal rTMS on blood flow in the DLPFC (BA45/46) and the
VLPFC (BA47).
Table 3.1: Prefrontal brain regions that show significantly increased rCBF 1 min
after rTMS.
Brain region BA Hemisphere MNI coordinates T value
x y z
DLPFC† BA 45/46 R 44 44 -1 8.31
VLPFC‡ BA 47 R 42 42 -8 4.39
Inferior frontal sulcus BA 46/48 R 32 36 20 3.77
BA, Brodmann area; R, right.
† Maxima of regional increases in normalised rCBF based on the contrast ”1 min< baseline” (P< 0.05, corrected for multiple comparisons over the whole brain).
‡ Maxima of regional increases in normalised rCBF based on the contrast ”1 min<baseline” (P< 0.001, uncorrected).
Figure 3.4 shows the results of the masked correlation analysis. A significant pos-
itive correlation of the time-course of activity in the stimulated region with the
time-course of activity in the VLPFC (BA47) was revealed (T = 8.31). We found no
regions that showed significant negative correlations in the PFC (Table 3.4). More-
over, we found no significant correlation between the time-course of rCBF in the
control region (left/right cerebellum) with the time-course of rCBF in the DLPFC
(BA45/46).
In summary, we found increased rCBF in the stimulated area, i.e., DLPFC (BA45/46)
and in two other prefrontal regions ipsilateral to the stimulated site: the VLPFC
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Figure 3.3: The time-course (1 to 25 min) of mean normalised activity (± SEM) in
the stimulated area [x = 50, y = 48, z = 16; BA45/46; (A)] and in the VLPFC [x =
42, y = 42, z = -8; BA47; (B)]. BL, baseline.
(BA47) and the inferior frontal sulcus. These regions showed a strong increase in
rCBF immediately after rTMS that returned to baseline within 9 min. Moreover,
we found that the time-course of rCBF in the VLPFC(BA47) is correlated with the
time-course of rCBF in the stimulated area.
3.5 Discussion
This study examined the neurophysiological effect of one long-duration train of low
frequency rTMS applied to the right DLPFC. By sequentially measuring rCBF after
prefrontal stimulation we were able to investigate three issues in this study: (1) the
duration of the ”off-line” neurophysiological effect, (2) whether unilateral prefrontal
stimulation leads to unilateral or bilateral ”off-line” effects and (3) the effects of low
frequency rTMS on remotely connected areas.
The most prominent increase in rCBF was found 1 min after the rTMS train in the
right DLPFC (BA45/46) and in the right VLPFC (BA47). While other studies found
effects with a delay of several min after cessation of the rTMS train [Chouinard
et al., 2003, Johnson et al., 2007], we did not find significantly changed rCBF at
later time points, as revealed by whole-brain analyses. One possible explanation is
that in the former study a different brain region was stimulated (the left primary
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Figure 3.4: The time-course of rCBF in the VLPFC (BA47) correlates positively
with the time-course of rCBF in the stimulated area (BA45/46). Results are dis-
played on a coronal section (y = 47 mm) of averaged anatomical MRI scans (corre-
lation analysis displayed at P < 0.001, uncorrected; masked with the contrast ”1
min > baseline” at P < 0.001, uncorrected). L, left; R, right.
and premotor cortex) while in the latter study behavioural effects and not rCBF
were reported after low frequency rTMS of the left DLPFC. In our study, ROI anal-
ysis revealed that increased rCBF in the right DLPFC (BA45/46) and right VLPFC
(BA47) showed a similar decay over time and returned to baseline values within
9 min. It is possible that the observed rCBF change is the result of unspecific
arousal or pain due to rTMS. The cerebellum has previously been reported to posi-
tively co-vary with experimentally induced cardiovascular arousal [Critchley et al.,
2000]. Additionally, it has been reported to be activated during capsaicine induced
pain [May et al., 1998]. To exclude that no such unspecific effects confounded our
results, we additionally analysed rCBF in both cerebellar hemispheres and found
no ”hemisphere”x”time” interaction. Moreover, we found no significant correlation
of the time-course of rCBF in the cerebellum as our control region with the time-
course of rCBF at the stimulation site (BA45/46). It thus seems that low frequency
rTMS indeed induced a temporally well circumscribed ”off-line”-rCBF effect on the
DLPFC (BA45/46) and the VLPFC (BA47) in our experiment. Thus, as a first con-
clusion, we find the general rule of thumb confirmed: the effects of 15 min of low
frequency rTMS applied to the right DLPFC last approximately half the duration
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of the stimulation train. One has to keep in mind, however, that with rCBF we
measured indirectly neuronal activity. It might be that rTMS affected neuronal
activity for a longer duration and in other regions. Moreover, rCBF was measured
while subjects were in a resting state. The effects of ”off-line” rTMS on rCBF might
be different depending on whether the targeted brain region is involved in the exe-
cution of a task or not.
Our results show that stimulating the right DLPFC ”off-line” leads to unilateral
prefrontal but not bilateral effects on blood flow. Most studies that applied rTMS
either ”off-line” or ”on-line” to the DLPFC found no effect under the site of stimu-
lation [Kimbrell et al., 2002, Ohnishi et al., 2004, Speer et al., 2003]. In one study
however, low frequency rTMS was applied to the left DLPFC and a bilateral activa-
tion in the DLPFC was found during stimulation [Nahas et al., 2001]. In contrast to
this, we measured rCBF ”off-line” and found only ipsilateral prefrontal activation
clusters. As a second conclusion, we therefore argue that experimental paradigms
in cognitive neuroscience which plan to use ”off-line” low frequency rTMS to affect
the functional integrity of an area in the PFC could employ a contralateral control
stimulation to avoid a side-effects bias.
By measuring rCBF sequentially, we were able to show that the time-course of
rCBF in the right VLPFC (BA47) is positively correlated with the time-course of
rCBF at the stimulation site (BA45/46). Within the PFC, the region in BA47 is
the only one that shows a time-course that is correlated with the one in the stimu-
lated area. This finding corroborates the hypothesis of connectivity between dorsal
(BA45/46) and ventral aspects (BA47) of the frontal lobes [Petrides and Pandya,
1999]. The VLPFC plays an important role in cognitive neuroscience, such as in
decision making [Sakagami and Pan, 2007] or emotion regulation [Ochsner et al.,
2004]. A direct stimulation of this brain area involves great discomfort for the
volunteer. As a third conclusion, we thus propose that ”off-line” long-train low fre-
quency rTMS applied to the right DLPFC can be readily used to target remote
connected areas, such as the VLPFC via indirect stimulation.
Interestingly, we only found lasting rCBF increases (and not decreases) in the PFC.
At first sight, this seems difficult to reconcile with studies showing a decrease in
cortical excitability after long-train low frequency rTMS [Chen et al., 1997, Ger-
schlager et al., 2001, Kosslyn et al., 1999, Maeda et al., 2000, Muellbacher et al.,
2000, Wassermann et al., 1998]. It is important to note, however, that these find-
ings were exclusively based on studies in primary motor or primary visual cortex.
It is assumed that rTMS as employed in our study induces long-term depression
(LTD) [Hallett, 2000, Thickbroom, 2007]. Since it has been suggested that rCBF
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changes reflect (pre)synaptic activity changes [Jueptner and Weiller, 1995], one
could expect a decrease in rCBF after LTD induction by low frequency rTMS. While
the chosen TMS protocol might indeed have induced a decrease in excitability in the
stimulated region, it also might have evoked compensatory regulatory responses
in order to maintain normal brain function, which in turn could account for the
observed increase.
On the other hand, the observed increased rCBF might also reflect an active in-
hibition process requiring energy [Ackermann et al., 1984]. This interpretation,
however, implies that low frequency rTMS as used in the current study increases
the activity of inhibitory interneurons. As several studies suggested, low-frequency
rTMS of the primary motor cortex does not lead to increased intracortical inhibi-
tion as revealed by subsequent paired-pulse TMS [Brighina et al., 2005, Daskalakis
et al., 2006, Fitzgerald et al., 2002, Romero et al., 2002]. Based on this evidence it
seems less likely that the observed increased rCBF results from an active inhibi-
tion process induced by low-frequency rTMS. Irrespective of the underlying phys-
iological mechanisms, one can assume that rTMS application induces a ”virtual
lesion” simply by adding neural noise to the system [Husain et al., 2002, Walsh and
Cowey, 2000, Walsh and Rushworth, 1999]. The observed increase in rCBF could
then again be interpreted as a regulatory response with a time-course reflecting the
duration of the ”virtual lesion” effect.
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3.6 Supplementary material
Figure 3.5: The time-course (1 to 25 min) of mean normalised activity (± SEM) in
the inferior frontal sulcus [x = 32, y = 36, z = 20; (A)] and in the cerebellum [x =
32, y = -70, z = -41; (B)]. Please note that the time-course of rCBF in these regions
does not correlate with the time-course of rCBF in the stimulated region (BA45/46).
BL, baseline.
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Table 3.2: Clusters of significant rCBF increase 1 min after stimulation compared
to baseline (P < 0.001, uncorrected).
Brain region Side T value MNI coordinates
x y z
Prefrontal cortex
DLPFC (BA45/46) R 5.31 50 48 16
VLPFC (BA47) R 4.39 42 42 -8
Inferior frontal sulcus (BA46/48) R 3.77 32 36 20
Other
Precentral gyrus (BA6/44) R 5.06 58 8 28
Posterior insula R 4.84 38 -18 -4
Paracentral lobule L 4.42 -12 -42 68
Supramarginal gyrus L 3.76 56 -22 32
Putamen R 3.71 30 10 -4
Anterior insula L 3.64 -30 8 8
Operculum R 3.49 50 14 4
Supplementary motor area R 3.41 6 -16 56
Table 3.3: Clusters of significant rCBF decrease 1 min after stimulation compared
to baseline (P < 0.001, uncorrected).
Brain region Side T value MNI coordinates
x y z
Parahippocampal gyrus R 4.40 26 -4 -36
Temporal pole R 4.09 18 12 -40
Middle temporal gyrus L 3.92 -66 -54 -12
Lingual gyrus L 3.71 -26 -60 0
Precuneus R 3.50 28 -56 0
3.6. Supplementary material 51
Table 3.4: Brain regions which show a time-course of rCBF that negatively cor-
relates with the time-course of rCBF in the stimulated region. Results are listed
based on the correlation analysis (P < 0.001, uncorrected), masked with the con-
trast baseline > 1 min (P < 0.001, uncorrected).
Brain region Side T value MNI coordinates∗
x y z
Parahippocampal gyrus R 4.33 25 -6 -36
Lingual gyrus R 4.13 -25 -63 4
∗ coordinates of peak cluster T value in correlation analysis (P< 0.001), masked with contrast 1 min> baseline (P< 0.001).
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3.7 Further comments on Study 1
Summary of main findings There are three main results of the study presented
in this chapter. First, 15 min of ”off-line” low frequency rTMS of the right DLPFC
leads to rCBF changes in the PFC which last approximately half the duration of
the stimulation train itself. Second, right dorsolateral prefrontal stimulation leads
to ipsilateral prefrontal rCBF effects. Third, low-frequency rTMS of the dorsal as-
pects of the frontal lobe (BA45/46) leads to rCBF changes in areas assumed to be
effectively connected with the stimulation site, such as the VLPFC (BA47).
These findings will be briefly discussed in the context of a recent social decision
making experiment that used that same rTMS protocol applied to the same stim-
ulation site as employed in the experiment described in this chapter. Furthermore
the often used term ”virtual lesion” in the context of in vivo experiments will be
discussed in the context of a recent in vitro study.
3.7.1 ”Off-line” rTMS of the DLPFC and social decision mak-
ing
The first study that reported on the neuroanatomical correlates of responder be-
haviour in the Ultimatum Game [Sanfey et al., 2003] reported that both the an-
terior insula and the lateral PFC (bilaterally) are more strongly activated when
responders face unfair offers compared to when they face fair offers. Since fMRI
data are correlative, the causal role of the lateral PFC in influencing responder be-
haviour is unclear. A recent rTMS experiment aimed to overcome the correlation-
causation problematic with respect to the results reported by Sanfey et al. [2003].
They applied ”off-line” rTMS to the dorsolateral prefrontal cortices of 52 subjects
(left DLPFC, n = 17; right DLPFC, n = 19; sham, n = 16) who were in the role of the
responder in an anonymous Ultimatum Game with a stake size of CHF 20. They
limited the proposer’s strategy space, meaning that only offers of CHF 10, 8, 6, or
4 were possible. Obviously CHF 10 is the fair offer, because it splits the stake size
equally, while CHF 4 is the most unfair offer. The authors suggest that inhibition
of a pre-potent response may be relevant for the responder behaviour in the Ulti-
matum Game because he/she faces two competing goals: a fairness goal (to punish
the proposer for having made unfair offers) and self-interest (to keep the money).
The question is which motivational impulse should be restrained.
The lateral PFC is generally thought to be involved in executive control, goal main-
tenance, and the inhibition of pre-potent responses [Miller and Cohen, 2001]. Thus
by applying ”off-line” low-frequency rTMS to the DLPFC, Knoch et al. [2006b] in-
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vestigated whether the transient ”virtual lesion” of the lateral PFC will lead to a
change in acceptance rate. The results showed that the group receiving rTMS to
the right DLPFC has a significantly higher acceptance rate than those receiving
rTMS applied to the left DLPFC and those receiving sham rTMS. Because subjects
self-reported fairness judgments with regard to different offers were not changed,
the authors suggested that subjects who received right prefrontal rTMS are less
able to resist the economic temptation to accept even unfair offers.
Since the stimulation coordinates in the experiment presented in this chapter were
the same, we may cautiously interpret the data reported by Knoch et al. [2006b]
in the light of our findings. Compared to baseline, we found increased rCBF in
BA46/48 and BA47 and rCBF was correlated in these two regions over time indi-
cating a possible connectivity. These results fit nicely with those of Knoch et al.
[2006b], because although they applied rTMS to the DLPFC, it is rather BA47
(VLPFC, mostly right lateralised) that has been related to inhibitory control func-
tions [Aron et al., 2003]. Therefore, it might be possible that the observed increase
in proposer offers were due, in part, by the indirect (transsynaptic) stimulation of
the VLPFC via the DLPFC. These two brain regions have been shown to be ef-
fectively connected using antero- and retrograde tracers in monkeys [Petrides and
Pandya, 1999].
Because we still know little about the neurophysiological processes that underlie
in vivo and in vitro effects of rTMS, an important open question is how the unspe-
cific stimulation of millions of neurons in the target area may result in prolonged
”disruption of normal function”.
3.7.2 Virtual lesion
A number of papers including the one presented in this chapter use the term ”vir-
tual lesion” to refer to the effects of low frequency rTMS applied to the cortex [Sack
et al., 2007, George et al., 2002, Knoch and Fehr, 2007]. When TMS is used in single
pulse mode, the term might be adequate, since it occurs first because the stimulus
transiently synchronises the activity of a large proportion of neurons under the coil
and second because it induces a long lasting generalised inhibitory post-synaptic
potential that reduces cortical activity for the next 50− 200 ms depending on stim-
ulus intensity [Siebner and Rothwell, 2003].
When low frequency rTMS is applied to a cortical area, it might be rather incor-
rect to speak of a transient ”virtual lesion”. First, rTMS of a given brain region
does not lead to a loss of function. Second, it was proposed that LTD might be the
mechanism by which low frequency rTMS induces transient decreases in general
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excitability of the neuronal networks in the targeted brain area [Sven Bestmann,
personal communication, Robertson et al., 2003, Hallett, 2000, Thickbroom, 2007].
The observations of decreased cortical excitability after low frequency rTMS are,
however, exclusively based on research in the motor system and therefore difficult
to apply to prefrontal regions. Furthermore, it is likely that LTD after low frequency
rTMS will only occur in a minority of neurons.
The hypothesis that rTMS might cause excitation and LTD by only affecting a mi-
nority of the whole population of neurons was recently corroborated by a in vitro
experiment using single pulse magnetic stimulation (MS) of neuronal cell cultures
[Rotem and Moses, 2008]. Using a concentric ring of one-cell layer rat hippocam-
pal neurons, Rotem and Moses [2008] investigated the neuronal network responses
to single pulse MS and made two important suggestions based on their findings:
first, it is not the total projected length that counts in MS but rather the length of
the longest contiguous stretch along the direction of the electric field. For example,
a long, but zigzag shaped axon may not be excited by MS. Second, some neurons
do not respond at all to MS, even when magnetic field density is doubled. Other
neurons respond already at lower intensities. The authors suggested that a sub-
population of initiating neurons contribute to the excitation of the network after
MS and that this might indicate that MS is a single neuron phenomenon.
It is important that future in vitro studies will also investigate the effects of low
frequency MS on neuronal responses. If a possible LTD induction is also restricted
to a few initiating neurons one might hypothesise that also a few neurons determine
the disruptive effects of low frequency rTMS in vivo. Therefore, it might be more
correct to speak of a ”disruption of normal function” of a brain area rather than of
a ”virtual lesion”.
Chapter 4
Study 2: DRD4 polymorphism
predicts the effect of L-DOPA on
gambling behaviour
4.1 Contributions
Experimental design, pilot study, data collection were performed by Daria Knoch
and me. Data analysis was done by me. Daria Knoch coauthored the paper that
resulted from this study. The comments on this study were written by me (section
4.6).
4.2 Introduction
Several lines of evidence link the DAergic system to impulse control [Cools, 2008],
and substance addiction [Dalley et al., 2007], as well as to non-substance addictions
such as pathological gambling [Bergh et al., 1997]. Anecdotal evidence for the latter
comes from numerous case reports describing the development of pathological gam-
bling in Parkinson’s disease after initiation of DAergic drug treatment [Voon et al.,
2007a]. However, not all individuals with Parkinson’s disease are at risk of develop-
ing pathological gambling during DAergic treatment. The fact that only a subgroup
of Parkinson’s disease patients treated with DAergic drugs develops pathological
gambling suggests an underlying vulnerability, possibly mediated by genetic fac-
tors. Support for this notion derives from research in healthy subjects suggesting
that genetic vulnerability for pathological gambling may be linked to variation in
the D4 receptor gene [Perez de Castro et al., 1997]. The D4 receptor gene contains a
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highly polymorphic region within its third exon, also referred to as the DRD4 exon
III variable tandem number repeat polymorphism (DRD4 polymorphism) [van Tol
et al., 1992]. The polymorphism is an imperfect repeat translated into 16 amino
acids found to be present two to eleven times in different alleles of DRD4 [Lichter
et al., 1993, Ding et al., 2002]. Presence of the 7R allele has been associated with
pathological gambling and other impulse control disorders such as attention-deficit
hyperactivity disorder (ADHD) [Faraone et al., 2001, Li et al., 2006]. Furthermore,
among individuals with ADHD, the 7R allele has been associated with poor per-
formance on laboratory measures of impulse control as well [Langley et al., 2004].
Poor impulse control and ADHD are both related to pathological gambling [Steel
and Blaszczynski, 1998, Specker et al., 1995].
These lines of evidence suggest that both DAergic drug challenge and the DRD4
polymorphism might also influence gambling behaviour measured in the labora-
tory. In particular, an individuals’ behavioural response to a drug challenge might
be determined by genetic variation in the DRD4 gene. Up to now, no study has
investigated how the interaction of genetic factors with the administration of a
DAergic drug affects gambling behaviour. This can only be investigated by using a
pharmacogenetic approach.
Building on the evidence mentioned above, we hypothesised that the administra-
tion of a DAergic drug has a differential effect on gambling behaviour depending
on variation in the D4 receptor gene. In order to explore a gene-drug interaction on
gambling behaviour systematically, we used healthy subjects to avoid the confound-
ing effects of Parkinson’s disease. We used L-DOPA versus placebo administration
to investigate how the presence or absence of the 7R allele determines the impact
of DAergic stimulation on gambling behaviour.
4.3 Results
We administered 300 mg of the DA precursor L-DOPA in a double-blind, parallel-
groups, placebo-controlled experiment to 205 healthy males. Subjects played 40
trials of a gambling task that was administered 60 min after L-DOPA intake, when
the plasma level of L-DOPA reached its peak (mean ± SEM: 4.35 ± 0.38 mg/l blood
serum). These pharmacokinetic parameters were determined in a separate study
involving ten healthy young male subjects (Figure 4.2). In the gambling task (see
section 4.5), participants opened 6.05 out of ten boxes on average (SD ± 0.82).
ANOVA revealed no increase in gambling behaviour associated with L-DOPA com-
pared to placebo administration [F = 0.81, P = 0.37, see Figure 4.1 (A)]. L-DOPA
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administration differed, however, with respect to its impact on gambling behaviour
as a function of the subjects’ DRD4 polymorphism. We found a significant positive
interaction between drug treatment and genotype on gambling behaviour [F = 5.43,
P < 0.05, see Figure 4.1 (B)]. Specifically, increased gambling was observed in sub-
jects who carry the 4/7 genotype and who received L-DOPA, but not in those who
received L-DOPA and who carry the 4/4 genotype (t = 3.27, P < 0.01; Cohen’s d =
0.90). In contrast, no genotype effect on gambling behaviour was observed in the
placebo group (t = 0.11, P = 0.92).
Figure 4.1: Gambling behaviour as indexed on the y axises by the average number
of opened boxes over all trials that were ended by the subject voluntarily. (A) No in-
crease in gambling behaviour was observed following L-DOPA compared to placebo
administration. (B) Increased gambling behaviour was observed in subjects who
carry the 4/7 genotype of the DRD4 polymorphism and who received L-DOPA but
not in those who carry the 4/4 genotype. This genotype effect on gambling behaviour
was absent in the placebo group. Error bars indicate SEM.
The observed effect on gambling behaviour was not attributable to side-effects of
drug administration. There were no significant drug treatment group differences
on measures of side-effects at baseline and before the gambling task was performed
(all P < 0.10), except for the factor ”alertness”, for which a marginally significant
difference was revealed (t = 1.68, P = 0.09). However, the interaction term be-
tween drug treatment and genotype on gambling behaviour remains significant if
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we control for this factor (F = 4.66, P = 0.03).
Because the observed differential drug effect on gambling behaviour could be at-
tributed to pre-existing trait differences in subjects’ propensity to act impulsively,
we measured subjects’ self-reported impulsivity and self-control capacity, at the be-
ginning of the experimental session. However, we found no differences across drug
treatment groups for either impulsivity (F = 0.35, P = 0.56), or self-control (F =
1.38, P = 0.24). In addition, the interaction term between drug treatment and
genotype on gambling behaviour remains significant if we control for impulsivity
and self-control (F = 4.53, P = 0.03). Finally, measures of impulsivity and self-
control did not correlate with gambling behaviour (r = -0.01, P = 0.79; r = -0.03, P
= 0.64, respectively).
4.4 Discussion
This study is the first to show that individual genetic predispositions predict gam-
bling behaviour in a non-clinical sample in response to the administration of a
DAergic drug. Specifically, we found that L-DOPA administration was associated
with increased gambling behaviour in carriers of the 4/7 genotype of the DRD4
polymorphism, but not in carriers of the 4/4 genotype. These findings highlight the
importance of including genetic information in pharmacological intervention stud-
ies investigating behaviour, and might explain the failure of previous attempts to
find an effect of DAergic stimulation on gambling behaviour.
Previous association studies have linked the 7R allele of the DRD4 polymorphism
with higher self-reported novelty-seeking [Kluger et al., 2002] and laboratory mea-
sures of impulsivity [Congdon et al., 2008] in the healthy population. These findings
suggest an important role of the D4 receptor in the modulation of inhibitory con-
trol processes. Poor inhibitory control has been discussed as a critical vulnerability
marker for drug abuse in humans [Verdejo-Garcia et al., 2008] and predicted high
doses of cocaine self-administration in rats [Dalley et al., 2007].
Our findings suggest that the relative ability for impulse control as determined by
the DRD4 polymorphism genotype might be predictive of whether an individual is
able to avoid excessive drug intake after exposure to a DAergic drug. Finally, our
results are of clinical relevance for Parkinson’s disease patients as the individual
DRD4 polymorphism genotype might assist in predicting the probability of devel-
oping an impulse control disorder, such as a pathological gambling.
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4.5 Methods
4.5.1 Subjects
205 healthy young males with mean (± SD) age of 23.5 years (± 3.6) took part in
a double-blind, placebo controlled experiment that the local ethics committee had
previously approved. Standardised interviews, under supervision of a neurologist
(P.S.), revealed that the subjects had no significant general psychiatric, medical,
or neurological disorders. They were included in the study after having provided
written informed consent. Three subjects reported nausea and their data were
discarded. Two subjects were excluded from further analysis because they did not
understand the instructions.
4.5.2 Experimental procedure
All experiments took place at the experimental laboratory of the Institute for Em-
pirical Research in Economics in Zurich, Switzerland, where a total of ten sessions
were conducted. All sessions started at 08:30 a.m. Subjects were randomly as-
signed to receive either a single dose of 300 mg of Madopar (consisting of 300 mg
L-DOPA and 75 mg benserazide, a peripheral DOPA-decarboxylase inhibitor) or a
placebo. They then received a standardised meal and 100 ml of water. 12 h (i.e. on
the evening before the behavioural experiment) and 30 min before L-DOPA admin-
istration, subjects were required to ingest 10 mg of domperidone in order to avoid
possible peripheral DAergic side effects such as nausea and orthostatic hypoten-
sion. After subjects read the instructions, we checked whether they understood
the rules of the gambling task by having them answer control questions. With the
exception of two subjects, all answered these control questions correctly. To assess
potential side effects of L-DOPA treatment, subjects were asked to rate their subjec-
tive feelings, using visual analogue scales (VAS). Subjects performed the gambling
task 60 min after L-DOPA intake, when the plasma level of L-DOPA reached its
peak (Figure 4.2). The task was implemented in zTree software and presented on
computer screens [Fischbacher, 2007]. After the gambling task, subjects also filled
out personality questionnaires that assessed motor impulsivity [Patton et al., 1995]
and self-control [Tangney et al., 2004], and were asked to perform a mouthwash to
collect buccal epithelial cells for the preparation of DNA. Subjects received a flat
fee of CHF 100 (CHF 1.00 ≈ $ 0.90) for participation in the experiment. Each point
in the gambling task was worth CHF 0.25. Payment according to the earned points
was done for each subject in private at the end of the experiment.
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Figure 4.2: Pharmacokinetics of L-DOPA concentration [mg/l] in serum after oral
administration of 300 mg of Madopar to ten healthy young men. Error bars indicate
SEM.
4.5.3 Genotyping
Subjects rinsed their mouth with 25 ml of Candida-mouthwash and spit it into
sterile 50-ml polypropylene tubes. The samples were stored at 4 ◦C if they were not
to be processed within 2 h of collection. From these samples, DNA was extracted
and amplified (Genetica, Zurich, Switzerland).
The following procedure was performed: the tubes were centrifuged at 1600 RCF/g
using a Hettich Rotina 46 S centrifuge. The remaining pellet was resuspended in
180 µl ATL and Proteinase K was added (30 µl of a 20-mg/ml stock solution). This
solution was hybridised for 3 h at 58◦C. Then, the solution was stirred and trans-
ferred into a 2 ml test tube. The tube was centrifuged for 1 min at 10’000 rpm. From
this a standard EZ1 DNA extraction was performed using the BioRobot EZ1 follow-
ing the QIAamp Blood Kit Protocol (obtained from Quiagen AG, Hombrechtikon,
Switzerland). The obtained DNA concentration was then measured using a pho-
tometer (NANODROP, Fisher Scientific GmbH, Schwerte, GE). The exon III repeat
region of the DRD4 receptor was characterised by PCR amplification employing the
following primers:
F5’-TTCCTACCCTGCCCGCTCATGCTGCTGCTCATCTGG-3’
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R5’-ACCACCACCGGCAGGACCCTCATGGCCTTGCGCTC-3’
PCR reactions were performed using 5 µl Master Mix (Thermo scientific), 2µl pri-
mers (0.5 M), 0.6µl Mg/Cl2 (2.5 mM), 0.4l DMSO 5% and 1l of water to total of 9l
total volume and an additional 1l of genomic DNA was added to the mixture. All
PCR reactions were employed on a Biometra T1 Thermocycler (Biometra, Goettin-
gen, Germany). PCR reaction conditions were as follows: preheating step at 94.0◦C
for 5 min, 34 cycles of denaturation at 94.0◦C for 30 s, reannealing at 55◦C for 30 s
and extension at 72◦C for 90 s. The reaction proceeded to a hold at 72◦C for 5 min.
The reaction mixture was then electrophoresed on a 3% agarose gel (AMRESCO)
with ethidium bromide to screen for genotypes.
4.5.4 Subject grouping according to the DRD4 exon III VNTR
polymorphism genotype
Subjects were grouped according to the two most frequent genotypes (Table 4.1).
The 4/4 and the 4/7 genotypes account for the majority of the observed genotypes
(64% and 20%, respectively) at a global level [Lichter et al., 1993] and in our sample
(47.50% and 21.00%, respectively). We thus compared a group of subjects who are
homozygous for the 4R allele (4/4 homozygotes, n = 95) with a group of subjects
that carry a 4R and a 7R allele (4/7 heterozygotes, n = 42). As an alternative
approach, we grouped subjects according to presence or absence of the 7R allele. In
this analysis, we compared a group of subjects who carry at least one 7R allele (n
= 54) with those who do not carry the 7R allele (n = 146). This grouping yielded
similar results. ANOVA revealed again a significant positive interaction between
drug treatment and genotype on gambling behaviour (F = 4.73, P < 0.05). In the
L-DOPA group, 7R allele carriers opened significantly more boxes than those who
do not carry the 7R allele (t-test, two-sided, t = 2.67, P < 0.01; Cohen’s d = 0.63).
Again, there was no genotype effect present in the placebo group (t-test, two-sided,
t = 0.42, P = 0.68).
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Table 4.1: Genotype frequencies for the DRD4 polymorphism, sorted according to
frequency.
Genotype Number of subjects Frequency
4/4 95 47.5%
4/7 42 21.0%
2/4 32 16.0%
3/4 13 6.5%
2/7 5 2.5%
7/7 5 2.5%
2/2 2 1.0%
3/7 2 1.0%
4/5 2 1.0%
2/5 1 0.5%
3/3 1 0.5%
Total 200 100%
4.5.5 Gambling task
Gambling behaviour was measured by letting subjects play 40 trials of a task, in
which the risk associated with acting increases dynamically with each additional
action taken [Slovic, 1966]. Figure 4.3 depicts one exemplary trial of the gambling
task. In this task, the expected marginal value of opening an additional box (pro-
vided one has already successfully opened n− 1 boxes) is positive for opening up to
five boxes and is negative for opening six boxes or more (see Figure 4.4).
4.5.6 Measures of drug related side effects
VAS were recorded prior to substance administration and just immediately before
the gambling task was performed. Items in the scale were alert - drowsy, calm - ex-
cited, strong - feeble, muzzy - clear-headed, well coordinated - clumsy, lethargic - en-
ergetic, contented - discontented, troubled - tranquil, mentally slow - quick-witted,
tense - relaxed, attentive - dreamy, incompetent - proficient, happy - sad, antago-
nistic - amicable, interested - bored and withdrawn - gregarious. These dimensions
were presented as 10 cm lines on a computer screen and volunteers marked their
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Figure 4.3: One exemplary trial of the gambling task. In each of the 40 trials,
subjects were presented with an array of ten closed boxes on a computer screen. In
a sequence from left to right, subjects had the possibility of opening box after box (by
pressing a button one). They were told that nine boxes contained monetary rewards
(”win boxes”), while one box (”loss box”) contained a ”devil” that would make them
lose all the money they had collected in the current trial, simultaneously ending
the current trial. Opening a ”win box” was associated with a payoff of one point (=
0.25 CHF). After opening a ”win box”, subjects had to decide whether they wanted
to open another box or to terminate the trial (by pressing a button two) and earn all
win points. Once the ”loss box” was opened, subjects earned nothing for that trial.
The ”devil” was randomly assigned to one of the ten boxes in each trial, thus, no
learning was involved in this task. The average number of boxes opened in those
trials that subjects voluntarily terminated served as an indicator of a subject’s level
of gambling behaviour. In the above example, the subject had won nothing for that
trial, since the loss box was opened after successfully opening of five win boxes.
Figure 4.4: The red line depicts the expected marginal value of opening a further
box given one has already opened n safe boxes (y axis on the left: EV [n/safe on
n − 1]). Thus, opening more than five boxes is associated with a negative expected
marginal value and is considered a risk seeking strategy while opening less than
five boxes is considered a risk averse strategy. The histogram (y axis on the right:
density) indicates the distribution of the average number of boxes that have been
opened by subjects in the placebo group in trials where they decided to stop and
earn the accumulated points.
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current state on each line with a mouse click. In line with previous studies, the fac-
tors ”alertness”, ”contentedness”, and ”calmness” were calculated from these items
[Norris, 1971, Chamberlain et al., 2006].
4.5.7 Statistical analysis
The statistical analysis is based on univariate one-way ANOVA. All tests are two-
sided tests. We examined the impact of drug [with a binary indicator for drug
indicating whether the subject received L-DOPA (= 1) or placebo (= 0)], the impact
of genotype [with a binary indicator for genotype in subjects who carry the 4/7 geno-
type (= 1) and the 4/4 genotype (= 0)], and the impact of the interactions between
these two variables in an univariate one-way ANOVA on gambling behaviour. In
a more detailed analysis, we also incorporated the two trait variables impulsivity
and self control.
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4.6 Further comments on Study 2
Summary of main findings Using a simple and intuitively comprehensible gam-
bling task, we found that subjects who receive L-DOPA and carry at least one copy
of the 7R allele of the DRD4 polymorphism show increased gambling behaviour
compared to non-7R carriers. L-DOPA administration was not associated with a
change in gambling propensity compared to placebo administration when the DRD4
polymorphism was not considered. Moreover, the DRD4 polymorphism did not pre-
dict gambling behaviour in the placebo group. Finally, we did not observe a corre-
lation between self-reported impulsivity and self-control with gambling behaviour.
The following discussion begins with a critical evaluation of the gambling task from
a sensorimotor perspective. Subsequently, different sections speculate about the po-
tential influence of two brain regions in which both the DRD4 has been reported to
be expressed and which are also often reported to be activated during risky deci-
sion making: the PFC and the vStr. Since the relative impact of different brain
structures cannot be clearly addressed in pharmacogenetic studies investigating
behaviour, additional neuroimaging studies may serve this purpose. This combina-
tion has, however, inherent pitfalls, which will be discussed. Finally, the findings
reported in this chapter will be discussed from a clinical perspective and ethical
issues of using pharmacogenetics for individualised treatment in psychiatry will be
addressed.
4.6.1 Motor repetitive behaviour
Rylander [1972] first used the term ”punding” to describe a distinctive stereotyped
behaviour in amphetamine and cocaine addicts. Punding is a peculiar behaviour
characterised by an intense fascination with repetitive, purposeless, excessive ac-
tivities such as the manipulation of technical equipment, handling, examining or
sorting through common objects, grooming and hoarding [Friedman, 1994]. These
behaviours seem to be similar to the stereotyped behaviours that occur in animals
given amphetamine [Ridley and Baker, 1982]. The phenomenon has only recently
come to the attention of physicians, since accumulating evidence shows punding in
Parkinson’s disease patients, triggered by DAergic replacement therapy [Friedman,
1994, Black and Friedman, 2006]. These lines of evidence suggest that punding is
related to DAergic stimulation.
The gambling task [Slovic, 1966] presented in this chapter requires two basic motor
actions: to press a button one on a computer keyboard to open boxes containing
monetary rewards and to press another button two to stop opening boxes and collect
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the accrued money in the trial. Since subjects opened 6.05 boxes on average (SD =
0.82), they performed seven motor actions on average: six identical actions (button
one presses) and one different action (a button two press) at the end of a trial. Thus,
if the administration of L-DOPA caused motor repetitive behaviour reminiscent of
punding this could have resulted in a more frequent repetition of button one presses
compared to placebo administration, appearing as increased gambling propensity.
We did, however, not observe a significant difference in gambling behaviour be-
tween the two drug treatment groups suggesting that L-DOPA treatment alone did
not cause motor repetitive behaviour in the context of the gambling task. If repeti-
tive behaviour were the underlying mechanism by which the 7R carriers contribute
to the pharmacogenetic effect on gambling, it would remain to be explained how the
different D4 receptor isoforms (the 7R and 4R variants) differentially affect motor
repetitive behaviour.
A recent knock-out study in mice suggested that the D4 receptor might play a mod-
ulatory role in DAergic drug stimulated motor behaviours. When the D4 receptor
was disabled, DA synthesis and the concentration of DA’s major metabolite DOPAC
(see section 2.2.1) increased in the dorsal striatum and the mice showed locomo-
tor supersensitivity to ethanol, cocaine, and methamphetamine [Rubinstein et al.,
1997]. It is a feasible hypothesis that DAergic stimulation also caused increased
repetitive behaviours in these D4 receptor knock-out mice, although the authors
did not report on stereotypical behaviour specifically. The authors discussed the
observed motor hyper-responsiveness to DAergic drugs in the context of the often
reported blunted response of the 7R receptor variant to DA (see section 2.2.1). Al-
though speculative, it might therefore also be possible that subjects who carry a 7R
allele react with motor repetitive behaviour in response to DAergic stimulation.
4.6.2 DRD4 modulation
Prefrontal cortex and impulse control
Based on the suggestion that the lateral PFC plays an important role in impulse
control [Miller and Cohen, 2001, Aron et al., 2003] and the observation that lesions
to this structure may cause an increased gambling propensity in the laboratory
[Clark et al., 2003, Manes et al., 2002, Floden et al., 2008] suggests an important
role of this brain region in influencing gambling behaviour in healthy subjects as
well. Moreover, the observation that the absence of DA in PFC is detrimental for
its normal function [Brozoski et al., 1979] together with the observation that lat-
eral PFC function may stand in an inverted U-shaped relationship with DA content
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[Vijayraghavan et al., 2007, Cools, 2008] suggests that DAergic modulation of lat-
eral prefrontal cortical function might influence gambling behaviour by causing a
deficit in impulse control. In the following, the potential role of poor impulse control
as a cause of the observed increase in gambling behaviour will be discussed in the
context of the potential role the DRD4 might play herein.
Descriptive model The ”overdose” model is a rather descriptive attempt to ex-
plain findings of reversal learning deficits in the ”on-state” in medicated early
Parkinson’s disease patients [Gotham et al., 1988, Swainson et al., 2000, Cools
et al., 2003]. It states that L-DOPA medication leads to a relative DAergic ”over-
dose” of the vStr, which is projecting to the ventrolateral aspects of the PFC, re-
sulting in diminished impulse control [Cools et al., 2003]. We found, however, no
main effect of L-DOPA on gambling behaviour suggesting that the hypothesised
DAergic ”overdose” of the lateral PFC [Cools et al., 2003] was perhaps not pro-
nounced enough to cause impulse control deficits. It might, however, be possible
that only those subjects who have a genetic predisposition for poor impulse control
and pathological gambling (the 7R carriers) responded to L-DOPA administration
with an increased gambling propensity. In other words, while the DAergic ”over-
dose” of the ventral frontostriatal circuitry might have been insufficient to cause
impulse control deficits in non-7R carriers, it might have been sufficient in the 7R
carriers. This explanation does, however, not explain how an increased DA concen-
tration might interact with the DRD4 on a mechanistic level.
Mechanistic model A first question that arises is whether the L-DOPA medi-
ated increase in DA levels directly affect the DRD4 in the PFC or whether they
are stimulated via the DAergic projections from the striatum to the PFC. To an-
swer this question, we have to know where DA synthesis and storage in the hu-
man brain after L-DOPA administration is highest (see section 2.2.1). An early
study investigated the distribution of AADC in post mortem human brains and
reported highest AADC concentration in striatum, the hypothalamus and the ven-
tral tegmental area along with relatively low concentrations in the PFC [Lloyd and
Hornykiewicz, 1972]. More recent studies have used either 18F-labelled L-DOPA or
11C-labelled L-DOPA as PET tracers to assess the rate of DA synthesis and storage
in the living human brain [Gjedde et al., 1991, Moore et al., 2003, Ito et al., 2008].
These studies generally report a high rate of DA synthesis in the nigrostriatal and
mesolimbic DAergic system and a relatively low synthesis in the PFC. In summary,
these studies suggest that L-DOPA administration mainly increases DA concentra-
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tions in the striatum and less so in the PFC. Therefore, stimulation of the DRD4 in
PFC are likely a result from an increased DA concentration in the striatum via its
projections to the PFC.
The next question is how a presynaptic DA release impacts on the two DRD4 vari-
ants (4R and 7R) and how these are different in modulating PFC function. Although
highly speculative, the literature reviewed in section 2.2.1 on page 15 allows the fol-
lowing reasoning. There is evidence that the DRD4 is located in human PFC [Lahti
et al., 1997, Primus et al., 1997]. Moreover, there is evidence that the DRD4 is ex-
pressed on GABAergic interneurons in primate PFC [Mrzljak et al., 1996] and that
DRD4 activation inhibits GABAergic transmission [Wang et al., 2002]. Therefore,
less DRD4 activation leads to increased GABAergic transmission in PFC. Molecu-
lar biological approaches have shown both an increased and decreased functional
potency of the 7R variant compared to the 4R variant [Asghari et al., 1995, van
Craenenbroeck et al., 2005, Wedemeyer et al., 2007, Schoots and Van Tol, 2003]. If
the 7R variant is less efficient in signal transmission compared to the 4R variant,
carriers of the 7R allele would show decreased inhibition of GABAergic signalling
and thus increased PFC function. Increasing DAergic transmission and the result-
ing increase in DRD4 activation should therefore result in a relative improvement
of PFC function compared to non-7R carriers. Improved PFC function might re-
sult in better impulse control and should, therefore, result in decreased gambling
propensity. However, if the 7R variant is more efficient in signal transmission as
suggested by Wedemeyer et al. [2007], this were more consistent with the results
presented in this chapter.
Given the many uncertainties with respect to the anatomical distribution and func-
tions of the DRD4 in humans, these arguments are purely speculative and the
question whether DAergic stimulation of the DRD4 leads to a general improve-
ment or reduction in PFC function remains elusive. Nevertheless, the finding that
the DRD4 is located on GABAergic interneurons in PFC suggests its potentially
powerful role in modulating PFC function.
Striatum and reward sensitivity
It is generally assumed that DAergic neurons projecting from the vStr to the PFC
play a critical role in the anticipation of rewards [Schultz et al., 1997]. As opposed
to the many studies that have shown a predominant prefrontal localisation of the
DRD4, others have suggested that it is located in the vStr [Svingos et al., 2000,
Rivera et al., 2002]. This suggests that the receptor may mediate a direct effect on
reward processing. The DRD4, which belongs to the D2-type receptors, exerts an in-
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hibitory effect on adenylyl cyclase to and formation of cAMP upon DA binding [Chio
et al., 1994, see also section 2.2.1 on page 14]. Because some have suggested that
the 7R variant is less efficient in inhibiting cAMP formation [Asghari et al., 1995],
the 7R allele carriers may have chronically elevated cAMP levels which might re-
sult in a relatively higher baseline activity (or excitability) of the vStr [Hutchison
et al., 2002].
A recent imaging genetics study revealed that the presence of the 7R allele was
associated with relatively greater vStr reactivity in response to positive and neg-
ative feedback-associated monetary rewards [Forbes et al., 2009]. Furthermore,
the study has shown that the presence of the 9R allele of the 40 base-pair VNTR
DAT polymorphism, which is linked with reduced DAT expression and presumably
greater striatal synaptic DA content [Heinz et al., 2000], showed increased vStr
activation in the anticipation of the monetary rewards as well. The authors sug-
gested that increased vStr activity might be associated with a relatively increased
sensitivity for immediate rewards together with a decreased sensitivity for adverse
outcomes [Forbes et al., 2009]. Thus, L-DOPA administration, which increases DA
concentration mainly in the striatum [Ito et al., 2008], could have led to a relatively
greater increase in vStr activity in 7R allele carriers compared to the 4R carriers.
These subjects perhaps placed more weight on the monetary rewards versus po-
tential losses in the gambling task, resulting in the observed increase in gambling
propensity.
4.6.3 Self-reported impulsivity and gambling behaviour
The finding that gambling behaviour was not related to self-reported measures
of impulsivity and self-control is consistent with previous studies that also failed
to observe relations between self-reports and behavioural measures [Crean et al.,
2000, Mitchell, 1999]. The lack of such a correlation might be due to the fact that
self-report questionnaire based methodology have inherent limitations. Specifi-
cally, self-report methods may not reflect the most reliable and accurate data re-
garding a particular construct, given a number of factors. First, participants may
perceive negative consequences as a result of reporting particular behaviours and
may therefore not answer truthfully. There also is the possibility that participants
lack insight into their behaviour, which could interfere with their ability to provide
an accurate report. Finally, individuals might be prone to certain self-perception
biases that diverge dramatically from their actual behaviour. Performance on a be-
havioural task is less sensitive to biased self-perceptions, lack of insight into own
behaviour and is less influenced by social desirability.
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4.6.4 Specificity of L-DOPA effects
Because Parkinson’s disease is associated with a loss of DAergic neurons and L-
DOPA supplementation is an efficient strategy to treat the disease, one might ex-
pect that L-DOPA administration leads mainly to an increase in DA concentration
in the CNS. However, many studies suggest that the effects of L-DOPA administra-
tion are by no means uniquely DAergic.
Norepinephrine A study conducted in the seventies suggested that the admin-
istration of L-DOPA systemically to rats appears to modify brain NE metabolism.
There seems to be a transient increase in brain NE concentration, because some of
the L-DOPA that enters the brain is converted to NE and there is an apparent brief
acceleration in the turnover of brain NE. These changes occurred when L-DOPA
could still be detected in the brain [Chalmers et al., 1971]. However, others have
also reported that a very large intraperitoneal dose of L-DOPA (450 mg/kg) did not
affect brain NE content [Everett and Borcherding, 1970].
Serotonin Since L-DOPA may act as an inhibitor of TrpH [Naoi et al., 1994], it
may interfere with the biochemical conversion of tryptophan to 5-HTP, which is
the rate limiting step in 5-HT synthesis. Therefore L-DOPA administration may
have a substantial impact on the serotonergic system and it was reported that the
intraperitoneal administration of 400 mg/kg L-DOPA to mice led to a 63% reduction
in 5-HT content in the brain [Everett and Borcherding, 1970].
Implication for modulation of PFC Although DA is the most potent endoge-
nous ligand known to activate the DRD4, it can also be activated by NE at submi-
cromolar concentrations [Lanau et al., 1997, Newman-Tancredi et al., 1997]. While
the affinity of the DRD4 for NE is at least five- to ten-fold lower than its affinity for
DA [Oak et al., 2000], NE has a higher affinity for the D4 receptor than for any of
the adrenergic receptors [Arnsten and Li, 2005]. The DRD4 has therefore also been
referred to as a catecholamine receptor [Arnsten and Li, 2005]. Since NE terminals
are present in the PFC, this suggests that L-DOPA administration might have two
non-dissociable effects on the DRD4 in the PFC: one direct effect via increasing DA
levels and an indirect effect via increasing NE levels.
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4.6.5 Combining fMRI with neuropharmacological modula-
tion
Given the unclear relative impact of DRD4 stimulation on the activity of different
brain structures (vStr and PFC), it might be interesting to run a follow-up neu-
roimaging experiment using the same gambling task, polymorphism and a phar-
macological approach similar or equal to the one described in this chapter.
However, there are some important caveats to be considered when combining neu-
ropharmacological modulation with neuroimaging experiments that rely on the
BOLD (blood oxygen level dependent)-signal or H215O-PET as measures of rCBF.
DAergic drugs are known to have vasoactive properties and may have direct effects
on measures of rCBF. It has been shown that the vascular tree in prefrontal cortical
areas of rhesus monkeys is directly innervated by DAergic afferents [Krimer et al.,
1998]. A cholinergic vasodilatative system originating in the rat medial septal nu-
cleus has also been shown [Sato et al., 2001] and activation of nicotinic receptors
has been reported to cause an increase in cortical [Uchida et al., 1997] and hip-
pocampal rCBF [Kagitani et al., 2000]. 5-HT might play a similar role given its
vasoconstrictory affect via the 5-HT1B receptor [5-HT1B agonists (triptans) are used
in the treatment of migraine headache, which is hypothesised to result from a va-
sodilation of cranial blood vessels].
Central to this issue is the question whether these vasoactive properties are inde-
pendent of any vasodilation due to the increased metabolic demands after neuronal
activation. For example, if a phasic DA release increases the activity of a given
post-synaptic neuron and in doing so increases local rCBF, this were not a major
problem because the increased rCBF then reflects an increase in activity of the
post-synaptic neuron. However, all the studies mentioned [Krimer et al., 1998,
Sato et al., 2001, Kagitani et al., 2000, Uchida et al., 1997] have controlled for
metabolic effects and blood pressure [Sato et al., 2001] and still found vasodilata-
tory effects mediated by the cholinergic and DAergic system suggesting that the
release of certain neurotransmitters may affect rCBF in ways that are independent
of the neuronal metabolic process.
However, most of the fMRI designs are relatively protected from the tonic vasoac-
tive effects of psychotropic drugs for two reasons. First, the modelling uses a high-
pass filter that removes the effects of slow drifts in the BOLD signal. Second,
one identifies regionally specific foci of differential activation. These foci are likely
smaller than the region of monoaminergic or cholinergic vascular innervation.
In the future, more emphasis should be placed on PET tracer studies [e.g. using
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a recently developed tracer that is highly selective for the DRD41, Prante et al.,
2008] in the context of decision making experiments because only these studies
may answer some of the questions mentioned above.
4.6.6 Does one gene determine one behaviour?
It has been pointed out already in the eighties that genes do not stand in a simple
unidirectional relationship with behaviour [Pfaff, 1989]. The relationship between
the one-dimensional simplicity of the genome (20′000− 25′000 genes) and the three-
dimensional complexity of the CNS is clearly not straightforward. It was suggested
that the one gene/one enzyme hypothesis can in no way become a one gene/one
synapse hypothesis let alone a one gene/one behaviour hypothesis [Changeux et al.,
1998]. The action of many genes may ”converge” on a given brain structure, and a
single gene may have ”divergent” effects on several different structures [Changeux,
1983].
An important issue in this context is the observation that the development of the
CNS is guided by temporally and spatially regulated expression of proteins sug-
gesting that some genes and proteins may influence CNS organisation only during
specific phases of its development. For example Gorski et al. [2003] investigated the
in vivo requirements for brain derived neurotrophic factors (BDNF) during develop-
ment by generating an early-onset forebrain-specific BDNF mutant mice. Although
these mice completely lacked BDNF in the forebrain during embryogenesis, they
were healthy and no loss of specific cortical excitatory or inhibitory neurons was
detected at birth. However, the neocortex of 5 wk old mice was thinner, which was
attributable at least partly to neuronal shrinkage suggesting that BDNF plays a
general role in supporting neuronal survival.
A recent study has shown that the valine allele of the BDNF valine to methionine
substitution (Val(66)Met) polymorphism was associated with significantly higher
mean neuroticism scores on the NEO-Five Factor Inventory in healthy subjects
[Sen et al., 2003]. In light of the fact that BDNF is a universal neurotrophic
factor supporting neuronal growth in the CNS in many species [Zigmond et al.,
1999], it seems particularly difficult to provide any mechanism by which the BDNF
Val(66)Met polymorphism might affect behaviour.
There is evidence to suggest that this developmental issue might be relevant for
the DRD4 polymorphism as well. For example, Durston et al. [2005] reported that
the average prefrontal gray matter volume is partially determined by the absence
12-[4-(4-(2-18F-ethoxy)phenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine
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versus presence of the 7R allele. Therefore, one could speculate that the DRD4
might play a regulatory role in the neuronal growth of prefrontal cortical inhibitory
interneurons, on which the receptor is expressed (see also section 4.6.2). This sheds
a different light on the relationship between DA and its impact on the DRD4 in
adults. This issue is also important for the development of drugs which selectively
bind to the DRD4 and which might be relevant for the treatment of certain DRD4-
related psychiatric diseases.
Implications for pharmacogenetic studies Given the hypothetical impact of
the DRD4 polymorphism on brain development [Durston et al., 2005], the poly-
morphism may therefore be associated with a phenotype (e.g. ADHD) that rather
results from differences in brain morphology than from a difference in signal trans-
mission at the DRD4. A novel drug for the treatment of e.g. ADHD in adults may
therefore erroneously be informed by genetic association studies pointing towards
the DRD4 as a potential target for drug action. However, if a drug (e.g. olanzap-
ine) is used that binds specifically to the DRD4 and shows a DRD4 polymorphism
dependent effect on a certain behaviour or disease symptom, it may be assumed
that this in fact results from differences in signal transmission at the DRD4 and
not from general differences in CNS development. However, this argument is ex-
clusively valid for DRD4 selective compounds and not for e.g. L-DOPA, because of
its lack of specificity for the DRD4. A general increase in CNS DA availability stim-
ulates several types of DA receptors and their density and number may partly be
determined by regional brain volume in turn. Therefore, L-DOPA administration
may lead to behavioural effects that are conditional on the DRD4 polymorphism
but these differential effects may have their origin in the difference in brain mor-
phology. In summary, a pharmacogenetic approach to investigate behaviour or to
treat psychiatric diseases should use a drug that is specific for the receptor polymor-
phism under investigation [but see Cohen et al., 2007]. Likewise, a more precise
model of a gene-behaviour relationship can be established.
4.6.7 Implications for clinical practice in psychiatry
Pharmacogenetics has been proclaimed as a way of using genetic information in
medicine in general to improve patient outcome. One of the areas where these
techniques are likely to be applied in the future is in the pharmacotherapy of psy-
chiatric disorders [”personalised psychiatry”, see Morley and Hall, 2004]. While
pharmacogenetics has the potential to positively impact on the treatment of psy-
chiatric conditions, its use also raises some ethical and economic issues.
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Treatment of Parkinson’s disease
In this chapter, we show first evidence for a genotype dependent effect of anti-
Parkinsonian medication on gambling behaviour. At first glance these results sug-
gest that a subgroup of subjects might be vulnerable to pathological gambling. How-
ever, our experimental design does not allow making assertions about the general
population of Parkinson’s disease patients that suffers from pathological gambling.
We used healthy male students as subjects and a task that has not been tested for
external validity with respect to pathological gambling (as opposed to the South
Oaks Gambling Task ) [Lesieur and Blume, 1987] (but see section 5.5.3 on page
102). Moreover, we cannot draw conclusions from these results about a single in-
dividuum, since we have aggregate data at hand here. Most critically, however,
the present data do not inform about the behavioural addiction process that might
underlie pathological gambling. The investigation of the development of addiction
processes in a controlled laboratory environment is for ethical reasons unfeasible
in humans. Therefore, human addiction research is restricted to transsectional or
longitudinal studies of individuals that are already addicted or become addicted
during the study (e.g. pathological gamblers).
Therefore, the results presented here can only be viewed as a first hint for further
studies investigating genetic risk factors for pathological gambling in Parkinson’s
disease patients. A number of questions have to be answered before it is worthwhile
to bring genotyping of candidate genes such as the DRD4 gene into clinical routine
in the pharmacotherapy of Parkinson’s disease. These may include the following:
1. How does gambling behaviour relate to L-DOPA treatment and DRD4 geno-
type in Parkinson’s disease patients?
2. What other polymorphisms contribute to the same phenotype?
3. How does this relationship depend on disease severity/ stage?
4. What is the influence of patients’ sex?
5. Is there a drug dose − addiction severity relationship?
A hypothetical scenario To get a glimpse into future issues that may arise in
this context, we shall look at the following hypothetical scenario. Let’s assume
that we had initiated a longitudinal study with a sample of 250 Parkinson’s disease
patients not suffering from pathological gambling. Results show that within 1 y
after the initiation of L-DOPA therapy, six out of a 100 patients who carry a 7R
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allele had developed pathological gambling, but only three of all the 4R carriers.
Carrying a 7R allele thus triples the risk of suffering from pathological gambling
in these patients. We therefore consider new strategies for clinical practice in the
treatment of Parkinson’s disease.
Personalised treatment: costs and benefits To assess whether genotyping
could potentially help to improve drug therapy in Parkinson’s disease patients,
a coarse qualitative cost/benefit analysis will be given here. Some of the com-
mon costs of pathological gambling include financial hardship (via debts and asset
losses) that may lead to legal consequences, such as bankruptcy, loans, or criminal
acts to gain money [Ladouceur et al., 1994]. Costs imposed on the society by patho-
logical gambling include the cost of crimes committed by some individuals and costs
related to their treatment. Interpersonal problems between gamblers and their sig-
nificant others include domestic violence, relationship breakdown, neglect of family,
and may cause secondary costs due to the negative impact on the physical and men-
tal health of family members [Raylu and Oei, 2002].
A personalised treatment also bears costs. As part of the preventive strategy, psy-
chiatrists/ neurologists have to warn patients of the potential risk of developing the
gambling disorder due to DAergic drug treatment. They should be informed about
this fact before initiation of drug treatment [Voon et al., 2007a]. Moreover, drug
administration should be monitored more carefully by the physician in subjects at
risk, since an escalation of drug self-administration is often observed concomitantly
with the onset of pathological gambling [Voon et al., 2007b]. Such provisions are
relatively inexpensive, yet they might be effective.
On the other hand, insurance companies have to decide whether they are willing
to bear costs associated with the new treatment strategy. They will view pre-
therapeutic genotyping only as economic if the costs for genotyping and person-
alised treatment by the physician are offset by savings from avoiding the costs of
treating patients. The financial damage to an individual that suffers from patho-
logical gambling (see above) will not have to be covered by the insurance. However,
this does not apply to the costs that arise for the treatment of health problems
arising secondary to the gambling disorder. These secondary costs will be imposed
on the insurance company and will likely be higher than those for genotyping and
personalised treatment. Therefore, insurance companies have a clear incentive to
support or request pre-therapeutic genotyping of Parkinson’s disease patients in
the future.
Based on the results of the hypothetical study mentioned above, we now decide to
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employ the devised strategy for the treatment of all Parkinson’s disease patients
who carry a 7R allele. We therefore treat 6% of these 7R allele carriers correctly
and 94% incorrectly. This seems to be rather inefficient. However, since pathologi-
cal gambling has such a fatal impact on a patient’s social and economical wellbeing,
these costs are far outweighed by the relatively low costs of an adjustment of the
treatment strategy in the 7R allele carriers after genotyping of all 250 Parkinson’s
disease patients. However, a pharmacogenetics based treatment of Parkinson’s di-
sease patients bears a number of ethical risks mainly for the patients but also for
the society.
Patient discrimination Because individuals may suffer from discrimination,
patient privacy is an important issue raised by the application of pharmacogenetic
testing to clinical treatment [Morley and Hall, 2004]. Although genetic testing does
not show whether a patient will suffer from pathological gambling, testing may re-
sult in a patient being labelled as a ”high risk” individual. Such patients may suffer
similar insurance or employment discrimination to those individuals identified as
being at high risk of developing a genetic disease such as Huntington’s disease
[Morley and Hall, 2004]. Subject’s access to certain medications might also be re-
stricted, since it is possible that only certain medications interact with the DRD4
polymorphism to increase the risk for pathological gambling. Yet, these medications
might be also the most effective in treating motor symptoms for certain patients.
Gene patenting In the context of ethics and genetics, a bothersome issue is the
gene patenting laws. For example, the U.S. Patent Application No. 200-602-63359 is
issued for the human DRD4 and includes all associated ”cardiovascular disorders,
gastrointestinal and liver diseases, haematological disorders, neurological disor-
ders and respiratory diseases”. Most critically, the ”invention also features com-
pounds which bind to and/or activate or inhibit the activity of DRD4 as well as
pharmaceutical compositions comprising such compounds.”
Patenting of genes incur large costs on behalf of science, economy and society. Ge-
netic code is not simply a chemical substance, but rather a form of information
with many different functions. Scientific research should not be constrained by a
patent whose aim is to protect one commercial use, but in this case protects all
potential uses that are somehow linked to the information contained in the gene.
The monopolistic character of gene patents therefore impedes scientific progress.
In case of the U.S. Patent No. 200-602-63359, it is possible that the patent holder
will handicap research with the aim of developing more efficient ADHD medication.
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Moreover, patent holders may block access to genetic resources and will cause high
costs in the health care system, which have to be raised for continuing research and
development in medicine.
In principle, it is possible that the patent holders of the U.S. Patent No. 200-602-
63359 could also assert their claim if future DRD4 genotype-based therapies for
Parkinson’s disease were to be employed. This sheds a different light on the hypo-
thetical cost/ benefit analysis outlined above. It is questionable whether insurance
companies are also willing to cover costs of the patent claims.
The dopamine hypothesis of ADHD: revision necessary?
It is generally hypothesised that the neurobiological basis of ADHD is a relative
hypo-DAergic state and is based on numerous findings, including observations of re-
duced volume of DAergic brain structures (e.g. smaller caudate nucleus and globus
pallidus in ADHD subjects compared to control groups) [Swanson et al., 2007] and
the observation that administering methylphenidate (MPH) leads to a reduction
of ADHD symptomatology. MPH is an amphetamine that inhibits DA-reuptake by
binding to the dopamine transporter (DAT) and thereby increases synaptic avail-
ability of DA. The hypothesis is further supported by genetic association stud-
ies showing that genes related to the DAergic system may play a role in ADHD
[Faraone et al., 2005] with most consistent associations being reported for the DAT
gene and the DRD4 gene [Roman et al., 2001, Li et al., 2006].
However, the DA deficit hypothesis of ADHD has recently been challenged [Gonon,
2009]. For example, it has been shown that atomoxetine, which exclusively binds
and inhibits the norepinephrine transporter (NET), is also an effective treatment
of ADHD. Furthermore, it has long been known that MPH also binds to the NET
although with a somewhat lower affinity [Gatley et al., 1996, Kuczenski and Se-
gal, 1997]. Finally, the question arises whether L-DOPA that effectively treats the
DAergic deficits in Parkinson’s disease patients is also effective to treat ADHD.
The data presented in here suggest that DAergic stimulation is associated with
an increased propensity to gamble in subjects who carry at least one 7R allele.
If an increased gambling propensity can be viewed as a form of poor inhibitory
control (which is the primordial symptom of ADHD) it is surprising that L-DOPA
administration did not lead to a reduction in gambling propensity in the 7R allele
carriers.
Since we did not check whether ADHD symptomatology was present in our sub-
jects, we have to be cautious in drawing conclusions about populations of ADHD
affected individuals. Interestingly, however, previous studies showed that L-DOPA
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treatment of ADHD is not effective in treating symptoms [Overtoom et al., 2003].
Future studies should more closely investigate whether the differences in signal
transduction at the DRD4 are partly responsible for ADHD using D4 selective ago-
nists/antagonists (see also 4.6.6).
Chapter 5
Study 3: Prejudice and truth: the
effect of testosterone
administration on bargaining
behaviour
5.1 Contributions
Experimental design was done by Ernst Fehr and me. Data collection and data
analysis for the study presented in this chapter were done by me. Ernst Fehr coau-
thored the paper that resulted from this study. The comments on this study were
written by me (section 5.5).
5.2 Introduction and results
TE is a steroid hormone, which is secreted in mammals by male testes and, to a
much lesser extent, the female ovaries. TE is present in the CNS throughout life
and affects brain development and sexual behaviour. In rodents, TE administration
leads to substantial increases in aggressive behaviours [Beeman, 1947, Edwards,
1969]. Folk wisdom generalises and adapts these findings to humans, suggesting
that TE induces antisocial, egoistic, or even aggressive behaviours [Bjorkqvist et al.,
1994, Booth et al., 2006]. In fact, this ”wisdom” has even reached the courtrooms
because steroid induced rage has been used as legitimate defence in the United
States [Pope and Katz, 1990]. As we will document below, the folk wisdom also
strongly affected the subjects in our study because most of them believed in the
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folk hypothesis.
There is indeed evidence suggesting a link between TE and antisocial behaviour
in humans [Dabbs et al., 1995, Dabbs and Hargrove, 1997]. In a sample of 692
adult male prisoners, for example, those who had a history of rape, murder, and
armed robbery had higher salivary TE levels than those who had only a history of
theft and drug abuse [Dabbs et al., 1995]. According to disciplinary records, those
inmates with relatively higher TE levels were reported to be more involved in overt
confrontations in prison and more likely to violate prison rules compared to those
with relatively lower levels. A similar pattern was observed in a study comprising
87 female prison inmates [Dabbs and Hargrove, 1997].
While these facts are consistent with the folk hypothesis, they do not constitute
convincing evidence for two reasons. First, the evidence is purely correlative and
does not show that TE is causally involved in generating the observed behaviours.
Second, the alternative hypothesis proposing that TE plays an important role in
status-related behaviours in human social interaction can also explain the norm
violating behaviours [Mazur and Booth, 1998, Mazur, 2005, Josephs et al., 2003,
2006, Schultheiss et al., 1999, Rowe et al., 2004]. According to this hypothesis,
TE induces status-seeking and leadership in situations that constitute a potential
challenge to a person’s status. Thus, in settings such as prisons, where rigid social
hierarchies impose subordinate positions on individuals, those who are predisposed
to seek leadership and status may question the hierarchy in antisocial and rebel-
lious ways [Mazur and Booth, 1998, Booth et al., 2006]. Thus, the folk hypothesis
and the status hypothesis make identical predictions in these situations.
While the status hypothesis constitutes a plausible alternative to the folk hypoth-
esis, it unfortunately remains largely based on correlative evidence [Mazur and
Booth, 1998, Mazur, 2005, Josephs et al., 2003, 2006, Schultheiss et al., 1999, Rowe
et al., 2004]. However, a rigorous separation of the two hypotheses is possible be-
cause TE-induced leadership and status seeking may take a prosocial dimension if
the prosocial behaviour enables individuals to master a social challenge or to secure
their leadership. Thus, the task is to generate an experimental situation where the
folk hypothesis predicts antisocial behaviour while the status hypothesis predicts
prosocial behaviour.
The Ultimatum Game [Gueth et al., 1982] represents such a situation because pre-
vious evidence [Camerer, 2003, Knoch et al., 2006b] indicates the existence of a
strong fairness norm in this game. Thus, subjects can behave prosocially in this
game by obeying the norm or they can behave antisocially by violating it. We
therefore examined the impact of exogenously administered TE and placebo on the
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propensity to obey or violate the fairness norm in this game.
Real money is at stake in the Ultimatum Game; two parties, A and B, have to agree
on the division of 10 money units (MUs). Party A, often referred to as the proposer,
is in a kind of leadership position because only she can propose how the 10 MUs
will be allocated between A and B. Party B, often referred to as the responder, is
in the weaker position because B can only accept or reject A’s proposal, but cannot
make a counteroffer. Thus, A has the power to stipulate an ultimatum to B, which
gave the game its name. If B accepts A’s proposal, the proposed allocation will be
implemented. Party B can also reject A’s proposal, however; in this case, neither
party earns anything.
This bargaining game is ideal for our purposes because many studies [Camerer,
2003, Knoch et al., 2006b] indicate that player B perceives low bargaining offers
as unfair, while the equal split is the salient fairness norm in this situation. As a
consequence, many subjects in the role of B reject low offers, meaning that neither
player earns anything. From the viewpoint of the folk hypothesis, the question is
therefore whether the administration of TE increases the frequency of low offers.
In the context of our experiment, low offers constitute an unambiguous violation
of a prevailing normative standard and can thus be viewed as a form of antisocial
behaviour. Low offers can be considered antisocial, not just due to the fact that
they violate a fairness norm, but also because they bear the increased risk of social
conflict (i.e. a rejection), meaning that both players may ultimately end up with
zero earnings. Thus, the folk hypothesis unambiguously predicts that TE leads to
more unfair offers.
The status hypothesis proposes that subjects who receive TE will place a higher
value on status than subjects with placebo. Previous evidence suggests that this
impact of TE on status concerns is most likely to occur in situations in which sub-
jects’ status is potentially challenged [Mazur and Booth, 1998, Josephs et al., 2003,
2006, Archer, 2006]. This is exactly the situation of a proposer in the Ultimatum
Game, who has the power to make the offer and thus can influence the subsequent
course of action. The proposer can assert her leadership by achieving mutual coop-
eration (i.e., by inducing the responder to accept the offer), or she can risk the denial
of leadership by making an unfairly low offer. Thus, because the risk of rejection
implies a denial of leadership, subjects who place a high value on status gain more
from an acceptance compared to those placing a low value on status. Therefore, if
TE increases status concerns, we should observe fairer offers among subjects who
received TE. In a double-blind, placebo-controlled study design a total of 60 women
participated in our experiment in the role of a proposer. All of them were required
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to not take contraceptives, had a regular menstrual cycle and were in the early
follicular phase of the cycle, when the endogenous level of sex steroids tends to be
low and stable. Every subject played three independent Ultimatum Games with
three different responders. To avoid having the experience of acceptances or re-
jections affect the proposers’ behaviour, they did not receive feedback about their
responders’ actions until the end of the experiment. In each game, the proposer
could offer the responder 0, 2, 3 or 5 MUs (out of 10 MUs). 0.5 mg of TE or placebo
was applied sublingually 4 h before subjects played the Ultimatum Game. This is
a well established procedure [Tuiten et al., 2000] that has reliably shown to gen-
erate behavioural effects [van Honk et al., 2001, 2005]. We recruited only women
because the parameters (quantity and time course) for inducing neurophysiologi-
cal effects after a single sublingual administration of 0.5 mg of TE are known in
women [Tuiten et al., 2000], whereas these parameters are unknown in men. In
order to check whether subjects noticed the substance they had been given, we also
asked them whether they believed they received placebo or TE. Their beliefs were
unrelated to the actual substance they received (Mann-Whitney test, P = 0.208, n
= 60, two-tailed), indicating that they did not know what they had been given.
However, even though subjects did not know whether they received placebo or TE, it
is important to control for the possible influence of their beliefs because TE is prob-
ably one of the most widely discussed hormones in the popular press and, therefore,
it is possible that prior knowledge about TE might affect their behaviour [Bjorkqvist
et al., 1994]. Ethical concerns require researchers to inform subjects that they will
either receive a placebo or TE, and the prior knowledge about TE may pollute a
possible impact of TE on behaviour. In particular, subjects’ behaviour may be af-
fected by their belief in the folk hypothesis. A survey that we conducted several
months after the experiment confirmed subjects’ strong beliefs in the folk hypothe-
sis: they believed that TE increases contentious, selfish and aggressive behaviour.
52% of them even spontaneously mentioned the word ”aggressive” when asked to
indicate how TE administration affects the behaviour of individuals. We also gave
subjects a list of paired behavioural or intentional attributes such as ”aggressive
- peaceful”. The subjects then could express their views about whether TE makes
people strongly aggressive, weakly aggressive, weakly peaceful, strongly peaceful
or neither aggressive nor peaceful”. 80% of the subjects expressed the view that
TE makes people strongly or weakly aggressive. The list of paired attributes also
contained words such as contentious and selfish. 83% agreed that TE makes people
more contentious and roughly 50% thought that it makes them more selfish (only
5% thought that it makes them less selfish). In view of these strong subjective be-
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liefs in the folk hypothesis, we controlled for subjects’ beliefs about whether they
had received TE or placebo in our statistical analysis. In addition, we always con-
trolled for repeated measurements by taking each subjects’ average offer across the
three Ultimatum Games as the unit of observation.
The folk hypothesis predicts that proposers with TE make lower offers. In contrast
to this prediction, subjects who received TE actually made significantly higher of-
fers (ANOVA, main effect of TE, F = 5.78, P = 0.020, n = 60), with placebo subjects
offering on average 3.40 MUs, while subjects with TE offered 3.90 MUs [Figure 5.1
(A)]. Thus, while we find no support for the folk hypothesis, our results are consis-
tent with the status hypothesis. However, we also find strong support for a ”belief
effect”. Subjects who merely believed that they have received TE make much lower
offers than those who believed they received placebo [Figure 5.1 (B); ANOVA, main
effect of believed TE, F = 8.97, P = 0.004, n = 60]. Interestingly, if we control simul-
taneously for both the belief and the TE effects the belief effect is even larger than
the actual TE effect. The belief effect reduces offers by 0.92 MU while the pure TE
effect increases offers by 0.64 MUs. No interaction effect between TE and believed
TE is observed (ANOVA, interaction between TE and believed TE, F = 0.90, P =
0.346, n = 60).
Interestingly, the belief effect is present regardless of whether subjects actually
Figure 5.1: The proposers’ mean offers across treatments and beliefs. (A) Mean
offers in the placebo and the TE group. Subjects who received TE make signif-
icantly fairer offers. (B) Mean offers for the subjects who believed that they re-
ceived placebo compared to those subjects who believed that they received TE. Sub-
jects who believed that they received TE make much more unfair offers. Error bars
indicate SEM.
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received TE or whether they actually received placebo. Among the subjects who
were randomly assigned to the placebo group, those who believed that they received
placebo offered on average 3.66 MU, and 51% of the offers were even at the max-
imum of 5 MU [Figure 5.2 (A)]. This result is in sharp contrast with the offers of
those who actually received placebo but believed they received TE. These subjects
make extremely low average offers of 2.37 MU; only 10.5% of the offers were at the
maximum of 5 MU, while 53% of the offers were only 2 MU. We are not aware of
any other study that reports such low offers in the Ultimatum Game. Even the
proposers in the society with the lowest offer in the cross-cultural study of Henrich
et al. [2005] offered a higher average share (26%) to the responder [Henrich et al.,
2005]. A similar belief effect is present in those subjects who were randomly as-
signed to the TE group. The average offer in the group that actually received TE
and believed they received TE was 0.67 MU lower than in the group that received
TE and believed they received placebo [Figure 5.2 (B)].
The pure TE effect is present regardless of subjects’ beliefs. If we exclusively anal-
Figure 5.2: Distribution of proposers’ offers conditional on their beliefs. (A) Distri-
bution of offers for subjects who received placebo. Among these subjects, those who
believed that they received TE (red bars) make much more unfair offers compared
to those who believed that they received placebo (blue bars). (B) Distribution of of-
fers for subjects who received TE. A similar pattern prevails among these subjects:
those who believed that they received TE (red bars) make more unfair offers com-
pared to those who believed that they received placebo (blue bars). In both graphs,
the modal choice for those who believed that they received placebo is the fair split,
i.e., an offer of 5, while the modal offer is below 5 for those who believed that they
received TE.
5.2. Introduction and results 85
yse data from subjects who believed that they received placebo [Figure 5.3 (A)],
we find that those who actually received TE made relatively high average offers of
4.11 MU, with 63% of all offers at the maximum. In contrast, those who actually
received placebo made offers that were 0.45 MU lower and only 51% of the offers
were equal to the maximal offer. We observe an even stronger effect among those
who believe they received TE [Figure 5.3 (B)]. Those who believe they received TE
but actually received placebo offered only 2.37 MU, while those who share the same
belief but actually received TE offered 3.43 MU on average. This TE effect is also
visible in the salient rightwards shift of the distribution of offers depicted in Figure
5.3 (B).
Figure 5.3: Distribution of proposers’ offers across the placebo and the TE group.
(A) Distribution of offers for subjects who believed that they received placebo.
Among these subjects, those who received TE (violet bars) made more fair offers
compared to those who received placebo (green bars). (B) Distribution of offers
for subjects who believed that they received TE. A similar pattern prevails among
these subjects: those who received TE (violet bars) made much fairer offers than
those who received placebo (green bars).
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5.3 Discussion
Taken together, these results cast strong doubt on the folk hypothesis and are con-
sistent with the status hypothesis. However, higher offers among the subjects with
TE could also be due to a possible impact of TE on subjects’ mood or anxiety. For this
reason, we controlled for potential indirect effects of TE in several ways (see section
5.4). We measured subjects’ mood, their calmness, and their wakefulness immedi-
ately after substance administration and again 4 h later, immediately before they
made their decisions in the Ultimatum Game. Immediately after the administra-
tion of TE or placebo, the two groups were identical in all these dimensions (Mann-
Whitney tests: wakefulness P = 0.941, mood P = 0.863, calmness P = 0.287, n = 60,
two-tailed). There were also no differences between the TE and the placebo group
immediately before playing the Ultimatum Game (Mann-Whitney tests: wakeful-
ness P = 0.365, mood P = 0.157, calmness P = 0.411, n = 60, two-tailed). We also
measured changes between the first and the second measurement and found no dif-
ferences (Mann-Whitney tests: wakefulness P = 0.760, mood P = 0.328, calmness P
= 0.732, n = 60, two-tailed). These results indicate that TE neither influenced sub-
jects’ mood and arousal; nor did it affect changes in these variables throughout the
experiment. Therefore, the higher prevalence of fair offers in the TE group cannot
be attributed to indirect effects operating via these variables.
Perhaps our finding that TE increases fair bargaining behaviour can be attributed
to the effects of TE on anger or anxiety. Or maybe our randomisation did not work
perfectly and there were trait differences across the treatments in subjects’ propen-
sity to feel anger and anxiety. To address these questions, we measured subjects’
propensity to feel anger or anxiety (trait anger and trait anxiety, respectively), at
the beginning of the experimental session. We found no significant differences be-
tween the TE and placebo group (Mann-Whitney tests: trait anger: P = 0.402, trait
anxiety: P = 0.807, n = 60, two-tailed). Moreover, it is a priori rather unlikely that
TE increased fair behaviour due to an increase in subjects’ anxiety or fear because
the literature points in the opposite direction. If anything, TE may have a fear and
anxiety reducing effect [van Honk et al., 2005, Aikey et al., 2002]; and a lower fear
of being rejected should lead to a decrease in Ultimatum Game offers. However,
we nevertheless examined this question more thoroughly and thus measured sub-
jects’ actual feelings of anxiety (state anxiety) and anger (state anger) immediately
after substance administration, and 4 h later, immediately before they played the
Ultimatum Game. Again, there are no significant differences between the placebo
group and the TE group. Neither after substance administration (Mann-Whitney
tests: state anger: P = 0.788, state anxiety: P = 0.528, n = 60, two-tailed) nor
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before the beginning of the Ultimatum Game (Mann-Whitney tests, state anxiety:
P = 1.000; state anger: P = 0.615, n = 60, two-tailed) are there differences across
treatment groups, nor is there a treatment difference in the changes of these vari-
ables between the two time points of the measurements (Mann-Whitney tests: state
anger: P = 0.637, state anxiety: P = 0.339, n = 60, two-tailed).
In principle, TE application could also have had indirect effects via moderating
CORT levels in our subjects. An androgen based down regulation of the HPA axis
has been discussed in the literature [Viau, 2002]. To address this issue, we re-
peatedly measured subjects’ salivary CORT levels as a reliable and valid measure
of HPA axis activity [Kirschbaum and Hellhammer, 1994]; these measures were
taken before the administration of TE and before the subjects played the Ultima-
tum Game. We find no significant difference across the two treatment groups at
either time of CORT measurements (Mann-Whitney tests: before TE administra-
tion P = 0.726, before playing the Ultimatum Game P = 0.960, n = 58; two-tailed),
nor do we observe any differences in CORT changes between the two measures
(Mann-Whitney test, P = 0.546). Thus, there are no differences in CORT levels and
CORT changes across the TE and placebo group.
Another interesting question concerns the potential role of endogenous baseline TE
levels in our experiment. If subjects in the TE group exhibited higher baseline TE
levels, one could argue that the difference in baseline TE levels causes the effect
on proposers’ offers and not the exogenous administration per se. For this reason,
we measured salivary TE levels immediately before the substance administration.
We find no significant difference in baseline TE levels in the two treatment groups
(Mann-Whitney test: P = 0.739, n = 59, two-tailed). Furthermore, we also con-
trolled for a potential impact of baseline TE at the individual subject level by con-
trolling for baseline levels in an ANOVA of the offers. This analysis again confirms
that TE administration also increases proposers’ offers if we control for baseline
TE (ANOVA, main effect of TE, controlled for baseline TE values, F = 6.21, P =
0.016), and the impact of baseline TE on proposers’ offers is insignificant (ANOVA,
main effect of baseline TE values, F = 1.09, P = 0.362, N= 59). Finally, we checked
whether the effect of exogenous TE on proposer behaviour is a function of baseline
TE levels in the sense that subjects with low endogenous baseline levels react par-
ticularly strongly to the exogenous administration of TE. However, the interaction
effect between endogenous TE levels and the exogenous TE administration on pro-
posers’ offers is also insignificant (ANOVA, F= 1.13, P = 0.345, n = 59). Thus, these
results unambiguously show that endogenous baseline TE levels cannot explain the
higher prevalence of fair offers. Rather, it is the experimental administration of TE
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that caused the higher bargaining offers.
The fact that TE enhances aggression in some animals and the broad media cov-
erage of results suggesting a relationship between endogenous TE-levels and an-
tisocial behaviour has led public opinion to believe that TE may generally cause
antisocial, selfish and aggressive behaviours. However, our results cast serious
doubt on the folk hypothesis because subjects with exogenously administered TE
make much fairer offers in the bargaining game. The increase in fair bargaining
behaviour among subjects with TE also led to a higher acceptance rate (ANOVA,
F = 4.18, P = 0.046, n = 60), thereby reducing bargaining conflicts and increasing
the efficiency of social interactions. Indirect effects of TE on mood, arousal, anxiety,
anger or stress cannot explain these results. We also observe that the endogenous
TE level does not affect behaviour or the effect of TE on behaviour in our setting.
Thus, we can conclude that TE administration causes an increase in fair bargaining
offers in our subjects. This result is consistent with the status hypothesis [Mazur
and Booth, 1998, Mazur, 2005, Josephs et al., 2003, 2006, Schultheiss et al., 1999]
which proposes that subjects with TE care more for their status, which in turn in-
creases the utility loss associated with rejections. It is also worthwhile to point
out that if the status hypothesis is correct, then TE subjects do not comply with
the fairness norm because they value fairness per se but because norm compliance
helps them to assert their status and their leadership role.
The impact of TE on compliance with the fairness norm in our setting supports
the view that biological factors play an important role in human social interaction
[Mazur and Booth, 1998, Mazur, 2005, Josephs et al., 2003, 2006, Schultheiss et al.,
1999, Kosfeld et al., 2005]. This does, of course, not mean that psychological factors
are not important. In fact, our finding that subjects’ beliefs about TE are powerful
predictors of behaviour in the bargaining game points towards the importance of
psychological and social factors. This finding also teaches an important method-
ological lesson for future studies: it is crucial to control for subjects’ beliefs because
the pure substance effect may be otherwise under- or overestimated. Thus, it is im-
portant to keep an eye on biological and socio-psychological factors in human social
interaction for substantive and for methodological reasons.
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5.4 Methods
5.4.1 Subjects
Sixty-two healthy women (mean age ± SD: 25.3 ± 6.20 years) participated in the
study after providing written informed consent to the study; the local ethics com-
mittee had previously approved it. Only women were recruited because the pa-
rameters (quantity and time course) for inducing neurophysiological effects after
a single sublingual administration of 0.5 mg of TE are known in women [Tuiten
et al., 2000], whereas these parameters are unknown in men. Before admission
to the study, all subjects were screened in a telephone interview to exclude medi-
cation intake, somatic diseases, or any neurological or psychiatric disorders. They
were further instructed to abstain from alcohol or caffeine intake and smoking 24 h
before the experiment. Additionally, only subjects who did not use hormonal contra-
ceptives participated in the study and all of them were checked for having a regular
menstrual cycle. Moreover, we conducted a pregnancy test before the beginning of
the experiment, to preclude pregnancy. Subjects were all invited to the experiment
within 10 d after the beginning of the menstrual cycle, when endogenous levels of
sex hormones tend to be low and stable. A physician was at the experimenter’s
disposal during the course of the whole experiment. Two subjects were excluded
from the analysis because they had an overall score of 2 SD above the mean in the
global severity index of the Symptom Checklist for psychopathological symptoms
[Derogatis, 1977].
5.4.2 Experimental procedure
All experiments took place at the experimental laboratory of the Institute for Em-
pirical Research in Economics, where a total of ten sessions were conducted. All
sessions started at 1.00 pm and lasted approximately 5 h. Following oral instruc-
tions at the beginning of each session, subjects were randomly assigned to the TE
or placebo group (double-blind, placebo-controlled study design). They received one
single dose of TE or placebo, sublingually. Due to the established time lag of 4 h for
behavioural effects to appear after sublingual application of 0.5 mg TE in young,
healthy women [Tuiten et al., 2000, van Honk et al., 2001, 2005], a long waiting
period was an integral part of our study. During this period, our subjects were re-
quired to stay in the laboratory room and read newspapers. This was to ensure that
no social interaction outside the laboratory took place.
The TE preparation contained 0.5 mg of TE base with hydroxy-propyl-β-cyclodextrin
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as a carrier [Stuenkel et al., 1991]. The placebo contained no TE but was otherwise
identical. Both preparations were manufactured by Laboswiss, in Davos, Switzer-
land. The Ultimatum Game is played with two types of players, a proposer and a
responder, who have to agree on the division of 10 MUs. The proposer can decide
upon the distribution of the 10 MUs. In our experiment, the proposer could pro-
pose an offer of 5, 3, 2, or 0 MUs to the responder. This ensured a clear separation
between an offer that is regarded as fair (5 MUs) and offers that are perceived as
unfair (3, 2 or 0 MUs). The responder then had to either accept or reject this pro-
posal. If the responder accepted the proposer’s offer, the proposed allocation was
implemented. However, the responder could also reject the proposal; in this case
neither party earned anything.
Subjects were randomly and anonymously assigned to the role of either the pro-
poser or the responder and did not know the identity of the persons with whom
they were matched in the experiment. After subjects read the instructions (they
are available from the authors upon request), we checked whether they had under-
stood the payoff structure by having them complete several control questions. All
subjects answered these control questions correctly. In addition, we summarised
the experimental procedure orally. In the experiment, every proposer made three
propositions on the distribution of MUs while paired with three different randomly
selected interaction partners. No pair of subjects interacted twice. The proposer
did not receive feedback about the responders’ choices until the end of the experi-
ment. All decisions in the Ultimatum Game were implemented in zTree software
and presented on computer screens [Fischbacher, 2007]. Subjects received a base
fee of one hundred Swiss francs for participation in the experiment. Each MU in
the Ultimatum Game was worth one Swiss franc. Each subject received her earn-
ings consisting of the base fee plus the earned MUs in private at the end of the
experiment.
5.4.3 Salivary measurements
We measured salivary TE concentrations before administration of 0.5 mg of sub-
lingual TE or placebo. We deliberately measured salivary TE levels because taking
blood is highly invasive and could induce stress in subjects. Salivary TE has proven
to be a reliable measure of the biologically active, non-protein bound proportion
(”free TE”) of TE in blood serum. Before sublingual application of either TE or
placebo, mean (± SD) baseline salivary TE concentration was 38.51 pg/ml (± 38.83
pg/ml) in the group randomly assigned to receive the placebo and 38.68 pg/ml (±
34.85 pg/ml) in the group randomly assigned to receive TE. We additionally anal-
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ysed salivary CORT levels before TE or placebo administration and immediately be-
fore the Ultimatum Game was played. Before administration of TE or placebo, sali-
vary CORT concentrations were 10.60 nmol/l (± 6.11 nmol/l) in the placebo group
and 10.00 nmol/l (± 5.10 nmol/l) in the TE group. Before the Ultimatum Game
was played, salivary CORT concentrations were 4.96 nmol/l (± 3.19 nmol/l) in the
placebo group and 4.72 nmol/l (± 2.59 nmol/l) in the TE group. We used the IBL
SaliCaps Kit (IBL-Hamburg, Hamburg, Germany) for saliva specimen collection;
subjects were requested to transfer 1 ml of saliva into the test tubes, which were
then immediately frozen at -80 C. Saliva analysis was performed by IBL-Hamburg
(Germany) using commercially available chemiluminescence-immunoassay with an
intra- and inter-assay coefficient of variation lower than 10%.
5.4.4 Questionnaires
The validated German versions of the following questionnaires were included: The
90-item Symptom Checklist (revised version) [Derogatis, 1977], the Multidimen-
sional Mood Questionnaire [Steyer et al., 1997], the State-Trait Anxiety Inventory
[Laux, 1981], and the State-Trait Anger Expression Inventory [Schwenkmezger
et al., 1992]. Psychological well-being was assessed at the beginning of the exper-
iment by the 90-item Symptom Checklist (revised version). This is a multidimen-
sional self-report instrument designed to screen for a broad range of psychologi-
cal problems and symptoms of psychopathology. The inventory contains a total of
ninety items, each of which is rated on a 5-point scale indicating the degree of dis-
tress associated with each symptom [Derogatis, 1977]. The global severity index is
calculated from the sum of all ratings divided by the number of rated items. This
global severity index forced the exclusion of two subjects from the analysis, due to
an overall score of 2 SD above the mean. We assessed the treatment group subjects
believed themselves to be in by asking them at the end of the experiment whether
they believed they received TE or placebo.
We measured mood and arousal at the beginning of the study and immediately
before the Ultimatum Game (i.e., 4 h after substance administration) by means of
the Multidimensional Mood Questionnaire (MDBF) . The MDBF consists of three
subscales, termed elevated vs. depressive mood, wakefulness vs. sleepiness, and
calmness vs. restlessness. Subjects rate these items on a 5-step scale ranging from
1 (not at all) to 5 (very strongly). Subscale scores are calculated by summing up the
respective item ratings [Steyer et al., 1997].
Anxiety was measured by the State-Trait Anxiety Inventory [Laux, 1981]. The
inventory is measured by a 40-item self-rated psychometric instrument. The state-
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trait anxiety measure consists of items rated on four-point intensity scales (1 = not
at all; 2 = somewhat; 3 = moderately; 4 = very much). Trait anxiety was assessed
at the beginning of the experiment, while state anxiety was assessed immediately
after the administration of the substance and before the start of the Ultimatum
Game. State anxiety denotes a transitory emotional state characterised by subjec-
tive feelings of tension and apprehension. Trait anxiety indicates individual differ-
ences in anxiety proneness and refers to a general tendency to respond to perceived
threats in the environment with anxiety.
Anger was measured by the State-Trait Anger Expression Inventory [Schwenkmez-
ger et al., 1992]. The inventory is measured by a 20-item self-rated psychometric
instrument. The state and trait anger measure consists of items rated on four-point
intensity scales (1 = not at all; 2 = somewhat; 3 = moderately; 4 = very much). Trait
anger was again assessed at the beginning of the experiment, and the state mea-
sure was assessed twice, once immediately after the substance administration and
once at the beginning of the behavioural task. State anger denotes the intensity
of angry feelings experienced ”right now, at this moment”. Trait anger represents
individual differences in general proneness to react angrily in anger provoking sit-
uations.
5.4.5 Statistical analysis
Statistical analysis is based on non-parametric Mann-Whitney tests and ANOVA.
All tests are two-tailed tests. We examined the impact of TE [with a binary indi-
cator for TE indicating whether the subject received TE ( = 1) or placebo ( = 0)],
the impact of belief about TE administration [(with a binary indicator for subjects
who believed they received TE ( = 1) or placebo ( = 0)], the impact of baseline levels
of salivary TE (we grouped subjects into four equally sized groups), and the im-
pact of the interactions between these variables in a univariate one-way ANOVA
on proposers’ offers in the Ultimatum Game.
5.4.6 Post-hoc online survey
All subjects that participated in the experiment in Chapter 5 were approached by
email and asked whether they would be willing to participate in the survey. They
were informed that they will receive an Amazon gift-certificate upon answering all
questions. 92% of all subjects participated. The survey was structured as follows:
first, subjects were asked how TE administration would modify any given person’s
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behaviour. They were asked to answer this question without the aid of class books
or any other information material. Second, they were asked whether they expect
the administration of TE would modify their behaviour if they were to receive it (see
Table 5.1). Third, they were given a list of 13 two-poled opposed items, where they
could indicate the expected behaviour modification after application of TE ranging
from ”none”, ”weak behaviour modification” to ”strong behaviour modification” (see
Table 5.2).
Table 5.1: Items subjects spontaneously mentioned are listed in the left column.
The middle column shows the percentage of subjects who mentioned the respective
item at least once. The right column shows the percentage of subjects who indicated
that the effect would also appear if they were to receive TE.
Items Percentage Percentage(self)
aggressive 56% 68%
risk seeking 25% 78%
dominant 2% 0%
interested in sex 5% 100%
self confident 20% 64%
mood changes 20% 64%
other behaviours 33% 72%
biological effects 18% 60%
no change 2% 100%
drive 10% 80%
goal oriented 5% 33%
egoistic 3% 50%
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Table 5.2: Subjective ratings of the believed effects of TE administration. Pairs of
the two opposed-poled items are listed in the left and right columns. The average
ratings (± SD) of 55 subjects are indicated (1 = change towards left item, 5 = change
towards right item).
Left pole Average rating ± SD Right pole
diffident 4.35 0.68 laddish
aggressive 1.70 0.84 peaceful
risk seeking 1.63 0.88 risk averse
dominant 1.78 0.69 submissive
distrustful 2.97 0.67 trustful
generous 3.19 0.62 greedy
fearful 4.13 0.67 fearless
awake 2.5 0.86 tired
dizzy 3.33 0.78 clear-thinking
egoistic 2.19 0.78 altruistic
manly 1.78 0.74 less manly
competitive 1.69 0.78 less competitive
self-confident 1.89 0.79 insecure
5.5. Comments on Study 3 95
5.5 Further comments on Study 3
Summary of main findings We found that sublingual administration of 0.5 mg
of TE to 60 female proposers playing a one-shot and anonymous Ultimatum Game
was associated with an increase in fair offers compared to placebo administra-
tion. Moreover, those subjects who believed to have received TE made substantially
lower offers compared to those who believed to have received placebo. The TE ef-
fect on proposer offers was significant in an ANOVA controlled for the TE believed
treatment group. The effect of the believed TE treatment group was also significant.
In the following, these findings will be discussed in two different parts. The first
part discusses the obtained findings on the level of content. Alternative explana-
tions for the observed effect of TE on proposer offers as well as additional control
experiments will be suggested. Furthermore, data on the responder behaviour will
be provided and discussed in the context of status. The discussion of status will be
closed by providing a potential further TE administration experiment investigating
competitive behaviour in the laboratory. Subsequently, a critical discussion of the
external validity of experimental economic paradigms and neuroeconomic experi-
ments will be provided with reference to the findings presented in this chapter.
The second part discusses the neuroendocrinological aspects of TE administration
experiments. More specifically, the relative specificity of TE administration effects
on the androgen system will be discussed. Moreover, the role of the enzyme aro-
matase, which metabolises TE into E2, in mediating TE administration effects will
be looked at more closely. Furthermore, because the employed methodological ap-
proach leads to supraphysiological TE serum levels, the potential inhibitory feed-
back responses on the level of the HPG-axis will be discussed. Each section closes
with a discussion of potential control experiments.
5.5.1 Status and proposer behaviour, loose ends...
We have argued that the observed increase in proposer offers after TE administra-
tion are consistent with other findings in the field of human TE research showing
that the hormone may play an important role in status seeking. From the viewpoint
of experimental economics, the study presented in this chapter suffers from the lack
of some fundamental control conditions. Without these we are not able to rule out a
number of alternative explanations for the effect obtained. These alternatives are
listed below, each of which is illustrated with an example.
1. TE administration causes proposers to behave more altruistically compared
96 Chapter 5. Study 3: Testosterone and bargaining behaviour
to placebo administration. For example, proposers receiving TE might make
higher offers because the hormone increases their sense for fairness.
2. TE administration changes proposers’ risk attitudes. These may influence
the proposer’s decision, because the probability of having no money (due to a
rejection by the responder) is a function of the proposer’s offer. For example,
proposers might make higher offers because TE administration causes them
be more risk averse compared to placebo administration.
3. TE administration affects proposers’ beliefs about the responders’ behaviour
(but not placebo administration). For example, proposers receiving TE assume
that an offer of 30% of the pie is rejected in 50% of the cases and proposers
receiving placebo assume that an offer of 30% is rejected in 40% of the cases.
If risk preferences are not affected by TE administration, then the TE group
should increase their offers compared to the placebo group.
One possible control paradigm would be the Dictator Game mentioned in section 1.
In one-shot, anonymous settings proposers usually transfer substantial amounts to
the responder in this game. It is common for over 50% of proposers to give some of
the money away thereby reducing their own payoff [Camerer, 2003]. These results
appear robust as they have been discovered in a large number societies [Henrich
et al., 2005]. Dictator Game results have often been used as evidence against the ra-
tionally self-interested individual (homo economicus) model of economic behaviour.
This has the following reason: if individuals were only concerned with their own
economic well being, proposers (acting as dictators) would allocate the entire good
to themselves and give nothing to the responder. Many have suggested, that the
observed Dictator Game behaviour is, in fact, altruism.
Why is the Dictator Game a suitable control paradigm for the one presented in
this chapter? The first obvious reason is that proposer offers cannot be rejected;
the threat of rejection is only present in the Ultimatum Game but not in the Dic-
tator Game. A potential effect of TE administration on selfishness is less likely
to be observed in the Ultimatum Game, since selfish behaviour (low offers) is usu-
ally punished by the responder. Because selfish proposers may anticipate this, they
increase their offers. Thus, if proposers receiving TE made lower offers in the Dic-
tator Game compared to those receiving placebo one could assume that TE admin-
istration causes proposers to become more selfish and this would reject the first
alternative explanation.
The first objection poses that the observed increase in fair proposer offers is due to a
positive impact of TE on prosocial behaviour. To investigate this issue more closely,
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we also investigated the role of the responder in the present experiment. It is gen-
erally agreed that unfair proposer offers are rejected by the responder because she
reciprocates unfair behaviour and therefore punishes unfair proposer behaviour
(also referred to as altruistic punishment, [Fehr and Gaechter, 2002]). Thus, the
rejection of unfair offers is driven by prosocial motives. On the other hand, a status
concerned proposer is largely driven by the motivation to avoid a rejection. There-
fore, strategic motives play an important role. Responder behaviour, on the other
hand, is mostly driven by social preferences. From this perspective, it is interest-
ing to see whether TE administration might perhaps affect responder behaviour as
well, since we do not know whether the observed increase in fair proposer offers
is due to strategic reasons or rather reflect an effect of TE on prosocial motives.
Therefore, if TE administration caused an increase in fair proposer offers due to
prosocial motives, we should also expect an increased rejection rate of unfair offers
in responders receiving TE compared to those receiving placebo. However, if TE ad-
ministration increases proposer’s offers due status concerns and the strategic goal
of avoiding a rejection, we should expect no effect of TE on a responder’s rejection
behaviour.
While a status concerned proposer is largely driven by the motivation to avoid a
rejection constituting a status threat (the term  in the status model described on
page 30. Therefore, for a status concerned proposer, strategic motives play an im-
portant role. Responder behaviour, on the other hand, is mostly driven by social
preferences (altruistic preferences). From this perspective, it is interesting to see
what impact TE administration has on responder behaviour. Therefore, if TE ad-
ministration caused an increase in fair proposer offers due to prosocial motives,
we should also expect an increased rejection rate of unfair offers in responders re-
ceiving TE compared to those receiving placebo. However, if TE administration
increases proposer’s offers due status concerns and the strategic goal of avoiding a
rejection, we should expect no effect of TE on a responder’s rejection behaviour.
Using the same procedure as described in section 5.4.2, we administered TE or
placebo to 55 healthy females who were in the role of the responder. The results (see
Figure 5.4) show that exogenous administration of TE did not result in a change in
responder’s rejection rate of unfair proposer offers.
The importance of the second alternative explanation has been weakened by the
results of a previous study showing that female subjects who receive TE behave
more risk seeking in the IOWA Gambling Task [van Honk et al., 2004]. However,
since behaviour in the latter task is also driven by learning effects, we need a bet-
ter control task to clearly disprove the second explanation. A suitable control task
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Figure 5.4: Bars indicate ratio of rejections of the respective proposer offers in the
placebo and the TE group. Error bars indicate SEM. Please note that the standard
errors are computed based on the number of offers.
would be to run an Ultimatum Game-isomorphic task in which the responder is
replaced by a computer. Thus, a proposer would make offers which are accepted
or rejected by a computer by a stochastic mechanism. The probabilities of these
rejections should be equal to those observed when the responder is a human par-
ticipant. From the proposer’s perspective, the paradigm is reduced to a risk taking
task which has no social component. By holding constant all other aspects of the
game we could reveal whether the observed increase in proposer offers as reported
in this chapter is due to a general effect of TE on risk attitudes. Thus, if offers in the
Ultimatum Game-isomorphic risk taking task are equal in the TE and the placebo
group, this would reject the second alternative explanation. If offers were lower in
the risk taking task in the TE group compared to the placebo group, this would sug-
gest that subjects become more risk-seeking. Because increased risk-seeking would
be rather associated with lower proposer offers, this would strengthen our idea that
TE administration increases status concerns by placing more weight on the threat
of a human veto.
In order to reject the third alternative explanation, we would have to repeat the
experiment presented in here and the beliefs of the proposers about the responder
behaviour have to be elicited. An essential point in eliciting beliefs is that there has
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to be an incentive for subjects to make accurate predictions about the responder’s
behaviour. This is usually achieved by offering an additional amount of money for
a correct estimation about a given responder’s rejection behaviour. Given that the
second explanation has been rejected and these beliefs are not affected by TE versus
placebo administration the third alternative explanation could be rejected as well.
5.5.2 Competition
Battles over status often take the form of competitive interactions. Winning a com-
petition is associated with a rise in status while losing a competition is associated
with a loss of status. There is evidence from animal as well as in human studies
that TE might play an important role in competition.
In the nineties, an influential theory was formulated to account for TE-aggression
associations in monogamous birds [Wingfield et al., 1990]. This hypothesis, the
challenge hypothesis, states that TE levels increase at the beginning of the mating
season to allow reproductive functions, but also to allow aggressive behaviour in
competitive interactions over territory or mating partners. Moreover, the hypothe-
sis states that circulating levels of TE correlate with aggression only during periods
of social instability and that male-male interactions over status and access to sex-
ually receptive females also tend to increase TE secretion. This hypothesis has
been extended to chimpanzees [Muller and Wrangham, 2004] and humans [Archer,
2006]. Although it was never stated explicitly in the theory put forward by Mazur
and Booth [1998], the reciprocal model is likely based on (or has co-evolved with)
the challenge hypothesis (see section 2.3.4 on page 32). According to the reciprocal
model, the anticipation of status challenges causes increased TE secretion and after
a victory, increased TE levels are supposed to reinforce further acts of dominance.
After a defeat, TE levels decline and discourage further battles over status [Mazur,
1985]. In summary, the animal literature suggests two important aspects in the
context of TE and competition: first, TE secretion not only affects competitive be-
haviours, but it also reacts to it and second, TE has its major impact in uncertain
situations.
Human studies investigated the role of TE in real-world athletic competitions [Gla-
due et al., 1989, Mazur et al., 1992, Mazur and Lamb, 1980, Mccaul et al., 1992]
and rigged laboratory competitions [Josephs et al., 2006, Mehta and Josephs, 2006].
Several studies have shown that winners’ serum TE levels increase relative to
losers for a few hours following a competition. This evidence suggests TE plays an
important role in competitive interactions in humans as well. However, the recip-
rocal nature of TE-behaviour relationships in competitive interactions emphasises
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the importance of examining competition after exogenous administration of TE.
A competition experiment could take the form of a modification of a paradigm de-
scribed previously by Niederle and Vesterlund [2007]. Its fundamental ideas will be
briefly summarised here. The experiment consists of four rounds, in which all sub-
jects are given the task of adding numbers. All subjects perform these calculations
in three rounds. Every round involves doing sums of five two-digit random num-
bers, and payoff is related to the number of correct results and the time given to
solve these is 5 min (referred to as a real-effort task). Whereas the tasks remain the
same in all rounds, the form of payout is varied. In the first round, payout is accord-
ing to a piece-rate scheme - for every correct sum, subjects receive x Swiss Francs.
For the second round, subjects receive 4x Swiss Francs per correct result, however
only those players who ”win” (achieved the highest number of correct sums) in ran-
domly allocated groups of four. The others receive nothing. In the third round, every
subject is asked to decide if they wish to play another round of piece-rate payout, or
if they prefer to play another round with competitive payout. The decision in this
round is the main dependent variable and measures the preference for competing
against others. Winners of round three are determined based on the comparison
relative to the other group members’ performance in round two1. Finally, all par-
ticipants are asked for a last decision, which however does not involve doing sums.
Rather, the results of the first round are taken and subjects are asked to decide if
they wish to receive a further payout for that task according to the piece-rate mode,
or if they prefer the extra payout following the competition mode. Subjects were,
of course, not informed about the other contestant’s performance. Thus, the deci-
sion in the fourth round is not about performing in a competition, but rather about
a payment scheme, and therefore mainly reflects risk taking behaviour. Whereas
risk behaviour is relevant in both round three and four, competitiveness is only
measured in round three.
Although this experiment is well designed from an experimental economist’s per-
spective, it has a major shortcoming if looked at from a (neuro-)psychological per-
spective. First, subjects may likely have an a priori knowledge about their perfor-
mance in the real-effort task (number of solved calculations). Imagine an individual
(who is not competitive at all) who knows (from past experiences in school or work-
ing as a waiter/waitress) that he/she is good in doing sums. It is likely that this per-
son will choose the competitive payout in the third round of the paradigm described
1This has the following consequences: first, the performance of a player who enters the tourna-
ment is evaluated against the performance of participants who also performed under the tourna-
ment. Second, a participant’s choice does not affect the payment, thus there are no externalities
associated with tournament entry.
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above, despite the fact that he/she is not competitive. Therefore, previous experi-
ence is likely the strongest predictor of the decision in round three. This a priori
knowledge therefore generates noise with respect to the measure of competitive-
ness, which may be substantial. Others have used different real-effort tasks, such
as finding a way through a virtual 3D maze as fast as possible [Gneezy et al., 2003].
However, in the context of TE administration experiments, this measure could be
confounded in two ways: again by previous knowledge about the own visuospatial
performance and more importantly by the fact that visuospatial performance might
be improved by TE administration [see e.g. Aleman et al., 2004].
To improve the design above, we might examine how situations with non-athletic
competition generally appear. First, people are rarely forced into competition with
others in environments where they perform poorly. However, people are often will-
ing to compete in environments where they perform well. Second, the number of
contestants is not always known (e.g. in competition for a job). Therefore, a certain
degree of ambiguity is usually associated with the decision to enter into a competi-
tion (unknown probability of winning or losing) Therefore, an improved design for
a competition experiment should offer the contestants the opportunity to choose be-
tween a number of different real-effort tasks that can be done on a computer in the
laboratory (such as doing sums, target-detection tasks, and verbal fluency tasks).
All subjects should be informed about the fact that each subject may choose a task
in which he/she performs well. Subjects will only be paired with others that choose
the same real-effort task. Since the number of the other contestants is not known,
there is a certain ambiguity associated with the decision to enter competition. Ac-
cordingly, the piece-rate payout is again x for every correctly solved problem and
in the competition mode, payout is x ∗ n (where n denotes the number of subjects
that chose the same real-effort task). The probability of winning is therefore 1/n
for a given subject. Importantly, round four controls for this ambiguity as in the
experiment described before [Niederle and Vesterlund, 2007]. It has to be expected
that the motivation to enter competition increases, since each subject can choose a
real-effort task in which he/she performs well. However, since this fact is common
knowledge (each participant knows that all other participants are able to choose a
task in which they perform well), this should counteract each participant’s motiva-
tion to choose the competition mode in round three. This modified paradigm could
be employed in a laboratory experiment involving TE or placebo administration as
described previously in this chapter.
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5.5.3 External validity of economic games
One critique experimental economics often face is that of their low external valid-
ity of their experiments due to the high degree of artificiality [Loewenstein, 1999].
Artificiality often implies experimental control, however, and therefore increases
internal validity. External validity refers to the ability to generalise from the re-
search context to the settings that the research is intended to approximate. Inter-
nal validity refers to the ability to draw confident conclusions from one’s research.
The design of an experiment is therefore always directed by a trade-off between the
demands for high internal as well as external validity.
For example, we recruited only female subjects for the experiment in this chap-
ter and one might criticise the subject pool bias. The question that arises here is
whether we can extend the findings that TE administration increases the frequency
of fair proposer offers also to men. Moreover, it is important to know whether some
sort of selection bias was present in the group of female subjects that volunteered
for the experiment described here. One might assume that they differ with respect
to anxiety, since ingesting TE is not a usual thing to do for women. A t-test indeed
revealed that trait anxiety scores on the State-Trait Anxiety Inventory [Laux, 1981]
of the present sample of females were significantly higher than those of a sample
of females who volunteered for a regular experiment (P < 0.01). Therefore, women
who were willing to ingest TE had significantly lower trait anxiety scores. This in
itself would not be a problem. However, if subjects with higher trait anxiety experi-
enced an anxiolytic effect of TE, this might not be true for subjects with lower trait
anxiety. This potential confound decreases the external validity of the experiment
presented in this chapter. Furthermore, subjects were mostly university students
from Switzerland and it were interesting to see whether TE administration had
a different effect given to subjects who have a different cultural background [see
e.g. Henrich et al., 2005]. Moreover, the money the subjects won in the Ultimatum
Game was only a small fraction of the overall payment and resulting in incentive di-
lution. Finally, some subjects had participated in similar experiments before, while
others did not. One might therefore criticise that we used a heterogeneous subject
pool of inexperienced and experienced individuals.
While the artificiality of anonymous laboratory tasks is also an attempt to remove
context effects, this is often difficult to accomplish. It has to be assumed that ex-
perimental subjects are engaged in a constant search for cues about how they are
supposed to behave [Loewenstein, 1999]. A relevant study in this context is the one
performed by [Hoffman et al., 1994], in which the authors investigated the influence
of environmental cues on proposer behaviour in the Dictator Game (see section 1).
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Proposers who were given detailed instructions about the elaborate measures that
had been taken to ensure anonymity gave away less money than in conditions that
did not ensure such a high degree of anonymity. The authors conclude that ”people
act as if they are other regarding because they are better off with the resulting rep-
utation. Only under conditions of social isolation are these reputation concerns of
little force”.
However, if human complex decision making processes are to be investigated in a
well controlled environment, this has to be performed in a laboratory. Experimental
economics offers a way to investigate complex decision making processes in the
laboratory at the cost of having a relatively low external validity. One has therefore
to be cautious in drawing conclusions directly from the laboratory into the real
world.
The combination of these paradigms with neurobiological methods may, however,
increase the external validity of the measure derived in a certain paradigm since
the combination allows us to draw a more fine-grained picture of the processes that
underlie human decision making. Because the knowledge of these neurobiological
processes could potentially also inform us about the underlying motives that drive
decision making in a particular paradigm, this will inform us about the type of
external environment to which the findings can be extended.
For example, a recent twin-study reported that trusting behaviour measured by
the Trust Game has a heritable component [Cesarini et al., 2008]. Since one can
assume that genetic behavioural traits are stable, the very aspect of Trust Game
behaviour that has proven to be heritable must have an external analogue. It is
unlikely that an individual’s genetic makeup will uniquely predict Trust Game be-
haviour, but not other, related behaviours outside the laboratory.
In a recent experiment, we could show that baseline cortical activity in the right
DLPFC predicts individual risk-taking behaviour in the laboratory [Gianotti et al.,
2009]. Baseline cortical activity was measured using resting-state EEG and a
source-localisation technique before subjects performed the risk-taking task. In-
dividuals with higher baseline cortical activity in the right DLPFC brain area dis-
played more risk aversion than did other individuals. Given that resting-state EEG
has been reported to capture stable individual differences in neural activity [Kon-
dacs and Szab, 1999], this finding demonstrates that neural characteristics rem-
iniscent of a psychological trait variable may partially predict highly complex be-
haviours such as risky decision making. As in the example described above, it is
unlikely that this relatively stable neurophysiological measure will only predict be-
haviour in the laboratory.
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In other cases, decision making paradigms have been externally validated directly.
For example, the gambling task applied in Chapter 4 has been successfully used
to predict children’s behaviour in real-world traffic. Those who were classified as
risk takers by the gambling task made more crossing decisions at a busy one-way
street than risk avoiders and tolerated shorter time intervals between initiation of
the crossing decision and arrival of the next vehicle [Hoffrage et al., 2003].
5.5.4 Testosterone rules...?
An issue that often comes up in personal discussions (especially between women
and men) is how much influence hormones have on our everyday life. The rodent
literature reviewed in section 2.3.3 suggests a strong influence of TE on socially
aggressive behaviour. On the other hand it has been suggested that one of TE’s role
in primate behaviour is to support non-aggressive dominance behaviour, which has
taken the form of ritualised demonstrations of power, rather than actual physical
fights resulting in injuries [Mazur, 1985, Mazur and Booth, 1998]. Therefore the
role of TE in primate behaviour is much more complex than in rodents. These dif-
ferences have been accounted for by the relatively greater influence of the neocortex
in guiding behaviour in primates as opposed to rodents [Mazur and Booth, 1998].
It has been hypothesised that the non-isometric brain expansion observed through-
out primate evolution might be due to the cognitive demands of the increasingly
complex social worlds these animals live in [Dunbar, 1992, 1998]. While parts of
the brain (such as the neocortex) concerned with higher-order cognitive capacities
get bigger across phylogenies, those parts of the brain involved in regulating the
hormonal control of primary motivated behaviours have become relatively smaller
(e.g. hypothalamus and the preoptic area) [Keverne et al., 1996]. It has therefore
been speculated that human social behaviour differs from that of animals in that
it is relatively liberated from the constraints of the hormonal state [Curley and
Keverne, 2005]. Thus, TE’s effect on human social behaviour may be strongly mod-
erated by intrapsychic, social, and cultural factors and may be less unidirectional
than in rodents [Christiansen, 2001].
Given the relatively strong manipulation of serum TE levels achieved by the proce-
dure presented in this chapter [see also Figure 5.5 below and Tuiten et al., 2002],
it is intriguing that it did neither affect subjects self-reports of anxiety, anger nor
other mental states (wakefulness, restlessness and mood). It is worth noting that no
study has yet reported an effect of a single dose of TE on consciously perceived emo-
tions or mental states in women [Tuiten et al., 2002, van Honk et al., 2001, 2004,
2005, van Honk and Schutter, 2007, Hermans et al., 2006a,b, 2008]. Nevertheless,
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most of these studies reported behavioural effects, which are mostly considered
to be generated outside of conscious awareness (e.g. Emotional Stroop Task effects
using subliminally presented angry facial expressions, subtle autonomic arousal re-
sponses and reduced startle effects). In summary, although it appears that TE has
effects on everyday human behaviour, these are likely not consciously noticeable.
It has been argued that this is due to the fact that TE acts mostly on subcortical
structures, whose size is relatively small compared to the neocortex.
The question whether TE ”rules” our lives can only be answered on a qualitative
level. The limited number of TE administration studies suggest that TE admin-
istration in humans has anxiety (but not fear) reducing effects, increases libido
[Christiansen, 2001], facilitates autonomic arousal in response to the presentation
of angry faces as well as decreases recognition of emotional facial expressions [Tu-
iten et al., 2002, van Honk et al., 2001, 2004, 2005, van Honk and Schutter, 2007,
Hermans et al., 2006a,b, 2008].
5.5.5 Specificity of testosterone effects
Throughout this chapter, the term ”TE administration causes” was used to refer to
the causal role of TE in modulating social decision making behaviour. The term ”TE
administration” refers to any process, that is initiated by the application of TE and
does not imply that TE is the major agent that causes the effects. Unfortunately,
it also precludes to make conclusions about the role of the hormone TE per se in
the reported effects. A deeper insight into the role of the androgen system in social
decision making behaviour is only possible if the pharmacological methodology is
refined.
Is testosterone a prohormone?
The idea that TE may act as a prohormone in mediating certain behavioural pro-
cesses (i.e. TE has to be metabolised into an active form with respect to the pro-
cess) is partly based on the early observations that not TE, but rather E2 is the
substance that defeminises the CNS in the developing mammalian fetus [Zigmond
et al., 1999]. As outlined in section 2.3.1 on page 22, the two major pathways of TE
metabolism involve the formation of two neuroactive steroids, DHT and E2. While
DHT is a classical androgen, which has a high affinity for the AR (see page 23), E2
activates its own receptor system (ER-α and ER-β). These metabolic pathways are
mediated by 5α-reductase (DHT) and aromatase (E2), respectively.
There is direct evidence from pharmacokinetic trials showing that sublingual TE
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administration leads to elevated DHT and E2 levels. For example, the pharma-
cokinetic study (see section 2.3.1) performed by Stuenkel et al. [1991] reported the
following: serum TE concentration increased 63-fold compared to baseline (± 24.2
SEM) 20 min after sublingual application of 5.0 mg of TE. Critically, serum levels
of DHT and E2 increased 9-fold (± 1.3) and one-fold (± 0.4), respectively. For DHT,
tmax was reached after ≈ 30 min and for E2, tmax was reached after ≈ 120 min. Al-
though this study was performed in hypogonadal males, it provides direct evidence
that elevated levels of neuroactive metabolites of TE are observed in blood serum
after TE administration.
There is no reason to believe that aromatisation or reduction of TE to either E2 or
DHT has not occurred in participants of the study published by Tuiten et al. [2002]
and in those taking part in the experiment presented in this chapter. It is therefore
possible that the TE effects we and others [Aleman et al., 2004, Hermans et al.,
2007, 2006a,b, 2008, van Honk et al., 2005, 2004, 2001] are not TE effects, but DHT
or E2 effects. Because TE and DHT both bind to the same type of receptor (AR;
although with different affinities), the investigation of the role of E2 in mediating
TE administration effects is much more interesting.
It is now agreed that E2 can have rapid cellular effects via membrane-bound recep-
tors [Simoncini and Genazzani, 2003]. For example, direct application of E2 rapidly
decreases the spontaneous firing of neurons in medial preoptic area [Kelly et al.,
1977]. E2 has also been reported to increase excitatory postsynaptic potentials in
the hippocampus within a few seconds [Wong and Moss, 1991]. Thus, if the hy-
pothetical secondary elevations of E2 in our experiment occurred within the same
time-frame as reported previously in hypogonadal males [i.e. 2-6 h after TE admin-
istration; Stuenkel et al., 1991], this increased E2 concentrations might have con-
founded the behavioural measure. Thus, the TE administration effect on proposer
behaviour could perhaps have resulted from a joint effect of TE on the AR (genomic
pathway), and an effect of the secondary elevations of E2 on membrane-bound re-
ceptors (non-genomic pathway). It has to be noted that the (neuro-)physiological
role and in particular the behavioural correlates of the rapid E2 effects are not well
known [Balthazart et al., 2006].
To meet these uncertainties, a seductive, but superficial approach is to administer
sublingual E2 approximately 15 min before behavioural testing. Likewise, we are
able to control for the potential rapid E2 effects on behaviour that might have oc-
curred due to the secondary serum elevations of E2 after TE administration. Due to
E2’s almost identical chemical structure to TE (high lipophilicity, almost identical
molecular weight), it should dissolve in HP-β-CD as well and should show a similar
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pharmacokinetic profile after sublingual administration. The hypothetical experi-
ment looks as follows: a first group of female subjects receives a single dose of 0.5
mg TE at the beginning of the experiment (group A). Another group B receives a
single dose of E2 after 225 min, i.e. 15 min prior to the time point when the neuro-
physiological effects of TE should appear (for pharmacokinetic data on sublingual
TE see Figure 2.3 on page 26). A third group serves as a control group receiving
placebo (group C). The behavioural task is performed 4 h after the beginning of the
experiment. The idea behind this design is that it allows a dissociation of slow,
genomic TE effects and rapid non-genomic E2 effects. It can be tested whether the
TE effects observed after 4 h (group A tested against group C) can be reproduced
by E2 administration 15 min prior to behavioural testing (group B tested against
group C). A seductive, but superficial approach is to administer sublingual E2 ap-
proximately 15 min before behavioural testing. Likewise, we are able to control for
the potential rapid E2 effects on behaviour that might have occurred due to the sec-
ondary serum elevations of E2 after TE administration. Due to E2’s almost identi-
cal chemical structure to TE (high lipophilicity, almost identical molecular weight),
it should dissolve in HP-β-CD as well and should show a similar pharmacokinetic
profile after sublingual administration. The hypothetical experiment looks as fol-
lows: a first group of female subjects receives a single dose of 0.5 mg TE at the
beginning of the experiment (group A). Another group B receives a single dose of
E2 after 225 min, i.e. 15 min prior to the time point when the neurophysiological
effects of TE should appear (for pharmacokinetic data on sublingual TE see Figure
2.3 on page 26). A third group serves as a control group receiving placebo (group C).
The behavioural task is performed 4 h after the beginning of the experiment. The
idea behind this design is that it allows a dissociation of slow, genomic TE effects
and rapid non-genomic E2 effects. It can be tested whether the TE effects observed
after 4 h (group A tested against group C) can be reproduced by E2 administration
15 min prior to behavioural testing (group B tested against group C).
Although seemingly simple, this approach does not properly address the role of TE
to E2 conversion effects. This is due to the fact that the enzyme aromatase shows
a specific distribution pattern in the brain and implies that TE is converted to E2
only in aromatase containing neurons. It was recently reported that a significant
fraction of aromatase appears to be located in presynaptic neuronal compartments
[Balthazart et al., 2006]. Based on this observation it was even hypothesised that
E2 might act as a neurotransmitter [Balthazart et al., 2006]. Therefore, only a
subset of neurons would ”secrete” increased amounts of E2 after TE administration.
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The role of aromatase
The anatomical distribution of aromatase likely plays an important role in deter-
mining the behavioural E2 effects following TE administration. In the rat brain,
aromatase expression has been detected in several sites in the hypothalamus in-
cluding the preoptic nucleus, the sexually dimorphic nucleus, the bed nucleus of the
stria terminalis, and the medial amygdala. It is also expressed in the hippocam-
pus and the pons [Wagner and Morrell, 1997, Lauber et al., 1997]. A recent in
vivo PET study in rhesus monkeys demonstrated the uptake of 11 C-vorozole, which
is a nonsteroidal aromatase inhibitor that reversibly binds to the heme domain of
aromatase, in hypothalamus and most notably, in the amygdala [Takahashi et al.,
2006].
To investigate the role of aromatase-mediated E2 effects in TE administration ex-
periments, a natural first step were to inhibit the enzyme pharmacologically. Fairly
selective compounds are available now, which have mainly clinical relevance in the
treatment of breast cancer [Mauras et al., 2003]. For example, the substance ex-
emestane (Aromasin ®), which has been shown to potently block aromatase, seems
to be well tolerated by healthy subjects, with no serious adverse events having
been reported. In a pharmacokinetic study involving ten healthy male subjects, the
administration of a single dose of 25 mg of exemestane resulted in highest concen-
trations within 1 h after oral administration [Mauras et al., 2003]. Exemestane has
a half-life of 8.9 h. Maximum suppression of E2 (62 ± 14%) was observed 12 h after
administration. E2 remained suppressed by 58 ± 21% at 24 h and returned to base-
line 3 − 6 d after treatment. Unfortunately, aromatase inhibition blocks one of the
major metabolisation pathways of TE which may result in an increase in TE con-
centrations in turn. However, Mauras et al. [2003] did not report changed plasma
TE levels at the time point of maximum E2 suppression. Only thereafter plasma
TE levels tended to increase by 32% (2 − 3 d after exemestane administration)
[Mauras et al., 2003]. Since decision making experiments are usually performed
within half a day, the administration of a single dose of exemestane seems to be
an interesting approach to investigate the role of aromatase in TE administration
experiments investigating behaviour.
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5.5.6 Suppression of the reproductive axis
Besides the unclear source of TE administration effects, the procedure we and oth-
ers [e.g. Tuiten et al., 2002, van Honk et al., 2001, 2004, 2005, van Honk and Schut-
ter, 2007, Hermans et al., 2006a,b, 2008] used give rise to a number of additional
limitations.
First, all studies used a dose of 0.5 mg of TE applied sublingually, resulting in
unphysiologically high levels of TE [ten-fold increased levels compared to baseline
as reported by Tuiten et al., 2002].
Figure 5.5: Pharmacokinetics of serum TE
after administration of a single dose of 0.5 mg
of sublingual TE with a HP-β-CD carrier to
eight healthy females (manufactured by La-
boswiss, Davos, Switzerland). The shaded
area indicates the normal physiological range
of serum TE concentration in healthy young
females.
We attempted to replicate these find-
ings in a small pharmacokinetic study
in which we administered our own
TE preparation (manufactured by La-
boswiss, Davos, Switzerland) to eight
healthy women. Serum TE concentra-
tions were measured once before TE ad-
ministration and 15, 30 and 60 min af-
ter administration. The results of this
study are shown in Figure 5.5. Mean
(± SEM) baseline concentrations were
0.47 ng/ml (± 0.07), tmax was reached
15 min after TE administration with a
corresponding maximum concentration
(cmax) of 1.85 ng/ml (± 0.37). Thus, the
sublingual application of TE resulted
in an almost 400% increase in serum
TE concentration relative to baseline.
While tmax is equal, cmax is lower than
the one reported previously [estimated
from Figure 2.3: 6 ng/ml; Tuiten et al., 2002]. Such high levels likely induce a
negative feed-back response on GnRH and LH release at the hypothalamic and
pituitary level, respectively.
LH is released in an episodic or pulsatile fashion from the pituitary gland and the
pulsatile secretion of LH seems to be a result of episodic hypothalamic discharge of
GnRH into the portal vein and subsequent stimulation of the pituitary [Santen and
Bardin, 1973]. Under physiological conditions, serum LH levels are kept within
a tight range, reflecting the balance between stimulation by GnRH and inhibition
by gonadal sex steroids [Karsch, 1987]. The negative feedback control of LH se-
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cretion is mediated primarily by E2 [Karsch, 1987]. LH secretion reacts sensitive
to elevated concentrations of E2 in women [Karsch, 1987] and since we can expect
substantial conversion of TE into E2 in the hypothalamus (see section 5.5.5), TE
administration might have affected GnRH and therefore LH secretion. Changes
in one hormonal axis are expected to affect other systems, which will then inter-
fere with the behavioural measure. For example, if GnRH and LH pulsatility is
changed, this should lead to a changed secretion of estrogens and androgens from
the ovaries in female subjects (see section 2.3.2). Unfortunately, we did not measure
LH and GnRH in the pharmacokinetic study described above, but future pharma-
cokinetic studies investigating E2 and TE administration effects should determine
these important parameters.
Second, because the sublingual administration interferes with the measurement,
salivary TE levels cannot be determined to verify the resulting rise in serum lev-
els of TE. Salivary steroid concentrations can easily be determined and correlate
well with the ones obtained from serum measurements [Riad-Fahmy et al., 1987,
Granger et al., 2004]. This approach has been used in a wealth of studies (see sec-
tion 5.4.3 and page 90). Female salivary TE concentrations range from 5 to 50 pg/ml
and its detection requires sensitive immuno-assays. However, after sublingual ap-
plication of 0.5 mg of TE these results may be confounded substantially by traces
of TE base remaining in the mouth giving yield to shifted measures. In fact, if only
0.0001% of the administered amount of TE is retained in the oral mucosa, sali-
vary TE concentrations measured thereafter would be twice as high as those that
are usually detected under normal conditions. Blood-sampling may avoid this con-
found, however, the use of syringes could interfere with the behavioural measure
due to psychological stress of the subjects Kirschbaum and Hellhammer [1994] (see
also page 27).
Third, relevant amounts of E2 are secreted from the ovary already 3 d after be-
ginning of menstruation [Nieschlag, 2006], which could affect behaviour, e.g. by
priming or additive effects. Furthermore, GnRH release and LH secretion responds
differently to E2 at different points in the menstrual cycle [Karsch, 1987].
There are possible solutions for the draw-backs mentioned in the sections above.
Since the negative hypothalamic feed-back response to exogenous TE seems to be
less sensitive in men compared to women [Nieschlag, 2006], a potential way to
achieve methodological improvements is to use male subjects. Moreover, a different
TE administration procedure could be used. TE is available in a cutaneous formula-
tion for men (approved for the treatment of male hypogonadism; Androgel ®), which
is easy to apply and should not interfere with TE measurements in saliva. Finally,
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a reliable inhibition of aromatase using exemestane is potentially more effective
in male subjects, since they secrete E2 in lower and more stable concentrations
[Weinbauer et al., 2000].
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Part V
General conclusions
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Neuroeconomics has recently emerged as an interdisciplinary effort to bridge the
gap between neuroscience and economic theories and methodology. Although many
argue that the flow of information between the two sub-disciplines is unidirectional,
neuroeconomics has challenged both standard economic theory and improved the
understanding of human individual and social decision making from a neurobiolog-
ical perspective. Past studies investigating the neurobiological aspects of decision
making primarily reported correlative data; relatively few investigated the causal
contribution of a given neurobiological system to decision making. The main goal of
the present thesis was to investigate whether human individual and social decision
making can be modulated using neuromodulatory approaches.
Central to neuroeconomic experiments is the use of monetary incentives to quantify
how much an individual subjectively values an outcome of a chosen option. These
options are usually presented in the form of experimental economics paradigms
involving one decision maker or many simultaneously interacting decision mak-
ers. The neuroeconomic studies presented in this thesis were performed in a well-
controlled laboratory environment, which is essential for the investigation of the
neurobiological aspects underlying individual and, in particular, social decision
making.
With respect to individual decision making, the present thesis reports data on the
role of the anti-Parkinsonian drug L-DOPA in gambling behaviour. Using an intu-
itively comprehensible gambling task, we were able to show that L-DOPA adminis-
tration caused an increase in gambling behaviour, conditional on a subjects’ DRD4
genotype. More specifically, we could show that DAergic stimulation in healthy hu-
mans is associated with an increased propensity to gamble in subjects who carry
a risk allele, the 7R allele of the DRD4 polymorphism, for impulse control related
disorders such as ADHD and pathological gambling. These findings are the first to
show a pharmacogenetic effect on risky decision making, emphasising the impor-
tance of including genetic information in neuropharmacological intervention stud-
ies investigating behaviour in the laboratory. While we can speculate about the
contribution of different brain structures in the modulation of gambling behaviour
based on the neuroanatomical distribution of the DRD4, future neuroimaging stud-
ies may provide a more detailed answer. fMRI and H215O-PET are seductive ap-
proaches for achieving this; these methods have to used with caution, however.
Many pharmacological compounds are known to be vasoactive and may therefore
interfere with rCBF in ways that are independent of the vasodilatative effects ob-
served as part of the neuronal metabolic process. A more elaborate way to inves-
tigate the distribution and role of the DRD4 in the human brain is to use receptor
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specific radioligands in PET. A further option is the use of EEG, which has proven
to be a sensitive measure in neuropharmacological studies.
We have suggested that the reported pharmacogenetic effect on gambling behaviour
may have important implications for the treatment of Parkinson’s disease patients,
since pathological gambling is increasingly reported as a side-effect of DAergic drug
treatment in these patients. Because pathological gambling is regarded as a be-
havioural addiction process, which is for obvious reasons not amenable to scientific
inquiry in the laboratory, a number of questions remain open. Moreover, the neuro-
physiological interactions of L-DOPA administration with the DRD4 polymorphism
probably differ in healthy subjects compared to patients affected with Parkinson’s
disease. However, if future association studies should find a statistical relationship
between certain polymorphisms such as the DRD4 polymorphism and pathologi-
cal gambling in medicated Parkinson’s disease patients, genotyping might become
part of clinical practice in the treatment of these patients. This will raise important
ethical questions, including those of patient discrimination by insurance companies
and those with respect to gene patent claims.
Concerning social decision making, the thesis shows evidence that social decision
making may be influenced by the well known hormone TE. Using the Ultimatum
Game, we were able to show that TE administration is associated with an increased
frequency of fair proposer offers. This finding contrasts with the impact of subjects’
beliefs about the TE treatment: those who believed they received TE made remark-
ably lower offers compared to those who believed they received placebo. These find-
ings show for the first time that people’s beliefs about TE and its actual behavioural
effects diverge dramatically and overhaul the traditional view that TE is the cause
of violence. The influence of the popular view about well-known substances such as
TE should receive particular attention in future studies investigating social deci-
sion making. While we suggest that the actual effect of TE is a manifestation of its
impact on status seeking behaviour, a number of issues remain unanswered, on the
methodological level, on the neuroendocrinological level, as well as with regards to
content. With respect to the latter, additional experiments have to be performed to
investigate whether TE administration in females in fact does not cause prosocial
behaviour per se. To further corroborate the status hypothesis, future experiments
should also investigate concepts which are closely related to status, such as com-
petitiveness and reputation formation.
In a further step, it should be investigated whether the effects reported are re-
stricted to females or if they also appear in males. Given that men have relatively
higher TE levels than women who have higher E2 levels in turn, it were interesting
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to see whether these hormones fulfill the same or different roles in either sex with
respect to social decision making. Neuroendocrinological studies in rodents, non-
human primates, and humans suggest an important role of the enzyme aromatase
in this context. The enzyme converts TE to E2 and there is much reason to believe
that many effects we observe after TE administration in fact result from its con-
version to E2. This enzyme can be inhibited pharmacologically and future experi-
ments should elucidate whether this inhibition can abolish TE effects or not. Recent
PET evidence in non-human primates suggests that aromatase is mainly located in
the amygdala, which is an important structure in regulating socio-emotional be-
haviours. Therefore, a preliminary hypothesis is that TE administration exerts its
effects on social decision making via an E2-mediated modulation of the amygdala.
From a methodological viewpoint, the sublingual administration of 0.5 mg TE to
women has many disadvantages. Although it results in a reliable increase in serum
TE levels within several min, the levels achieved are in the supraphysiological
range and likely result in a negative feed-back response on the level of the hy-
pothalamus resulting in a decreased secretion of LH and GnRH. These hypothala-
mic hormones may then affect other hormonal systems giving rise to a confound.
Moreover, the sublingual application precludes the measurement of sex hormones
in saliva. A potential way to achieve improvements in this context is to use a tran-
scutaneous TE administration procedure that allows for a convenient measurement
of the achieved TE levels in saliva. Moreover, the transcutaneous TE formulation
has an advantageous pharmacokinetic profile: serum levels are more stable and
better controllable.
In summary, the present thesis shows experimental evidence that complex deci-
sion making processes may be modulated on the neurochemical and on the neu-
roendocrinological level. Furthermore, the data presented here suggest that neu-
rostimulation is a promising approach for modulating decision making on the neu-
roanatomical level. These levels are clearly not independent, however, they all
constitute experimental points of contact for investigating the causal role of neuro-
biological systems in modulating human decision making. The ethical issues that
arise when performing studies using neuromodulatory methods have to be consid-
ered carefully. In all studies presented in this thesis each subject participated vol-
untarily and on the basis of the provision of all relevant information. The exper-
imental nature of the intended procedure was made clear at the outset, and all
participants were fully informed of any reasonably foreseeable risks or discomforts.
Moreover, they were informed about the fact that they would not derive any direct
benefit from their participation in the study. However, the findings presented in
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this thesis may have potential applications for a variety of psychiatric and neuro-
logical diseases such as addiction, depression and Parkinson’s disease. Since these
are often characterised by impaired decision making behaviour, the present experi-
ments may also contribute to a better understanding of these diseases. Finally, the
studies presented in this thesis may contribute to the development of new theories
and study designs in neuroendocrinology, neuropharmacology, neuroeconomics, and
social neuroscience.
Part VI
Appendix

Bibliography
B. Abler, H. Walter, A. Wunderlich, J. Grothe, C. Schonfeldt-Lecuona, M. Spitzer,
and U. Herwig. Side effects of transcranial magnetic stimulation biased task per-
formance in a cognitive neuroscience study. Brain Topogr, 17(4):193–196, 2005.
G. E. Abraham. Ovarian and andrenal contribution to peripheral androgens during
the menstrual cycle. J Clin Endocrinol Metab, 39:339–346, 1974.
R. F. Ackermann, D. M. Finch, T. L. Babb, and Jr. Engel, J. Increased glucose
metabolism during long-duration recurrent inhibition of hippocampal pyramidal
cells. J Neurosci, 4(1):251–264, 1984.
J. L. Aikey, J. G. Nyby, D. M. Anmuth, and P. J. James. Testosterone rapidly reduces
anxiety in male house mice (mus musculus). Horm Behav, 42(4):448–460, 2002.
A. Aleman, E. Bronk, R. P. Kessels, H. P. Koppeschaar, and J. van Honk. A sin-
gle administration of testosterone improves visuospatial ability in young women.
Psychoneuroendocrinology, 29(5):612–617, 2004.
APA. Diagnostic and statistical manual of mental disorders DSM-IV. American
Psychiatric Association, Washington, DC, 4th edition, 1995.
J. Archer. Testosterone and human aggression: an evaluation of the challenge hy-
pothesis. Neurosci Biobehav Rev, 30(3):319–345, 2006.
A. F. T. Arnsten and B. M. Li. Neurobiology of executive functions: catecholamine
influences on prefrontal cortical functions. Biol Psychiatry, 57:1377–1384, 2005.
A. R. Aron, P. C. Fletcher, E. T. Bullmore, B. J. Sahakian, and T. W. Robbins. Stop-
signal inhibition disrupted by damage to right inferior frontal gyrus in humans.
Nat Neurosci, 6(2):115–116, 2003.
V. Asghari, S. Sanyal, S. Buchwaldt, A. Paterson, V. Jovanovic, and H. H. M. Vantol.
Modulation of intracellular cyclic-amp levels by different human dopamine d4
receptor variants. J Neurochem, 65(3):1157–1165, 1995.
122 BIBLIOGRAPHY
J. Balthazart, M. Baillien, and G. F. Ball. Rapid control of brain aromatase activity
by glutamatergic inputs. Endocrinology, 147(1):359–366, 2006.
T. Baumgartner, M. Heinrichs, A. Vonlanthen, U. Fischbacher, and E. Fehr. Oxy-
tocin shapes the neural circuitry of trust and trust adaptation in humans. Neu-
ron, 58:639–650, 2008.
E. A. Beeman. The relation of the interval between castration and 1st encounter to
the aggressive behavior of mice. Anat Rec, 99(4):570–571, 1947.
H. M. Behre, K. Abshagen, M. Oettel, D. Huebler, and E. Nieschlag. Intramuscular
injection of testosterone undecanoate for the treatment of male hypogonadism:
phase i studies. Eur J Endocrinol, 140:414–419, 1999.
C. Bergh, T. Eklund, P. Sodersten, and C. Nordin. Altered dopamine function in
pathological gambling. Psychol Med, 27(2):473–475, 1997.
N. Birbaumer and R. F. Schmidt. Biologische Psychologie. Springer Medizin Verlag,
Heidelberg, 6., vollst. berarb. u. erg. aufl. edition, 2006.
M. Bixo, T. Baeckstroem, B. Winblad, and A. Andersson. Estradiol and testosterone
in specific regions of the human female brain in different endocrine states. J
Steroid Biochem Mol Biol, 55:297–303, 1995.
K. Bjorkqvist, T. Nygren, A. C. Bjorklund, and S. E. Bjorkqvist. Testosterone intake
and aggressiveness - real effect or anticipation. Aggr Behav, 20(1):17–26, 1994.
K. J . Black and J.H. Friedman. Repetitive and impulsive behaviors in treated
parkinson disease. Neurology, 67(7):1118–1119, 2006.
K. S. Blair, E. Finger, A. A. Marsh, J. Morton, K. Mondillo, B. Buzas, D. Goldman,
W. C. Drevets, and R. J. R. Blair. The role of 5-httlpr in choosing the lesser of
two evils, the better of two goods: examining the impact of 5-httlpr genotype and
tryptophan depletion in object choice. Psychopharmacology (Berl), 196(1):29–38,
2008.
F. E. Bloom, D. J. Kupfer, and B. S. Bunney. Psychopharmacology the fourth gener-
ation of progress. Raven Press, New York, NY, 1995.
A. Booth, D. A. Granger, A. Mazur, and K. T. Kivlighan. Testosterone and social
behavior. Soc Forces, 85(1):167–191, 2006.
BIBLIOGRAPHY 123
M. Brett, J.-L. Anton, R. Valabregue, and J.-B. Poline. Region of interest analysis
using an spm toolbox. Neuroimage, 16(2):497, 2002.
F. Brighina, G. Giglia, S. Scalia, M. Francolini, A. Palermo, and B. Fierro. Facili-
tatory effects of 1 hz rtms in motor cortex of patients affected by migraine with
aura. Exp Brain Res, 161(1):34–38, 2005.
T. J. Brozoski, R. M. Brown, H. E. Rosvold, and P. S. Goldman. Cognitive deficit
caused by regional depletion of dopamine in prefrontal cortex of rhesus-monkey.
Science, 205(4409):929–932, 1979.
H. G. Burger and S. R. Davis. The role of androgen therapy. Best Pract Res Clin
Endocrinol Metab, 16(3):383–393, 2002.
J. T. Cacioppo and G. G. Berntson. Social neuroscience. MIT press, Cambridge, M.
A., 2002.
C. F. Camerer. Behavioral game theory: experiments in strategic interaction. Prince-
ton University Press, Princeton, N.J., 2003.
J. J. Carmody. The birth of neuro-endocrinology: contemporary scientific blindness.
2008.
E. Cashdan. Hormones, sex, and status in women. Horm Behav, 29(3):354–366,
1995.
D. H. Catlin, C. K. Hatton, and S. H. Starcevic. Issues in detecting abuse of xenobi-
otic anabolic steroids and testosterone by analysis of athletes’ urine. Clin Chem,
43(7):1280–1288, 1997.
D. Cesarini, C. D. Dawes, J. H. Fowler, M. Johannesson, P. Lichtenstein, and B. Wal-
lace. Heritability of cooperative behavior in the trust game. Proc Natl Acad Sci
U S A, 105(10):3721–3726, 2008.
J. P. Chalmers, R. J. Baldessarini, and R. J. Wurtman. Effects of l-dopa on nor-
epinephrine metabolism in the brain. Proc Natl Acad Sci U S A, 68(3):662–666,
1971.
S. R. Chamberlain, U. Muller, A. D. Blackwell, L. Clark, T. W. Robbins, and B. J.
Sahakian. Neurochemical modulation of response inhibition and probabilistic
learning in humans. Science, 311(5762):861–863, 2006.
124 BIBLIOGRAPHY
F. M. Chang, J. R. Kidd, K. J. Livak, A. J. Pakstis, and K. K. Kidd. The world-wide
distribution of allele frequencies at the human dopamine d4 receptor locus. Hum
Genet, 98(1):91–101, 1996.
J. P. Changeux. Concluding remarks: on the ”singularity” of nerve cells and its
ontogenesis. Prog Brain Res, 58:465–478, 1983.
J. P. Changeux, D. Bertrand, P. J. Corringer, S. Dehaene, S. Edelstein, C. Lna, N. Le
Novre, L. Marubio, M. Picciotto, and M. Zoli. Brain nicotinic receptors: structure
and regulation, role in learning and reinforcement. Brain Res Brain Res Rev, 26
(2-3):198–216, 1998.
R. Chen, J. Classen, C. Gerloff, P. Celnik, E. M. Wassermann, M. Hallett, and L. G.
Cohen. Depression of motor cortex excitability by low-frequency transcranial
magnetic stimulation. Neurology, 48(5):1398–1403, 1997.
D. R. Cherek, W. Schnapp, F. G. Moeller, and D. M. Dougherty. Laboratory measures
of aggressive responding in male parolees with violent and nonviolent histories.
Aggr Behav, 22(1):27–36, 1996.
C. L. Chio, R. F. Drong, D. T. Riley, G. S. Gill, J. L. Slightom, and R. M. Huff. D4
dopamine receptor-mediated signaling events determined in transfected chinese
hamster ovary cells. J Biol Chem, 269(16):11813–11819, 1994.
P. A. Chouinard, Y. D. Van der Werf, G. Leonard, and T. Paus. Modulating neural
networks with transcranial magnetic stimulation applied over the dorsal premo-
tor and primary motor cortices. J Neurophysiol, 90(2):1071–1083, 2003.
K. Christiansen. Behavioural effects of androgen in men and women. J Endocrinol,
170(1):39–48, 2001.
B. Chung, K. J. Matteson, R. Voutilainen, T. K. Mohandas, and W. L. Miller. Human
cholesterol side-chain cleavage enzyme, p450scc - cdna cloning, assignment of the
gene to chromosome-15, and expression in the placenta. Proc Natl Acad Sci U S
A, 83(23):8962–8966, 1986.
L. Clark, F. Manes, N. Antoun, B.J. Sahakian, and T. W. Robbins. The contributions
of lesion laterality and lesion volume to decision-making impairment following
frontal lobe damage. Neuropsychologia, 41(11):1474–1483, 2003.
C. R. Cloninger, T. R. Przybeck, and D. M. Svrakic. The tridimensional personality
questionnaire: U.s. normative data. Psychol Rep, 69(3 Pt 1):1047–1057, 1991.
BIBLIOGRAPHY 125
J. M. Coates and J. Herbert. Endogenous steroids and financial risk taking on a
london trading floor. Proc Natl Acad Sci U S A, 105(16):6167–6172, 2008.
M. X. Cohen, A. Krohn-Grimberghe, C. E. Elger, and B. Weber. Dopamine gene
predicts the brain’s response to dopaminergic drug. Eur J Neurosci, 26(12):3652–
3660, 2007.
M. L. Collaer and M. Hines. Human behavioral sex differences: a role for gonadal
hormones during early development? Psychol Bull, 118(1):55–107, 1995.
D. E. Comings, N. Gonzalez, S. J. Wu, R. Gade, D. Muhleman, G. Saucier, P. John-
son, R. Verde, R. J. Rosenthal, H. R. Lesieur, L. J. Rugle, W. B. Miller, and J. P.
MacMurray. Studies of the 48 bp repeat polymorphism of the drd4 gene in im-
pulsive, compulsive, addictive behaviours: Tourette syndrome, adhd, pathological
gambling, and substance abuse. Am J Med Genet, 88(4):358–368, 1999.
E. Congdon, K. P. Lesch, and T. Canli. Analysis of drd4 and dat polymorphisms and
behavioral inhibition in healthy adults: implications for impulsivity. Am J Med
Genet B Neuropsychiatr Genet, 147B(1):27–32, 2008.
R. Cools. Role of dopamine in the motivational and cognitive control of behavior.
Neuroscientist, 14(4):381–395, 2008.
R. Cools, L. Clark, A. M. Owen, and T. W. Robbins. Defining the neural mecha-
nisms of probabilistic reversal learning using event-related functional magnetic
resonance imaging. J Neurosci, 22(11):4563–4567, 2002.
R. Cools, R. A. Barker, B. J. Sahakian, and T. W. Robbins. L-dopa medication reme-
diates cognitive inflexibility, but increases impulsivity in patients with parkin-
son’s disease. Neuropsychologia, 41(11):1431–1441, 2003.
R. Cools, L. Altamirano, and M. D’Esposito. Reversal learning in parkinson’s di-
sease depends on medication status and outcome valence. Neuropsychologia, 44
(10):1663–1673, 2006.
P. Corvol and C. W. Bardin. Species distribution of testosterone-binding globulin.
Biol Reprod, 8(3):277–282, 1973.
J. F. Couse, D. O. Bunch, J. Lindzey, D. W. Schomberg, and K. S. Korach. Prevention
of the polycystic ovarian phenotype and characterization of ovulatory capacity in
the estrogen receptor-alpha knockout mouse. Endocrinology, 140(12):5855–5865,
1999.
126 BIBLIOGRAPHY
J. P. Crean, H. de Wit, and J. B. Richards. Reward discounting as a measure of
impulsive behavior in a psychiatric outpatient population. Exp Clin Psychophar-
macol, 8(2):155–162, 2000.
H. D. Critchley, D. R. Corfield, M. P. Chandler, C. J. Mathias, and R. J. Dolan. Cere-
bral correlates of autonomic cardiovascular arousal: a functional neuroimaging
investigation in humans. J Physiol, 523 Pt 1:259–270, 2000.
O. Curet, T. Dennis, and B. Scatton. The formation of deaminated metabolites of
dopamine in the locus coeruleus depends upon noradrenergic neuronal activity.
Brain Res, 335(2):297–301, 1985.
J. P. Curley and E. B. Keverne. Genes, brains and mammalian social bonds. Trends
Ecol Evol, 20(10):561–567, 2005.
J. M. Dabbs. Age and seasonal-variation in serum testosterone concentration
among men. Chronobiol Int, 7(3):245–249, 1990.
J. M. Dabbs and M. F. Hargrove. Age, testosterone, and behavior among female
prison inmates. Psychosom Med, 59(5):477–480, 1997.
J. M. Dabbs, R. B. Ruback, R. L. Frady, C. H. Hopper, and D. S. Sgoutas. Saliva
testosterone and criminal violence among women. PAID, 9(2):269–275, 1988.
J. M. Dabbs, B. C. Campbell, B. A. Gladue, A. R. Midgley, M. A. Navarro, G. F.
Read, E. J. Susman, Lmjw Swinkels, and C. M. Worthman. Reliability of salivary
testosterone measurements - a multicenter evaluation. Clin Chem, 41(11):1581–
1584, 1995.
A. A. d’Alfonso, J. van Honk, E. Hermans, A. Postma, and E. H. de Haan. Laterality
effects in selective attention to threat after repetitive transcranial magnetic stim-
ulation at the prefrontal cortex in female subjects. Neurosci Lett, 280(3):195–198,
2000.
J. W. Dalley, T. D. Fryer, L. Brichard, E. S. J. Robinson, D. E. H. Theobald, K. Laane,
Y. Pena, E. R. Murphy, Y. Shah, K. Probst, I. Abakumova, F. I. Aigbirhio, H. K.
Richards, Y. Hong, J. C. Baron, B. J. Everitt, and T. W. Robbins. Nucleus accum-
bens d2/3 receptors predict trait impulsivity and cocaine reinforcement. Science,
315(5816):1267–1270, 2007.
A. R. Damasio. Descartes’ error, emotion, reason and the human brain. Putnam,
New York, NY, 1994.
BIBLIOGRAPHY 127
Z. J. Daskalakis, B. Moller, B. K. Christensen, P. B. Fitzgerald, C. Gunraj, and
R. Chen. The effects of repetitive transcranial magnetic stimulation on cortical
inhibition in healthy human subjects. Exp Brain Res, 174(3):403–412, 2006.
S. R. Davis and H. G. Burger. The role of androgen therapy. Best Pract Res Clin
Endocrinol Metab, 17(1):165–175, 2003.
S. R. Davis and J. Tran. Testosterone influences libido and well being in women.
Trends Endocrinol Metab, 12(1):33–37, 2001.
L.R. Derogatis. SCL-90-R, administration, scoring & procedures manual-I for the
R(evised) version. Johns Hopkins University School of Medicine: Eigendruck.,
1977.
R. Dias, T. W. Robbins, and A. C. Roberts. Dissociation in prefrontal cortex of affec-
tive and attentional shifts. Nature, 380(6569):69–72, 1996.
Y. C. Ding, H. C. Chi, D. L. Grady, A. Morishima, J. R. Kidd, K. K. Kidd, P. Flodman,
M. A. Spence, S. Schuck, J. M. Swanson, Y. P. Zhang, and R. K. Moyzis. Evidence
of positive selection acting at the human dopamine receptor d4 gene locus. Proc
Natl Acad Sci U S A, 99(1):309–314, 2002.
K. Doya. Modulators of decision making. Nat Neurosci, 11(4):410–416, 2008.
R. Dunbar. Neocortex size as a constraint on group-size in primates. J Hum Evol,
22:469–493, 1992.
R. Dunbar. The social brain hypothesis. Evol Anthropol, 6:178–190, 1998.
S. Durston, J. A. Fossella, B. J. Casey, H. E. H. Pol, A. Galvan, H. G. Schnack, M. P.
Steenhuis, R. B. Minderaa, J. K. Buitelaar, R. S. Kahn, and H. van Engeland.
Differential effects of drd4 and dat1 genotype on fronto-striatal gray matter vol-
umes in a sample of subjects with attention deficit hyperactivity disorder, their
unaffected siblings, and controls. Mol Psychiatry, 10(7):678–685, 2005.
R. P. Ebstein, O. Novick, R. Umansky, B. Priel, Y. Osher, D. Blaine, E. R. Bennett,
L. Nemanov, M. Katz, and R. H. Belmaker. Dopamine d4 receptor (d4dr) exon
iii polymorphism associated with the human personality trait of novelty seeking.
Nat Genet, 12(1):78–80, 1996.
D. A. Edwards. Early androgen stimulation and aggressive behavior in male and
female mice. Physiol Behav, 4(3):333–338, 1969.
128 BIBLIOGRAPHY
J. Ehrenkranz, E. Bliss, and M. H. Sheard. Plasma testosterone: correlation with
aggressive behavior and social dominance in man. Psychosom Med, 36(6):469–
475, 1974.
J. D. Elsworth and R. H. Roth. Dopamine synthesis, uptake, metabolism, and re-
ceptors: relevance to gene therapy of parkinson’s disease. Exp Neurol, 144(1):
4–9, 1997.
G. M. Everett and J. W. Borcherding. L-dopa: effect on concentrations of dopamine,
norepinephrine, and serotonin in brains of mice. Science, 168(933):847–850, 1970.
S. V. Faraone, A. E. Doyle, E. Mick, and J. Biederman. Meta-analysis of the associa-
tion between the 7-repeat allele of the dopamine d-4 receptor gene and attention
deficit hyperactivity disorder. Am J Psychiatry, 158(7):1052–1057, 2001.
S. V. Faraone, R. H. Perlis, A. E. Doyle, J. W. Smoller, J. J. Goralnick, M. A. Holm-
gren, and P. Sklar. Molecular genetics of attention-deficit/hyperactivity disorder.
Biol Psychiatry, 57(11):1313–1323, 2005.
E. Fehr and S. Gaechter. Altruistic punishment in humans. Nature, 415(6868):
137–140, 2002.
E. C. Finger, A. Marsh, B. Buzas, N. Kamel, R. Rhodes, M. Vythilingham, D. S.
Pine, D. Goldman, and J. R. Blair. The impact of tryptophan depletion and 5-
httlpr genotype on passive avoidance and response reversal instrumental learn-
ing tasks. Neuropsychopharmacology, 32(1):206–215, 2007.
U. Fischbacher. z-tree: zurich toolbox for ready-made economic experiments. Exper
Econ, 10(2):171–178, 2007.
P. B. Fitzgerald, T. L. Brown, and Z. J. Daskalakis. The application of transcranial
magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr
Scand, 105(5):324–340, 2002.
D. Floden, M. P. Alexander, C. S. Kubu, D. Katz, and D. T. Stuss. Impulsivity and
risk-taking behavior in focal frontal lobe lesions. Neuropsychologia, 46(1):213–
223, 2008.
E. E. Forbes, S. M. Brown, M. Kimak, R. E. Ferrell, S. B. Manuck, and A. R. Hariri.
Genetic variation in components of dopamine neurotransmission impacts ventral
striatal reactivity associated with impulsivity. Mol Psychiatry, 14(1):60–70, 2009.
BIBLIOGRAPHY 129
J. H. Friedman. Punding on levodopa. Biol Psychiatry, 36(5):350–351, 1994.
S. J. Gatley, D. Pan, R. Chen, G. Chaturvedi, and Y. S. Ding. Affinities of
methylphenidate derivatives for dopamine, norepinephrine and serotonin trans-
porters. Life Sci, 58(12):231–239, 1996.
M. S. George, Z. Nahas, F. A. Kozel, X. Li, S. Denslow, K. Yamanaka, A. Mishory,
M. J. Foust, and D. E. Bohning. Mechanisms and state of the art of transcranial
magnetic stimulation. J ECT, 18(4):170–181, 2002.
W. Gerschlager, H. R. Siebner, and J. C. Rothwell. Decreased corticospinal excitabil-
ity after subthreshold 1 hz rtms over lateral premotor cortex. Neurology, 57(3):
449–55, 2001.
L. R. R. Gianotti, D. Knoch, P. L. Faber, D. Lehmann, R. D. Pascual-Marqui, C. Diezi,
C. Schoch, C. Eisenegger, and E. Fehr. Tonic activity level in the right prefrontal
cortex predicts individuals’ risk taking. Psychol Sci, 20(1):33–38, 2009.
A. Gjedde, J. Reith, S. Dyve, G. Lger, M. Guttman, M. Diksic, A. Evans, and
H. Kuwabara. Dopa decarboxylase activity of the living human brain. Proc Natl
Acad Sci U S A, 88(7):2721–2725, 1991.
B. A. Gladue, M. Boechler, and K. D. Mccaul. Hormonal response to competition in
human males. Aggr Behav, 15(6):409–422, 1989.
U. Gneezy, M. Niederle, and A. Rustichini. Performance in competitive environ-
ments: Gender differences. QJE, pages 1049–1074, 2003.
F. Gonon. The dopaminergic hypothesis of attention-deficit/hyperactivity disorder
needs re-examining. Trends Neurosci, 32(1):2–8, 2009.
J. A. Gorski, S. A. Balogh, J. M. Wehner, and K. R. Jones. Learning deficits
in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuro-
science, 121(2):341–354, 2003.
A. M. Gotham, R. G. Brown, and C. D. Marsden. Levodopa treatment may benefit
or impair frontal function in parkinsons-disease. Lancet, 2(8513):970–971, 1986.
A. M. Gotham, R. G. Brown, and C. D. Marsden. Frontal cognitive function in
patients with parkinson’s disease ’on’ and ’off ’ levodopa. Brain, 111 ( Pt 2):299–
321, 1988.
130 BIBLIOGRAPHY
D. A. Granger, E. A. Shirtcliff, A. Booth, K. T. Kivlighan, and E. B. Schwartz. The
”trouble” with salivary testosterone. Psychoneuroendocrinology, 29(10):1229–
1240, 2004.
V. J. Grant and J. T. France. Dominance and testosterone in women. Biol Psychol,
58(1):41–47, 2001.
P. B. Grino, J. E. Griffin, and J. D. Wilson. Testosterone at high concentrations in-
teracts with the human androgen receptor similarly to dihydrotestosterone. En-
docrinology, 126(2):1165–1172, 1990.
W. Gueth, R. Schmittberger, and B. Schwarze. An experimental analysis of ultima-
tum bargaining. J Econ Behav Organ, 3:367–388, 1982.
M. Hallett. Transcranial magnetic stimulation and the human brain. Nature, 406
(6792):147–150, 2000.
M. Hallett. Transcranial magnetic stimulation: A primer. Neuron, 55(2):187–199,
2007.
A. Hamidovic, U. J. Kang, and H. de Wit. Effects of low to moderate acute doses
of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psy-
chopharmacol, 28(1):45–51, 2008.
J. A. Harris, P. A. Vernon, and D. I. Boomsma. The heritability of testosterone: A
study of dutch adolescent twins and their parents. Behav Genet, 28(3):165–171,
1998.
A. Heinz, D. Goldman, D. W. Jones, R. Palmour, D. Hommer, J. G. Gorey, K. S.
Lee, M. Linnoila, and D. R. Weinberger. Genotype influences in vivo dopamine
transporter availability in human striatum. Neuropsychopharmacology, 22(2):
133–9, 2000.
D. H. Hellhammer. Stress: the brain-body connection. S. Karger, Basel, 2008.
J. Henrich, R. Boyd, S. Bowles, C. Camerer, E. Fehr, H. Gintis, R. McElreath, M. Al-
vard, A. Barr, J. Ensminger, N. S. Henrich, K. Hill, F. Gil-White, M. Gurven, F. W.
Marlowe, J. Q. Patton, and D. Tracer. Economic man in cross-cultural perspec-
tive: Behavioral experiments in 15 small-scale societies. Behav Brain Sci, 28(6):
795–855, 2005.
BIBLIOGRAPHY 131
E. J. Hermans, P. Putman, J. M. Baas, H. P. Koppeschaar, and J. van Honk. A single
administration of testosterone reduces fear-potentiated startle in humans. Biol
Psychiatry, 59(9):872–874, 2006a.
E. J. Hermans, P. Putman, and J. van Honk. Testosterone administration re-
duces empathetic behavior: a facial mimicry study. Psychoneuroendocrinology,
31(August):859–866, 2006b.
E. J. Hermans, P. Putman, J. M. Baas, N. M. Gecks, J. L. Kenemans, and J. van
Honk. Exogenous testosterone attenuates the integrated central stress response
in healthy young women. Psychoneuroendocrinology, 32(8-10):1052–1061, 2007.
E. J. Hermans, N. F. Ramsey, and J. van Honk. Exogenous testosterone enhances
responsiveness to social threat in the neural circuitry of social aggression in hu-
mans. Biol Psychiatry, 63(3):263–270, 2008.
R. Hertwig and A. Ortmann. Experimental practices in economics: A methodologi-
cal challenge for psychologists? Behav Brain Sci, 24(3):383–389, 2001.
C. C. Hilgetag, H. Theoret, and A. Pascual-Leone. Enhanced visual spatial atten-
tion ipsilateral to rtms-induced ’virtual lesions’ of human parietal cortex. Nat
Neurosci, 4(9):953–957, 2001.
F. Hirayama and K. Uekama. Cyclodextrin-based controlled drug release system.
Adv Drug Deliv Rev, 36(1):125–141, 1999.
E. Hoffman, K. McCabe, K. Shachat, and V. Smith. Preferences, property rights,
and anonymity in bargaining games. Games Econ Behav, 7:346–380, 1994.
U. Hoffrage, A. Weber, R. Hertwig, and V. M. Chase. How to keep children safe in
traffic: Find the daredevils early. J Exp Psychol Appl, 9(4):249–260, 2003.
F. T. Husain, G. Nandipati, A. R. Braun, L. G. Cohen, M. A. Tagamets, and B. Hor-
witz. Simulating transcranial magnetic stimulation during pet with a large-scale
neural network model of the prefrontal cortex and the visual system. Neuroim-
age, 15(1):58–73, 2002.
Kent E Hutchison, John McGeary, Andrew Smolen, Angela Bryan, and Robert M
Swift. The drd4 vntr polymorphism moderates craving after alcohol consumption.
Health Psychol, 21(2):139–146, 2002.
132 BIBLIOGRAPHY
H. Ito, H. Takahashi, R. Arakawa, H. Takano, and T. Suhara. Normal database of
dopaminergic neurotransmission system in human brain measured by positron
emission tomography. Neuroimage, 39(2):555–565, 2008.
R. Jalinous. Technical and practical aspects of magnetic nerve stimulation. J Clin
Neurophysiol, 8(1):10–25, 1991.
J. A. Johnson, A. P. Strafella, and R. J. Zatorre. The role of the dorsolateral pre-
frontal cortex in bimodal divided attention: two transcranial magnetic stimula-
tion studies. J Cogn Neurosci, 19(6):907–920, 2007.
R. A. Josephs, M. L. Newman, R. P. Brown, and J. M. Beer. Status, testosterone, and
human intellectual performance: stereotype threat as status concern. Psychol
Sci, 14(2):158–163, 2003.
R. A. Josephs, J. G. Sellers, M. L. Newman, and P. H. Mehta. The mismatch effect:
when testosterone and status are at odds. J Pers Soc Psychol, 90(6):999–1013,
2006.
M. Jueptner and C. Weiller. Review: does measurement of regional cerebral blood
flow reflect synaptic activity? implications for pet and fmri. Neuroimage, 2(2):
148–156, 1995.
F. Kagitani, S. Uchida, H. Hotta, and A. Sato. Effects of nicotine on blood flow
and delayed neuronal death following intermittent transient ischemia in rat hip-
pocampus. Jpn J Physiol, 50(6):585–595, 2000.
F. J. Karsch. Central actions of ovarian steroids in the feedback regulation of pul-
satile secretion of luteinizing hormone. Annu Rev Physiol, 49:365–382, 1987.
M. J. Kelly, R. L. Moss, and C. A. Dudley. The effects of microelectrophoretically ap-
plied estrogen, cortisol and acetylcholine on medial preoptic-septal unit activity
throughout the estrous cycle of the female rat. Exp Brain Res, 30(1):53–64, 1977.
E. B. Keverne, F. L. Martel, and C. M. Nevison. Primate brain evolution: genetic
and functional considerations. Proc Biol Sci, 263(1371):689–696, 1996.
T. A. Kimbrell, R. T. Dunn, M. S. George, A. L. Danielson, M. W. Willis, J. D. Repella,
B. E. Benson, P. Herscovitch, R. M. Post, and E. M. Wassermann. Left prefrontal-
repetitive transcranial magnetic stimulation (rtms) and regional cerebral glucose
metabolism in normal volunteers. Psychiatry Res, 115(3):101–113, 2002.
BIBLIOGRAPHY 133
C. Kirschbaum and D. H. Hellhammer. Salivary cortisol in psychoneuroendocrine
research - recent developments and applications. Psychoneuroendocrinology, 19
(4):313–333, 1994.
S. J. Kish, K. Shannak, and O. Hornykiewicz. Uneven pattern of dopamine loss
in the striatum of patients with idiopathic parkinson’s disease. pathophysiologic
and clinical implications. N Engl J Med, 318(14):876–880, 1988.
A. N. Kluger, Z. Siegfried, and R. P. Ebstein. A meta-analysis of the association
between drd4 polymorphism and novelty seeking. Mol Psychiatry, 7(7):712–717,
2002.
D. Knoch and E. Fehr. Resisting the power of temptations: the right prefrontal
cortex and self-control. Ann N Y Acad Sci, 1104:123–134, 2007.
D. Knoch, L. R. Gianotti, A. Pascual-Leone, V. Treyer, M. Regard, M. Hohmann,
and P. Brugger. Disruption of right prefrontal cortex by low-frequency repetitive
transcranial magnetic stimulation induces risk-taking behavior. J Neurosci, 26
(24):6469–6472, 2006a.
D. Knoch, A. Pascual-Leone, K. Meyer, V. Treyer, and E. Fehr. Diminishing recipro-
cal fairness by disrupting the right prefrontal cortex. Science, 314(5800):829–832,
2006b.
D. Knoch, V. Treyer, M. Regard, R. M. Muri, A. Buck, and B. Weber. Lateralized and
frequency-dependent effects of prefrontal rtms on regional cerebral blood flow.
Neuroimage, 31(2):641–648, 2006c.
A. Kondacs and M. Szab. Long-term intra-individual variability of the background
eeg in normals. Clin Neurophysiol, 110(10):1708–1716, 1999.
I. J. Kopin. Catecholamine metabolism: basic aspects and clinical significance.
Pharmacol Rev, 37(4):333–364, 1985.
M. Kosfeld, M. Heinrichs, P. J. Zak, U. Fischbacher, and E. Fehr. Oxytocin increases
trust in humans. Nature, 435(7042):673–676, 2005.
S. M. Kosslyn, A. Pascual-Leone, O. Felician, S. Camposano, J. P. Keenan, W. L.
Thompson, G. Ganis, K. E. Sukel, and N. M. Alpert. The role of area 17 in visual
imagery: convergent evidence from pet and rtms. Science, 284(5411):167–70,
1999.
134 BIBLIOGRAPHY
L. S. Krimer, E. C. Muly, G. V. Williams, and P. S. Goldman-Rakic. Dopaminergic
regulation of cerebral cortical microcirculation. Nat Neurosci, 1(4):286–289, 1998.
R. Kuczenski and D. S. Segal. Effects of methylphenidate on extracellular
dopamine, serotonin, and norepinephrine: comparison with amphetamine. J
Neurochem, 68(5):2032–2037, 1997.
R. Ladouceur, D. Dub, and A. Bujold. Prevalence of pathological gambling and
related problems among college students in the quebec metropolitan area. Can J
Psychiatry, 39(5):289–293, 1994.
R. A. Lahti, R. C. Roberts, E. V. Cochrane, R. J. Primus, D. W. Gallager, and C. A.
Tamminga. [h-3]-ngd-94-1 binding in human postmortem brain of normals and
schizophrenics off-, or on-antipsychotic drugs at death. Schizophr Res, 24(1-2):
35–35, 1997.
F. Lanau, M. T. Zenner, O. Civelli, and D. S. Hartman. Epinephrine and norepin-
ephrine act as potent agonists at the recombinant human dopamine d4 receptor.
J Neurochem, 68(2):804–812, 1997.
A. D. Landman, L. M. Sanford, B. E. Howland, C. Dawes, and E. T. Pritchard.
Testosterone in human saliva. Experientia, 32(7):940–941, 1976.
K. Langley, L. Marshall, M. van den Bree, H. Thomas, M. Owen, M. O’Donovan,
and A. Thapar. Association of the dopamine d4 receptor gene 7-repeat allele with
neuropsychological test performance of children with adhd. Am J Psychiatry, 161
(1):133–138, 2004.
M. E. Lauber, A. Sarasin, and W. Lichtensteiger. Sex differences and androgen-
dependent regulation of aromatase (cyp19) mrna expression in the developing
and adult rat brain. J Steroid Biochem Mol Biol, 61(3-6):359–364, 1997.
L. Laux. State-Trait-Angstinventar : theoretische Grundlagen und Handanweisung.
Beltz Testgesellschaft, Weinheim, [deutsche ausgabe] / edition, 1981.
H. R. Lesieur and S. B. Blume. The south oaks gambling screen (sogs): a new
instrument for the identification of pathological gamblers. Am J Psychiatry, 144
(9):1184–1188, 1987.
J. Lewald, H. Foltys, and R. Topper. Role of the posterior parietal cortex in spatial
hearing. J Neurosci, 22(3):RC207, 2002.
BIBLIOGRAPHY 135
D. Li, P. C. Sham, M. J. Owen, and L. He. Meta-analysis shows significant associa-
tion between dopamine system genes and attention deficit hyperactivity disorder
(adhd). Hum Mol Genet, 15(14):2276–2284, 2006.
J. B. Lichter, C. L. Barr, J. L. Kennedy, H. H. M. Vantol, K. K. Kidd, and K. J. Livak.
A hypervariable segment in the human dopamine receptor d(4) (drd4) gene. Hum
Mol Genet, 2(6):767–773, 1993.
M. S. Lidow, F. Wang, Y. Cao, and P. S. Goldman-Rakic. Layer v neurons bear the
majority of mrnas encoding the five distinct dopamine receptor subtypes in the
primate prefrontal cortex. Synapse, 28(1):10–20, 1998.
K. G. Lloyd and O. Hornykiewicz. Occurrence and distribution of aromatic l-amino
acid (l-dopa) decarboxylase in the human brain. J Neurochem, 19(6):1549–1559,
1972.
G. Loewenstein. Experimental economics from their vantagepoint of behavioural
economics. The Economic Journal, 109:25–34, 1999.
A. R. Lumia, K. M. Thorner, and M. Y. Mcginnis. Effects of chronically high-
doses of the anabolic-androgenic steroid, testosterone, on intermale aggression
and sexual-behavior in male-rats. Physiol Behav, 55(2):331–335, 1994.
J. M. Lusher, C. Chandler, and D. Ball. Dopamine d4 receptor gene (drd4) is asso-
ciated with novelty seeking (ns) and substance abuse: the saga continues ... Mol
Psychiatry, 6(5):497–499, 2001.
F. Maeda, J. P. Keenan, J. M. Tormos, H. Topka, and A. Pascual-Leone. Interindi-
vidual variability of the modulatory effects of repetitive transcranial magnetic
stimulation on cortical excitability. Exp Brain Res, 133(4):425–430, 2000.
F. Manes, B. Sahakian, L. Clark, R. Rogers, N. Antoun, M. Aitken, and T. W.
Robbins. Decision-making processes following damage to the prefrontal cortex.
Brain, 125(Pt 3):624–639, 2002.
A. A. Marsh, E. C. Finger, B. Buzas, N. Soliman, R. A. Richell, M. Vythilingham,
D. S. Pine, D. Goldman, and R. J. R. Blair. Impaired recognition of fear facial
expressions in 5-httlpr s-polymorphism carriers following tryptophan depletion.
Psychopharmacology (Berl), 189(3):387–394, 2006.
Nelly Mauras, John Lima, Deval Patel, Annie Rini, Enrico di Salle, Ambrose Kwok,
and Barbara Lippe. Pharmacokinetics and dose finding of a potent aromatase
136 BIBLIOGRAPHY
inhibitor, aromasin (exemestane), in young males. J Clin Endocrinol Metab, 88
(12):5951–5956, 2003.
A. May, H. Kaube, C. Buchel, C. Eichten, M. Rijntjes, M. Juptner, C. Weiller, and
H. C. Diener. Experimental cranial pain elicited by capsaicin: a pet study. Pain,
74(1):61–66, 1998.
A. Mazur. A biosocial model of status in face-to-face primate groups. Soc Forces, 64
(2):377–402, 1985.
A. Mazur. Biosociology of dominance and deference. Rowman & Littlefield, Lanham,
2005.
A. Mazur and A. Booth. Testosterone and dominance in men. Behav Brain Sci, 21
(3):353–363, 1998.
A. Mazur and T. A. Lamb. Testosterone, status, and mood in human males. Horm
Behav, 14(3):236–246, 1980.
A. Mazur, A. Booth, and J. M. Dabbs. Testosterone and chess competition. Soc
Psychol Q, 55(1):70–77, 1992.
K. D. Mccaul, B. A. Gladue, and M. Joppa. Winning, losing, mood, and testosterone.
Horm Behav, 26(4):486–504, 1992.
B. S. Mcewen. Steroid-hormones - effect on brain-development and function. Horm
Res, 37:1–10, 1992.
P. H. Mehta and R. A. Josephs. Testosterone change after losing predicts the deci-
sion to compete again. Horm Behav, 50(5):684–692, 2006.
R. H. Melloni, D. F. Connor, P. T. X. Hang, R. J. Harrison, and C. F. Ferris.
Anabolic-androgenic steroid exposure during adolescence and aggressive behav-
ior in golden hamsters. Physiol Behav, 61(3):359–364, 1997.
D. B. Miller and J. P. O’Callaghan. Neuroendocrine aspects of the response to stress.
Metabolism, 51(6 Suppl 1):5–10, 2002.
E. K. Miller and J. D. Cohen. An integrative theory of prefrontal cortex function.
Annu Rev Neurosci, 24:167–202, 2001.
S. H. Mitchell. Measures of impulsivity in cigarette smokers and non-smokers.
Psychopharmacology (Berl), 146(4):455–464, 1999.
BIBLIOGRAPHY 137
J. A. Molina, M. J. Sainz-Artiga, A. Fraile, F. J. Jimenez-Jimenez, C. Villanueva,
M. Orti-Pareja, and P. F. Bermejo. Pathologic gambling in parkinson’s disease: A
behavioral manifestation of pharmacologic treatment? Mov Disord, 15(5):869–
872, 2000.
R. Y. Moore, A. L. Whone, S. McGowan, and D. J. Brooks. Monoamine neuron
innervation of the normal human brain: an 18f-dopa pet study. Brain Res, 982
(2):137–145, 2003.
K. I. Morley and W. D. Hall. Using pharmacogenetics and pharmacogenomics in the
treatment of psychiatric disorders: some ethical and economic considerations. J
Mol Med, 82(1):21–30, 2004.
F. M. Mottaghy, M. Gangitano, R. Sparing, B. J. Krause, and A. Pascual-Leone.
Segregation of areas related to visual working memory in the prefrontal cortex
revealed by rtms. Cereb Cortex, 12(4):369–375, 2002.
L. Mrzljak, C. Bergson, M. Pappy, R. Huff, R. Levenson, and P. S. GoldmanRakic.
Localization of dopamine d4 receptors in gabaergic neurons of the primate brain.
Nature, 381(6579):245–248, 1996.
W. Muellbacher, U. Ziemann, B. Boroojerdi, and M. Hallett. Effects of low-frequency
transcranial magnetic stimulation on motor excitability and basic motor behavior.
Clin Neurophysiol, 111(6):1002–1007, 2000.
M. N. Muller and R. W. Wrangham. Dominance, aggression and testosterone in
wild chimpanzees: a test of the ’ challenge hypothesis ’. Anim Behav, 67:113–
123, 2004.
Z. Nahas, M. Lomarev, D. R. Roberts, A. Shastri, J. P. Lorberbaum, C. Teneback,
K. McConnell, D. J. Vincent, X. Li, M. S. George, and D. E. Bohning. Unilat-
eral left prefrontal transcranial magnetic stimulation (tms) produces intensity-
dependent bilateral effects as measured by interleaved bold fmri. Biol Psychiatry,
50(9):712–720, 2001.
M. Naoi, W. Maruyama, T. Takahashi, M. Ota, and H. Parvez. Inhibition of tryp-
tophan hydroxylase by dopamine and the precursor amino acids. Biochem Phar-
macol, 48(1):207–211, 1994.
M. L. Newman, J. G. Sellers, and R. A. Josephs. Testosterone, cognition, and social
status. Horm Behav, 47(2):205–211, 2005.
138 BIBLIOGRAPHY
A. Newman-Tancredi, V. Audinot-Bouchez, A. Gobert, and M. J. Millan. Nora-
drenaline and adrenaline are high affinity agonists at dopamine d4 receptors.
Eur J Pharmacol, 319(2-3):379–383, 1997.
M. Niederle and L. Vesterlund. Do women shy away from competition? do men
compete too much? QJE, 122(3):1067–1101, 2007.
E. Nieschlag. Testosterone action, deficiency, substitution. Cambridge University
Press, Cambridge, 3rd ed, reprinted edition, 2006.
H. Norris. Action of sedatives on brain stem oculomotor systems in man. Neu-
ropharmacology, 10(2):181–191, 1971.
J. N. Oak, J. Oldenhof, and H. H. M. van Tol. The dopamine d-4 receptor: one decade
of research. Eur J Pharmacol, 405(1-3):303–327, 2000.
K. N. Ochsner, R. D. Ray, J. C. Cooper, E. R. Robertson, S. Chopra, J. D. Gabrieli,
and J. J. Gross. For better or for worse: neural systems supporting the cognitive
down- and up-regulation of negative emotion. Neuroimage, 23(2):483–499, 2004.
T. Ohnishi, H. Matsuda, E. Imabayashi, S. Okabe, H. Takano, N. Arai, and
Y. Ugawa. rcbf changes elicited by rtms over dlpfc in humans. Suppl Clin Neuro-
physiol, 57:715–720, 2004.
J. Oldenhof, R. Vickery, M. Anafi, J. Oak, A. Ray, O. Schoots, T. Pawson, M. von
Zastrow, and H. H. Van Tol. Sh3 binding domains in the dopamine d4 receptor.
Biochemistry (Mosc), 37(45):15726–15736, 1998.
C. C. Overtoom, M. N. Verbaten, C. Kemner, J. L. Kenemans, H. van Engeland,
J. K. Buitelaar, M. W. van der Molen, J. van der Gugten, H. Westenberg, R. A. A.
Maes, and H. S. Koelega. Effects of methylphenidate, desipramine, and l-dopa on
attention and inhibition in children with attention deficit hyperactivity disorder.
Behav Brain Res, 145(1-2):7–15, 2003.
W. M. Pardridge and L. J. Mietus. Transport of steroid hormones through the rat
blood-brain barrier. primary role of albumin-bound hormone. J Clin Invest, 64(1):
145–154, 1979.
A. Pascual-Leone, J. M. Tormos, J. Keenan, F. Tarazona, C. Canete, and M. D.
Catala. Study and modulation of human cortical excitability with transcranial
magnetic stimulation. J Clin Neurophysiol, 15(4):333–343, 1998.
BIBLIOGRAPHY 139
J. H. Patton, M. S. Stanford, and E. S. Barratt. Factor structure of the barratt
impulsiveness scale. J Clin Psychol, 51(6):768–74, 1995.
I. Perez de Castro, A. Ibanez, P. Torres, J. Saiz-Ruiz, and J. Fernandez-Piqueras.
Genetic association study between pathological gambling and a functional dna
polymorphism at the d4 receptor gene. Pharmacogenetics, 7(5):345–348, 1997.
M. Petrides and D. N. Pandya. Dorsolateral prefrontal cortex: comparative cy-
toarchitectonic analysis in the human and the macaque brain and corticocortical
connection patterns. Eur J Neurosci, 11(3):1011–1036, 1999.
D. W. Pfaff. Patterns of steroid hormone effects on electrical and molecular events
in hypothalamic neurons. Mol Neurobiol, 3(3):135–154, 1989.
M. Pirmohamed. Pharmacogenetics and pharmacogenomics. Br J Clin Pharmacol,
52(4):345–347, 2001.
M. Pirmohamed and B. K. Park. Genetic susceptibility to adverse drug reactions.
Trends Pharmacol Sci, 22(6):298–305, 2001.
R.A. Poldrack. Can cognitive processes be inferred from neuroimaging data? Trends
Cogn Sci, 10(2):59–63, 2006.
H. G. Pope and D. L. Katz. Affective and psychotic symptoms associated with an-
abolic steroid use. Am J Psychiatry, 145(4):487–490, 1988.
H. G. Pope and D. L. Katz. Homicide and near-homicide by anabolic-steroid users.
J Clin Psychiatry, 51(1):28–31, 1990.
H. G. Pope, E. M. Kouri, and J. I. Hudson. Effects of supraphysiologic doses of
testosterone on mood and aggression in normal men: a randomized controlled
trial. Arch Gen Psychiatry, 57(2):133–140, 2000.
O. Prante, R. Tietze, C. Hocke, S. Loeber, H. Huebner, T. Kuwert, and P. Gmeiner.
Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-
based dopamine d4 receptor ligands: discovery of an inverse agonist radioligand
for pet. J Med Chem, 51(6):1800–1810, 2008.
R. J. Primus, A. Thurkauf, J. Xu, E. Yevich, S. McInerney, K. Shaw, J. F. Tallman,
and D. W. Gallager. Localization and characterization of dopamine d-4 binding
sites in rat and human brain by use of the novel, d-4 receptor-selective ligand
[h-3]ngd 94-1 .2. J Pharmacol Exp Ther, 282(2):1020–1027, 1997.
140 BIBLIOGRAPHY
L. Prockop, S. Fahn, and P. Barbour. Homovanillic acid: entry rate kinetics for
transfer from plasma to cerebrospinal fluid. Brain Res, 80(3):435–442, 1974.
F. E. Purifoy and L. H. Koopmans. Androstenedione, testosterone, and free testos-
terone concentration in women of various occupations. Soc Biol, 26(3):179–188,
1979.
S. Rahman, B. J. Sahakia, R. N. Cardinal, R. Rogers, and T. W. Robbins. Decision
making and neuropsychiatry. Trends Cogn Sci, 5(6):271–277, 2001.
N. Raylu and T. P. S. Oei. Pathological gambling. a comprehensive review. Clin
Psychol Rev, 22(7):1009–1061, 2002.
D. Riad-Fahmy, G. F. Read, R. F. Walker, S. M. Walker, and K. Griffiths. Determina-
tion of ovarian steroid hormone levels in saliva. an overview. J Reprod Med, 32
(4):254–272, 1987.
J. Riba, U. K. Kraemer, M. Heldmann, S. Richter, and T. M. Muente. Dopamine ag-
onist increases risk taking but blunts reward-related brain activity. PLoS ONE,
3(6):e2479, 2008.
R. M. Ridley and H. F. Baker. Stereotypy in monkeys and humans. Psychol Med,
12(1):61–72, 1982.
A. Rivera, B. Cullar, F. J. Girn, D. K. Grandy, A. de la Calle, and R. Moratalla.
Dopamine d4 receptors are heterogeneously distributed in the striosomes/matrix
compartments of the striatum. J Neurochem, 80(2):219–229, 2002.
E. M. Robertson, J. M. Tormos, F. Maeda, and A. Pascual-Leone. The role of the
dorsolateral prefrontal cortex during sequence learning is specific for spatial in-
formation. Cereb Cortex, 11(7):628–635, 2001.
E. M. Robertson, H. Theoret, and A. Pascual-Leone. Studies in cognition: the prob-
lems solved and created by transcranial magnetic stimulation. J Cogn Neurosci,
15(7):948–960, 2003.
R. D. Rogers, A. M. Owen, H. C. Middleton, E. J. Williams, J. D. Pickard, B. J.
Sahakian, and T. W. Robbins. Choosing between small, likely rewards and large,
unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci, 19
(20):9029–9038, 1999.
BIBLIOGRAPHY 141
J. P. Roiser, A. D. Blackwell, R. Cools, L. Clark, D. C. Rubinsztein, T. W. Robbins,
and B. J. Sahakian. Serotonin transporter polymorphism mediates vulnerability
to loss of incentive motivation following acute tryptophan depletion. Neuropsy-
chopharmacology, 31(10):2264–2272, 2006.
J. P. Roiser, U. Mueller, L. Clark, and B. S. Sahakian. The effects of acute tryptophan
depletion and serotonin transporter polymorphism on emotional processing in
memory and attention. Int J Neuropsychopharmacol, 10(4):449–461, 2007.
T. Roman, M. Schmitz, G. Polanczyk, M. Eizirik, L. A. Rohde, and M. H. Hutz.
Attention-deficit hyperactivity disorder: A study of association with both the
dopamine transporter gene and the dopamine d4 receptor gene. Am J Med Genet,
105(5):471–478, 2001.
J. R. Romero, D. Anschel, R. Sparing, M. Gangitano, and A. Pascual-Leone. Sub-
threshold low frequency repetitive transcranial magnetic stimulation selectively
decreases facilitation in the motor cortex. Clin Neurophysiol, 113(1):101–107,
2002.
R. M. Rose, J. W. Holaday, and I. S. Bernstei. Plasma testosterone, dominance rank
and aggressive behaviour in male rhesus monkeys. Nature, 231(5302):366–372,
1971.
A. Rotem and E. Moses. Magnetic stimulation of one-dimensional neuronal cul-
tures. Biophys J, 94(12):5065–5078, 2008.
R. Rowe, B. Maughan, C. M. Worthman, E. J. Costello, and A. Angold. Testos-
terone, antisocial behavior, and social dominance in boys: Pubertal development
and biosocial interaction. Biol Psychiatry, 55(5):546–552, 2004.
M. Rubinstein, T. J. Phillips, J. R. Bunzow, T. L. Falzone, G. Dziewczapolski,
G. Zhang, Y. Fang, J. L. Larson, J. A. McDougall, J. A. Chester, C. Saez, T. A.
Pugsley, O. Gershanik, M. J. Low, and D. K. Grandy. Mice lacking dopamine d4
receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell, 90
(6):991–1001, 1997.
J. S. Rubinsztein, P. C. Fletcher, R. D. Rogers, L. W. Ho, F. I. Aigbirhio, E. S. Paykel,
T. W. Robbins, and B. J. Sahakian. Decision-making in mania: a pet study. Brain,
124(Pt 12):2550–2563, 2001.
G. Rylander. Psychoses and the punding and choreiform syndromes in addiction to
central stimulant drugs. Psychiatr Neurol Neurochir, 75(3):203–212, 1972.
142 BIBLIOGRAPHY
A. T. Sack and D. E. Linden. Combining transcranial magnetic stimulation and
functional imaging in cognitive brain research: possibilities and limitations.
Brain Res Brain Res Rev, 43(1):41–56, 2003.
A. T. Sack, J. A. Camprodon, A. Pascual-Leone, and R. Goebel. The dynamics of
interhemispheric compensatory processes in mental imagery. Science, 308(5722):
702–704, 2005.
A. T. Sack, A. Kohler, S. Bestmann, D. E. Linden, P. Dechent, R. Goebel, and
J. Baudewig. Imaging the brain activity changes underlying impaired visuospa-
tial judgments: Simultaneous fmri, tms, and behavioral studies. Cereb Cortex,
2007.
M. Sakagami and X. Pan. Functional role of the ventrolateral prefrontal cortex in
decision making. Curr Opin Neurobiol, 17(2):228–233, 2007.
A. G. Sanfey, J. K. Rilling, J. A. Aronson, L. E. Nystrom, and J. D. Cohen. The
neural basis of economic decision-making in the ultimatum game. Science, 300
(5626):1755–1758, 2003.
R. J. Santen and C. W. Bardin. Episodic luteinizing hormone secretion in man.
pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest, 52
(10):2617–2628, 1973.
R. M. Sapolsky. Testicular function, social rank and personality among wild ba-
boons. Psychoneuroendocrinology, 16(4):281–293, 1991.
A. Sato, Y. Sato, and S. Uchida. Regulation of regional cerebral blood flow by cholin-
ergic fibers originating in the basal forebrain. Int J Dev Neurosci, 19(3):327–337,
2001.
O. Schoots and H. H. M. Van Tol. The human dopamine d4 receptor repeat se-
quences modulate expression. Pharmacogenomics J, 3(6):343–348, 2003.
D. Schultheiss and C. G. Stief. Highlighting 70 years of testosterone substitution.
Eur Urol, 4(6):1–3, 2005.
O. C. Schultheiss, K. L. Campbell, and D. C. McClelland. Implicit power motivation
moderates men’s testosterone responses to imagined and real dominance success.
Horm Behav, 36(3):234–241, 1999.
W. Schultz, P. Dayan, and P. R. Montague. A neural substrate of prediction and
reward. Science, 275(5306):1593–1599, 1997.
BIBLIOGRAPHY 143
P. Schwenkmezger, V. Hodapp, and C. D. Spielberger. Das State-Trait-
Aergerausdruck-Inventar STAXI [The State-Trait Anger Expression Inventory
(STAXI)]. Verlag Hans Huber, Bern, 1992.
P. Seeman, H. C. Guan, H. H. Van Tol, and H. B. Niznik. Low density of dopamine
d4 receptors in parkinson’s, schizophrenia, and control brain striata. Synapse, 14
(4):247–253, 1993.
J. G. Sellers, M. R. Mehl, and R. A. Josephs. Hormones and personality: Testos-
terone as a marker of individual differences. J Res Pers, 41(1):126–138, 2007.
S. Sen, R. M. Nesse, S. F. Stoltenberg, S. Li, L. Gleiberman, A. Chakravarti, A. B.
Weder, and M. Burmeister. A bdnf coding variant is associated with the neo per-
sonality inventory domain neuroticism, a risk factor for depression. Neuropsy-
chopharmacology, 28(2):397–401, 2003.
H. R. Siebner and J. Rothwell. Transcranial magnetic stimulation: new insights
into representational cortical plasticity. Exp Brain Res, 148(1):1–16, 2003.
T. Simoncini and A. R. Genazzani. Non-genomic actions of sex steroid hormones.
Eur J Endocrinol, 148(3):281–292, 2003.
P. Slovic. Risk-taking in children - age and sex differences. Child Dev, 37(1):169–
175, 1966.
M. H. Sohn, S. Ursu, J. R. Anderson, V. A. Stenger, and C. S. Carter. Inaugural ar-
ticle: the role of prefrontal cortex and posterior parietal cortex in task switching.
Proc Natl Acad Sci U S A, 97(24):13448–13453, 2000.
S. M. Specker, G. A. Carlson, G. A. Christenson, and M. Marcotte. Impulse con-
trol disorders and attention deficit disorder in pathological gamblers. Ann Clin
Psychiatry, 7(4):175–179, 1995.
A. M. Speer, M. W. Willis, P. Herscovitch, M. Daube-Witherspoon, J. R. Shelton,
B. E. Benson, R. M. Post, and E. M. Wassermann. Intensity-dependent re-
gional cerebral blood flow during 1-hz repetitive transcranial magnetic stimu-
lation (rtms) in healthy volunteers studied with h215o positron emission tomog-
raphy: I. effects of primary motor cortex rtms. Biol Psychiatry, 54(8):818–825,
2003.
Z. Steel and A. Blaszczynski. Impulsivity, personality disorders and pathological
gambling severity. Addiction, 93(6):895–905, 1998.
144 BIBLIOGRAPHY
R. Steyer, P. Schwenkmezger, P. Notz, and M. Eid. Der Mehrdimension-
ale Befindlichkeitsfragebogen (MDBF) [Multidimensional Mood State Question-
naire]. Hogrefe, Gttingen, 1997.
C. A. Stuenkel, R. E. Dudley, and S. S. Yen. Sublingual administration
of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates
episodic androgen release in hypogonadal men. J Clin Endocrinol Metab, 72
(5):1054–1009, 1991.
A. L. Svingos, S. Periasamy, and V. M. Pickel. Presynaptic dopamine d(4) receptor
localization in the rat nucleus accumbens shell. Synapse, 36(3):222–232, 2000.
R. Swainson, R. D. Rogers, B. J. Sahakian, B. A. Summers, C. E. Polkey, and T. W.
Robbins. Probabilistic learning and reversal deficits in patients with parkinson’s
disease or frontal or temporal lobe lesions: possible adverse effects of dopaminer-
gic medication. Neuropsychologia, 38(5):596–612, 2000.
J. M. Swanson, M. Kinsbourne, J. Nigg, B. Lanphear, G. A. Stefanatos, N. Volkow,
E. Taylor, B. J. Casey, F. X. Castellanos, and P. D. Wadhwa. Etiologic subtypes
of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and
environmental factors and the dopamine hypothesis. Neuropsychol Rev, 17(1):
39–59, 2007.
T. Takahashi, M. Bergstroem, P. Fraendberg, E.-L. Vesstroem, Y. Watanabe, and
B. Langstroem. Imaging of aromatase distribution in rat and rhesus monkey
brains with [11c]vorozole. Nucl Med Biol, 33(5):599–605, 2006.
J. P. Tangney, R. F. Baumeister, and A. L. Boone. High self-control predicts good
adjustment, less pathology, better grades, and interpersonal success. J Pers, 72
(2):271–324, 2004.
G. W. Thickbroom. Transcranial magnetic stimulation and synaptic plasticity: ex-
perimental framework and human models. Exp Brain Res, 180(4):583–93, 2007.
A. J. Tilbrook, A. I. Turner, and I. J. Clarke. Effects of stress on reproduction in non-
rodent mammals: the role of glucocorticoids and sex differences. Rev Reprod, 5
(2):105–113, 2000.
A. Tuiten, J. Van Honk, H. Koppeschaar, C. Bernaards, J. Thijssen, and R. Verbaten.
Time course of effects of testosterone administration on sexual arousal in women.
Arch Gen Psychiatry, 57(2):149–153, 2000.
BIBLIOGRAPHY 145
A. Tuiten, J. van Honk, R. Verbaten, E. Laan, W. Everaerd, and H. Stam. Can sub-
lingual testosterone increase subjective and physiological measures of laboratory-
induced sexual arousal? Arch Gen Psychiatry, 59(5):465–466, 2002.
S. Uchida, F. Kagitani, H. Nakayama, and A. Sato. Effect of stimulation of nicotinic
cholinergic receptors on cortical cerebral blood flow and changes in the effect dur-
ing aging in anesthetized rats. Neurosci Lett, 228(3):203–206, 1997.
J. R. Udry and L. M. Talbert. Sex-hormone effects on personality at puberty. J Pers
Soc Psychol, 54(2):291–295, 1988.
J. R. Udry, N. M. Morris, and J. Kovenock. Androgen effects on women’s gendered
behaviour. J Biosoc Sci, 27(3):359–368, 1995.
K. van Craenenbroeck, S. D. Clark, M. J. Cox, J. N. Oak, F. Liu, and H. H. M.
Van Tol. Folding efficiency is rate-limiting in dopamine d4 receptor biogenesis. J
Biol Chem, 280(19):19350–19357, 2005.
J. van Honk and D. J. Schutter. Testosterone reduces conscious detection of signals
serving social correction: implications for antisocial behavior. Psychol Sci, 18(8):
663–667, 2007.
J. van Honk, A. Tuiten, R. Verbaten, M. van den Hout, H. Koppeschaar, J. Thijssen,
and E. de Haan. Correlations among salivary testosterone, mood, and selective
attention to threat in humans. Horm Behav, 36(1):17–24, 1999.
J. van Honk, A. Tuiten, E. Hermans, P. Putman, H. Koppeschaar, J. Thijssen,
R. Verbaten, and L. van Doornen. A single administration of testosterone induces
cardiac accelerative responses to angry faces in healthy young women. Behav
Neurosci, 115(1):238–242, 2001.
J. van Honk, D. J. Schutter, E. J. Hermans, P. Putman, A. Tuiten, and
H. Koppeschaar. Testosterone shifts the balance between sensitivity for pun-
ishment and reward in healthy young women. Psychoneuroendocrinology, 29(7):
937–943, 2004.
J. van Honk, J. S. Peper, and D. J. Schutter. Testosterone reduces unconscious fear
but not consciously experienced anxiety: implications for the disorders of fear and
anxiety. Biol Psychiatry, 58(3):218–225, 2005.
146 BIBLIOGRAPHY
H. H. M. van Tol, C. M. Wu, H. C. Guan, K. Ohara, J. R. Bunzow, O. Civelli,
J. Kennedy, P. Seeman, H. B. Niznik, and V. Jovanovic. Multiple dopamine-d4
receptor variants in the human-population. Nature, 358(6382):149–152, 1992.
A. Verdejo-Garcia, A. J. Lawrence, and L. Clark. Impulsivity as a vulnerability
marker for substance-use disorders: Review of findings from high-risk research,
problem gamblers and genetic association studies. Neurosci Biobehav Rev, 32(4):
777–810, 2008.
V. Viau. Functional cross-talk between the hypothalamic-pituitary-gonadal and -
adrenal axes. J Neuroendocrinol, 14(6):506–513, 2002.
S. Vijayraghavan, M. Wang, S. G. Birnbaum, G. V. Williams, and A. F. T. Arnsten.
Inverted-u dopamine d1 receptor actions on prefrontal neurons engaged in work-
ing memory. Nat Neurosci, 10(3):376–384, 2007.
D. Voet, J. G. Voet, A. Maelicke, and W. Mueller-Esterl. Biochemie. VCH Verlagsge-
sellschaft, Weinheim, 1992.
V. Voon, M. N. Potenza, and T. Thomsen. Medication-related impulse control and
repetitive behaviors in parkinson’s disease. Curr Opin Neurol, 20(4):484–492,
2007a.
V. Voon, T. Thomsen, J. M. Miyasaki, M. de Souza, A. Shafro, S. H. Fox, S. Duff-
Canning, A. E. Lang, and M. Zurowski. Factors associated with dopaminergic
drug-related pathological gambling in parkinson disease. Arch Neurol, 64(2):212–
216, 2007b.
C. K. Wagner and J. I. Morrell. Neuroanatomical distribution of aromatase mrna
in the rat brain: indications of regional regulation. J Steroid Biochem Mol Biol,
61(3-6):307–314, 1997.
V. Walsh and A. Cowey. Transcranial magnetic stimulation and cognitive neuro-
science. Nat Rev Neurosci, 1(1):73–79, 2000.
V. Walsh and M. Rushworth. A primer of magnetic stimulation as a tool for neu-
ropsychology. Neuropsychologia, 37(2):125–135, 1999.
C. Wang, D. H. Catlin, L. M. Demers, B. Starcevic, and R. S. Swerdloff. Measure-
ment of total serum testosterone in adult men: Comparison of current laboratory
methods versus liquid chromatography-tandem mass spectrometry. J Clin En-
docrinol Metab, 89(2):534–543, 2004.
X. Wang, P. Zhong, and Z. Yan. Dopamine d-4 receptors modulate gabaergic sig-
naling in pyramidal neurons of prefrontal cortex. J Neurosci, 22(21):9185–9193,
2002.
E. M. Wassermann, F. R. Wedegaertner, U. Ziemann, M. S. George, and R. Chen.
Crossed reduction of human motor cortex excitability by 1-hz transcranial mag-
netic stimulation. Neurosci Lett, 250(3):141–144, 1998.
C. Wedemeyer, J. D. Goutman, M. E. Avale, L. F. Franchini, M. Rubinstein, and
D. J. Calvo. Functional activation by central monoamines of human dopamine
d-4 receptor polymorphic variants coupled to girk channels in xenopus oocytes.
Eur J Pharmacol, 562(3):165–173, 2007.
G. Weinbauer, J. Gromoll, M. Simoni, and E. Nieschlag. Physiologie der Hodenfunk-
tion. Andrologie. Thieme Verlag, 2000.
P. Werner, N. Hussy, G. Buell, K. A. Jones, and R. A. North. D2, d3, and d4 dopamine
receptors couple to g protein-regulated potassium channels in xenopus oocytes.
Mol Pharmacol, 49(4):656–661, 1996.
G. V. Williams and P. S. Goldmanrakic. Modulation of memory fields by dopamine
d1 receptors in prefrontal cortex. Nature, 376(6541):572–575, 1995.
J. C. Wingfield, R. E. Hegner, A. M. Dufty, and G. F. Ball. The challenge hypothesis
- theoretical implications for patterns of testosterone secretion, mating systems,
and breeding strategies. Am Nat, 136(6):829–846, 1990.
A. H. Wong, C. E. Buckle, and H. H. Van Tol. Polymorphisms in dopamine receptors:
what do they tell us? Eur J Pharmacol, 410(2-3):183–203, 2000.
M. Wong and R. L. Moss. Electrophysiological evidence for a rapid membrane action
of the gonadal steroid, 17 beta-estradiol, on ca1 pyramidal neurons of the rat
hippocampus. Brain Res, 543(1):148–152, 1991.
M. J. Zigmond, F. E. Bloom, S. C. Landis, J. L. Roberts, and L. R. Squire. Funda-
mental neuroscience. Academic Press, San Diego, California, 1999.
